Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 882 articles:
HTML format



Single Articles


    July 2021
  1. YU W, Buhari Y, Wang S, Tian X, et al
    Sterilizing Effects of Novel Regimens Containing TB47, Clofazimine and Linezolid in a Murine Model of Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0070621. doi: 10.1128/AAC.00706.
    PubMed     Abstract available


  2. VAN SCHIE L, Borgers K, Michielsen G, Plets E, et al
    Exploration of synergistic action of cell wall-degrading enzymes against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0065921. doi: 10.1128/AAC.00659.
    PubMed     Abstract available


  3. HANDELMAN M, Morogovsky A, Liu W, Ben-Ami R, et al
    Triazole resistant Aspergillus fumigatus in an Israeli patient with Chronic Cavitary Pulmonary Aspergillosis due to a novel E306K Substitution in Hmg1.
    Antimicrob Agents Chemother. 2021 Jul 19:AAC0108921. doi: 10.1128/AAC.01089.
    PubMed     Abstract available


  4. GOMIS-FONT MA, Pitart C, Del Barrio-Tofino E, Zboromyrska Y, et al
    Emergence of Resistance to Novel Cephalosporin-beta-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.
    Antimicrob Agents Chemother. 2021;65:e0008921.
    PubMed     Abstract available


  5. SERRANO-LOBO J, Gomez A, Rodriguez-Sanchez B, Munoz P, et al
    Azole resistant Aspergillus fumigatus clinical isolate screening in azole-containing agar plates (EUCAST E.Def 10.1): low impact of plastic trays used and poor performance in cryptic species.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0048221. doi: 10.1128/AAC.00482.
    PubMed     Abstract available


  6. ERNEST JP, Sarathy J, Wang N, Kaya F, et al
    Lesion penetration and activity limit the utility of second-line injectable agents in pulmonary tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0050621. doi: 10.1128/AAC.00506.
    PubMed     Abstract available


  7. CANAS MA, Tellez A, de la Maria CG, Dahl A, et al
    Development of high level daptomycin resistance (HLDR) in Abiotrophia and Granulicatella spp isolates from patients with infective endocarditis (IE).
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0252220. doi: 10.1128/AAC.02522.
    PubMed     Abstract available


  8. GEWITZ AD, Solans BP, Mac Kenzie WR, Heilig C, et al
    A Longitudinal Model-Based Biomarker Analysis of Exposure Response in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0179420. doi: 10.1128/AAC.01794.
    PubMed     Abstract available


  9. POUVARET A, Dureault A, Garcia-Hermoso D, Serris A, et al
    Combined high dose caspofungin and liposomal amphotericin B for the treatment of azole-resistant cerebral aspergillosis.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0047421. doi: 10.1128/AAC.00474.
    PubMed     Abstract available


  10. BIGGEL M, Nuesch-Inderbinen M, Jans C, Stevens MJA, et al
    Genetic context of optrA and poxtA in florfenicol-resistant enterococci isolated from flowing surface water in Switzerland.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0108321. doi: 10.1128/AAC.01083.
    PubMed     Abstract available


  11. BRENNAN-KROHN T, Friar L, Ditelberg S, Kirby JE, et al
    Evaluation of the Synergistic Activity of Antibacterial and Antifungal Drugs against Candida auris using an Inkjet Printer-Assisted Method.
    Antimicrob Agents Chemother. 2021 Jul 12:AAC0026821. doi: 10.1128/AAC.00268.
    PubMed     Abstract available


  12. WESTGEEST AC, Schippers EF, Delfos NM, Ellerbroek LJ, et al
    Complicated carriage with methicillin-resistant Staphylococcus aureus (MRSA): evaluation of the effectiveness of decolonization regimens advised in the Dutch national guideline.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0025721. doi: 10.1128/AAC.00257.
    PubMed     Abstract available


  13. GAMAL A, Long L, Herrada J, Aram J, et al
    Efficacy of Voriconazole, Isavuconazole, Fluconazole, and Anidulafungin in the treatment of emerging Candida auris using an immunocompromised murine model of disseminated candidiasis.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0054921. doi: 10.1128/AAC.00549.
    PubMed     Abstract available


  14. EGBELOWO O, Sarathy JP, Gausi K, Zimmerman MD, et al
    Pharmacokinetics and target attainment of SQ109 in plasma and human-like tuberculosis lesions in rabbits.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0002421. doi: 10.1128/AAC.00024.
    PubMed     Abstract available


  15. SWIFT SM, Sauve K, Cassino C, Schuch R, et al
    Exebacase is Active In Vitro in Pulmonary Surfactant and is Efficacious Alone and Synergistic with Daptomycin in a Mouse Model of Lethal Staphylococcus aureus Lung Infection.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0272320. doi: 10.1128/AAC.02723.
    PubMed     Abstract available


  16. MAPHANGA TG, Naicker SD, Kwenda S, Munoz JF, et al
    In-vitro antifungal resistance of Candida auris isolates from bloodstream infections, South Africa.
    Antimicrob Agents Chemother. 2021 Jul 6:AAC0051721. doi: 10.1128/AAC.00517.
    PubMed     Abstract available


    June 2021
  17. WERNGREN J, Mansjo M, Glader M, Hoffner S, et al
    Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 28:AAC0072021. doi: 10.1128/AAC.00720.
    PubMed     Abstract available


  18. GONZALEZ-JIMENEZ I, Garcia-Rubio R, Monzon S, Lucio J, et al
    Multi-resistance to non-azole fungicides in Aspergillus fumigatus TR34/L98H azole resistant isolates.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0064221. doi: 10.1128/AAC.00642.
    PubMed     Abstract available


  19. KOHLHOFF S, Hammerschlag MR
    In Vitro Activity of Nafithromycin (WCK 4873) against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0058521. doi: 10.1128/AAC.00585.
    PubMed     Abstract available


  20. ZENG S, Zhang J, Sun M, Zhang X, et al
    Nitric oxide-dependent electron transport chain inhibition by the cytochrome bc1 inhibitor and pretomanid combination kills Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0095621. doi: 10.1128/AAC.00956.
    PubMed     Abstract available


  21. CAMERON A, Mangat R, Mostafa HH, Taffner S, et al
    Detection of CTX-M-27 beta-Lactamase Genes on Two Distinct Plasmid Types in ST38 Escherichia coli from Three U.S. States.
    Antimicrob Agents Chemother. 2021;65:e0082521.
    PubMed     Abstract available


  22. PLAUNT AJ, Rose SJ, Kang JY, Chen KJ, et al
    Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.
    Antimicrob Agents Chemother. 2021;65:e0031621.
    PubMed     Abstract available


  23. RHODES NJ, Jozefczyk CC, Moore WJ, Yarnold PR, et al
    Characterizing Risk Factors for Clostridioides difficile Infection among Hospitalized Patients with Community-Acquired Pneumonia.
    Antimicrob Agents Chemother. 2021;65:e0041721.
    PubMed     Abstract available


  24. GUPTILL JT, Raja SM, Juel VC, Walter EB, et al
    Safety, Tolerability, and Pharmacokinetics of NTM-1632, a Novel Mixture of Three Monoclonal Antibodies against Botulinum Toxin B.
    Antimicrob Agents Chemother. 2021;65:e0232920.
    PubMed     Abstract available


  25. LIZZA BD, Betthauser KD, Ritchie DJ, Micek ST, et al
    New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65:e0231820.
    PubMed     Abstract available


  26. BROWN ELLIOTT BA, Wallace RJ Jr
    Comparison of In Vitro Susceptibility of Delafloxacin with Ciprofloxacin, Moxifloxacin, and Other Comparator Antimicrobials against Isolates of Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2021;65:e0007921.
    PubMed     Abstract available


  27. SINGH KV, Arias CA, Murray BE
    Efficacy of Omadacycline Against Multiresistant Enterococcus faecium Strains in a Mouse Peritonitis Model.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0070921. doi: 10.1128/AAC.00709.
    PubMed     Abstract available


  28. CHIN D, Goncheva MI, Flannagan RS, Heinrichs DE, et al
    Mutations in a membrane permease or hpt lead to 6-thioguanine resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0076021. doi: 10.1128/AAC.00760.
    PubMed     Abstract available


  29. GUTHRIDGE I, Smith S, Law M, Binotto E, et al
    The efficacy and safety of intravenous lincosamide therapy in methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0034321. doi: 10.1128/AAC.00343.
    PubMed     Abstract available


  30. TOYOTOME T, Onishi K, Sato M, Kusuya Y, et al
    Identification of novel mutations contributing to azole tolerance of Aspergillus fumigatus through in vitro exposure to tebuconazole.
    Antimicrob Agents Chemother. 2021 Jun 14:AAC0265720. doi: 10.1128/AAC.02657.
    PubMed     Abstract available


  31. SHETYE GS, Choi KB, Kim CY, Franzblau SG, et al
    In Vitro Profiling of Anti-tubercular Compounds by Rapid, Efficient, and Non-Destructive Assays Using Auto-luminescent Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0028221. doi: 10.1128/AAC.00282.
    PubMed     Abstract available


  32. HUANG DB, Gaukel E, Kerzee N, Borroto-Esoda K, et al
    Efficacy of Anti-Staphylococcal Lysin, LSVT-1701, in Combination with Daptomycin in Experimental Left-Sided Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0050821. doi: 10.1128/AAC.00508.
    PubMed     Abstract available


  33. SHIBATA M, Masuda M, Sasahara K, Sasabe H, et al
    Prediction of Human Pharmacokinetic Profiles of the Anti-tuberculosis Drug Delamanid from Nonclinical Data: Potential Therapeutic Value Against Extrapulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0257120. doi: 10.1128/AAC.02571.
    PubMed     Abstract available


  34. BACCANI I, Antonelli A, Di Pilato V, Coppi M, et al
    Detection of poxtA2, a presumptive poxtA ancestor, in a plasmid from a linezolid-resistant Enterococcus gallinarum.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0069521. doi: 10.1128/AAC.00695.
    PubMed     Abstract available


  35. LEW C, Mishra NN, Bayer AS, Rose WE, et al
    beta-lactam-induced cell envelope adaptations, not solely enhanced daptomycin binding, underlies daptomycin-beta-lactam synergy in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2021 Jun 7:AAC0035621. doi: 10.1128/AAC.00356.
    PubMed     Abstract available


  36. ZAINABADI K, Walsh KF, Vilbrun SC, Mathurin LD, et al
    Characterization of differentially detectable Mycobacterium tuberculosis in the sputum of subjects with drug sensitive or drug resistant tuberculosis before and after two months of therapy.
    Antimicrob Agents Chemother. 2021 Jun 1:AAC0060821. doi: 10.1128/AAC.00608.
    PubMed     Abstract available


    May 2021
  37. MIRANDA-CADENA K, Dias M, Costa-Barbosa A, Collins T, et al
    Erratum for Miranda-Cadena et al., "Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral, or Thymol with Anti-Candida Activities".
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  38. HERRERA-HIDALGO L, de Alarcon A, Lopez-Cortes LE, Luque-Marquez R, et al
    Erratum for Herrera-Hidalgo et al., "Is Once-Daily High-Dose Ceftriaxone plus Ampicillin an Alternative for Enterococcus faecalis Infective Endocarditis in Outpatient Parenteral Antibiotic Therapy Programs?"
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  39. VAN DAELE R, Debaveye Y, Lagrou K, Spriet I, et al
    Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  40. MARTSON AG, Boonstra JM, Sandaradura I, Kosterink JGW, et al
    Reply to Van Daele et al., "Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?"
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  41. QIN S, Peng J, Deng R, Peng K, et al
    Identification of Two Plasmids Coharboring Carbapenemase Genes and tmexCD1-toprJ1 in Clinical Klebsiella pneumoniae ST2667.
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  42. RUBIO AM, Kline EG, Jones CE, Chen L, et al
    In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  43. LIU L, Zhou X, Li B, Cheng F, et al
    In Vitro and In Vivo Activities, Absorption, Tissue Distribution, and Excretion of OBP-4, a Potential Anti-Clostridioides difficile Agent.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  44. SOLIMAN AM, Ramadan H, Zarad H, Sugawara Y, et al
    Coproduction of Tet(X7) Conferring High-Level Tigecycline Resistance, Fosfomycin FosA4, and Colistin Mcr-1.1 in Escherichia coli Strains from Chickens in Egypt.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  45. FAHEEM M, Zhang CJ, Morris MN, Pleiss J, et al
    Role of Synonymous Mutations in the Evolution of TEM beta-Lactamase Genes.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  46. LOMOVSKAYA O, Rubio-Aparicio D, Nelson K, Sun D, et al
    In Vitro Activity of the Ultrabroad-Spectrum Beta-Lactamase Inhibitor QPX7728 in Combination with Multiple Beta-Lactam Antibiotics against Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  47. KOVANDA LL, Sass G, Martinez M, Clemons KV, et al
    Efficacy and Associated Drug Exposures of Isavuconazole and Fluconazole in an Experimental Model of Coccidioidomycosis.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  48. HUANG HY, Wang CF, Lu PL, Tseng SP, et al
    Clinical Impact of the Revised 2019 CLSI Levofloxacin Breakpoints in Patients with Enterobacterales Bacteremia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  49. BARNES KB, Richards MI, Laws TR, Nunez A, et al
    Finafloxacin Is an Effective Treatment for Inhalational Tularemia and Plague in Mouse Models of Infection.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  50. BABOWICZ F, LaPlante R, Mitchell C, O'Donnell JN, et al
    Impact of Accelerate Pheno and BacT/Alert Virtuo on Clinical Processes and Outcomes in Patients with Sepsis and Concurrent Gram-Negative Bacteremia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  51. JIN L, Wang R, Gao H, Wang Q, et al
    Identification of a Novel Hybrid Plasmid Encoding KPC-2 and Virulence Factors in Klebsiella pneumoniae Sequence Type 11.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  52. LOS-ARCOS I, Berastegui C, Martin-Gomez MT, Grau S, et al
    Nebulized Micafungin Treatment for Scopulariopsis/Microascus Tracheobronchitis in Lung Transplant Recipients.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  53. MADRID-MORALES J, Sharma A, Reveles K, Velez-Mejia C, et al
    Validation of Available Extended-Spectrum-Beta-Lactamase Clinical Scoring Models in Predicting Drug Resistance in Patients with Enteric Gram-Negative Bacteremia Treated at South Texas Veterans Health Care System.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  54. SOBEL JD, Borroto-Esoda K, Azie N, Angulo D, et al
    In Vitro pH Activity of Ibrexafungerp Against Fluconazole-susceptible and -resistant Candida Isolates from Women with Vulvovaginal Candidiasis.
    Antimicrob Agents Chemother. 2021 May 17. pii: AAC.00562.
    PubMed     Abstract available


  55. JOHANSEN MD, Shalini, Kumar S, Raynaud C, et al
    Biological and biochemical evaluation of isatin-isoniazid hybrids as bactericidal candidates against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00011.
    PubMed     Abstract available


  56. WASSERMAN S, Davis A, Stek C, Chirehwa M, et al
    Plasma pharmacokinetics of high dose oral versus intravenous rifampicin in patients with tuberculous meningitis: a randomized controlled trial.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.00140.
    PubMed     Abstract available


  57. FREDERICKS LR, Lee MD, Eckert HR, Li S, et al
    Vaginal Isolates of Candida glabrata are Uniquely Susceptible to Ionophoric Killer Toxins Produced by Saccharomyces cerevisiae.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02450.
    PubMed     Abstract available


  58. MOK S, Roycroft E, Flanagan PR, Montgomery L, et al
    Overcoming the Challenges of Pyrazinamide Susceptibility Testing in Clinical Mycobacterium tuberculosis isolates.
    Antimicrob Agents Chemother. 2021 May 10. pii: AAC.02617.
    PubMed     Abstract available


  59. LAWAL OU, Fraqueza MJ, Worning P, Bouchami O, et al
    Staphylococcus saprophyticus causing infections in humans are associated with high resistance to heavy metals.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.02685.
    PubMed     Abstract available


  60. LIANG T, Yang X, Li R, Yang E, et al
    Emergence of W272C Substitution in Hmg1 in a Triazole-Resistant Isolate of Aspergillus fumigatus from a Chinese Patient with Chronic Cavitary Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.00263.
    PubMed     Abstract available


  61. JANICE J, Agyepong N, Owusu-Ofori A, Govinden U, et al
    Carbapenem-resistance determinants acquired through novel chromosomal integrations in XDR Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021 May 3. pii: AAC.00289.
    PubMed     Abstract available


    April 2021
  62. MAO Y, Valour F, Nguyen NTQ, Doan TMN, et al
    Multi-mechanistic Monoclonal Antibody Combination Targeting Key Staphylococcus aureus Virulence Determinants in a Rabbit Model of Prosthetic Joint Infection.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.01832.
    PubMed     Abstract available


  63. SONNENKALB L, Strohe G, Dreyer V, Andres S, et al
    Microevolution of Mycobacterium tuberculosis hetero-resistance subpopulations in a patient receiving 27 years of tuberculosis treatment in Germany.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02520.
    PubMed     Abstract available


  64. TASNEEN R, Mortensen DS, Converse PJ, Urbanowski ME, et al
    Dual mTORC1/mTORC2 inhibition as a Host-Directed Therapeutic Target in Pathologically Distinct Mouse Models of Tuberculosis.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.00253.
    PubMed     Abstract available


  65. LEY SD, Pillay S, Streicher EM, van der Heijden YF, et al
    Melting the Eis: non-detection of kanamycin resistance markers by routine diagnostic tests and identification of new eis-promoter variants.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02502.
    PubMed     Abstract available


  66. KIM DH, Kim SY, Koh WJ, Jhun BW, et al
    In Vitro Activity of Oxazolidinone against Nontuberculous Mycobacteria, Including Macrolide-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2021 Apr 26. pii: AAC.02306.
    PubMed     Abstract available


  67. YAO D, Zhang G, Chen W, Chen J, et al
    Pyrogallol and Fluconazole Interact Synergistically In Vitro Against Candida glabrata Through an Efflux-Associated Mechanism.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.00100.
    PubMed     Abstract available


  68. ABDELWAHAB MT, Court R, Everitt D, Diacon AH, et al
    The effect of Clofazimine Concentration on QT prolongation in patients treated for tuberculosis.
    Antimicrob Agents Chemother. 2021 Apr 19. pii: AAC.02687.
    PubMed     Abstract available


  69. LIN WH, Lee WT, Tsai HY, Jou R, et al
    Disputed rpoB mutations in Mycobacterium tuberculosis and tuberculosis treatment outcomes.
    Antimicrob Agents Chemother. 2021 Apr 12. pii: AAC.01573.
    PubMed     Abstract available


  70. HERRADA J, Gamal A, Long L, Sanchez SP, et al
    In Vitro and In Vivo Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris.
    Antimicrob Agents Chemother. 2021 Apr 12. pii: AAC.00306.
    PubMed     Abstract available


  71. POULSEN JS, Madsen AM, White JK, Nielsen JL, et al
    Physiological responses of Aspergillus niger challenged with itraconazole.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02549.
    PubMed     Abstract available


  72. OKOLIEGBE IN, Hijazi K, Cooper K, Ironside C, et al
    Trends of antimicrobial resistance and combination susceptibility testing of cystic fibrosis multidrug-resistant Pseudomonas aeruginosa: A ten-year update.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02483.
    PubMed     Abstract available


    March 2021
  73. STEWART AG, Price EP, Schabacker K, Birikmen M, et al
    Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.00130.
    PubMed     Abstract available


  74. WIEDERHOLD NP, Najvar LK, Olivo M, Morris KN, et al
    Ibrexafungerp Demonstrates in vitro Activity against Fluconazole-Resistant Candida auris and in vivo Efficacy with Delayed Initiation of Therapy in an Experimental Model of Invasive Candidiasis.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.02694.
    PubMed     Abstract available


  75. ORTIZ DE LA ROSA JM, Nordmann P, Poirel L
    Antioxidant molecules as a source of mitigation of antibiotic resistance genes dissemination.
    Antimicrob Agents Chemother. 2021 Mar 22. pii: AAC.02658.
    PubMed     Abstract available


  76. MAY M, Chang M, Dietz D, Shoucri S, et al
    Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  77. AURITI C, Goffredo BM, Ronchetti MP, Piersigilli F, et al
    High-Dose Micafungin in Neonates and Young Infants with Invasive Candidiasis: Results of a Phase 2 Study.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  78. MASUKO A, Takata I, Fujita K, Okumura H, et al
    In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  79. BOOT W, Schmid T, D'Este M, Guillaume O, et al
    A Hyaluronic Acid Hydrogel Loaded with Gentamicin and Vancomycin Successfully Eradicates Chronic Methicillin-Resistant Staphylococcus aureus Orthopedic Infection in a Sheep Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  80. NAKAMURA R, Oota M, Matsumoto S, Sato T, et al
    In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  81. URBANOWICZ P, Bitar I, Izdebski R, Baraniak A, et al
    Epidemic Territorial Spread of IncP-2-Type VIM-2 Carbapenemase-Encoding Megaplasmids in Nosocomial Pseudomonas aeruginosa Populations.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  82. OKA D, Yamaya N, Kuno T, Asakawa Y, et al
    In Vitro and In Vivo Antibacterial Activities of a Novel Quinolone Compound, OPS-2071, against Clostridioides difficile.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  83. ABUTALEB NS, Elkashif A, Flaherty DP, Seleem MN, et al
    In Vivo Antibacterial Activity of Acetazolamide.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  84. OUESLATI S, Emeraud C, Grosperrin V, Levy M, et al
    Polyclonal Dissemination of NDM-1- and NDM-9-Producing Escherichia coli and Klebsiella pneumoniae in French Polynesia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  85. DIAZ-GARCIA J, Mesquida A, Sanchez-Carrillo C, Reigadas E, et al
    Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  86. POILVACHE H, Ruiz-Sorribas A, Cornu O, Van Bambeke F, et al
    In Vitro Study of the Synergistic Effect of an Enzyme Cocktail and Antibiotics against Biofilms in a Prosthetic Joint Infection Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  87. PENNINGS LJ, Ruth MM, Wertheim HFL, van Ingen J, et al
    The Benzimidazole SPR719 Shows Promising Concentration-Dependent Activity and Synergy against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  88. LEE A, Wang N, Carter CL, Zimmerman M, et al
    Therapeutic Potential of Fosmanogepix (APX001) for Intra-abdominal Candidiasis: from Lesion Penetration to Efficacy in a Mouse Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  89. CHENG J, Yan J, Reyna Z, Slarve M, et al
    Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  90. XIANG R, Li M
    Identification of Tn6835 and a Novel Genomic Island, MMGI-1, in a Pan-Resistant Morganella morganii Strain.
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  91. MAZZANTINI D, Celandroni F, Calvigioni M, Lupetti A, et al
    In Vitro Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrum.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  92. ARDIZZONI E, Ariza E, Mulengwa D, Mpala Q, et al
    Thin layer agar-based direct phenotypic drug-susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance, otherwise missed by WHO endorsed diagnostic tests.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02263.
    PubMed     Abstract available


  93. MODLIN SJ, Marbach T, Werngren J, Mansjo M, et al
    Atypical Genetic Basis of Pyrazinamide Resistance in Mono-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.01916.
    PubMed     Abstract available


  94. KARAU MJ, Schmidt-Malan SM, Mandrekar J, Lehoux D, et al
    Activity of Lysin CF-296 Alone and in Addition to Daptomycin in a Rat Model of Experimental Methicillin-Resistant Staphylococcus aureus Osteomyelitis.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.00117.
    PubMed     Abstract available


  95. SU H, Zhu M, Tsui CK, van der Lee H, et al
    Potency of olorofim (F901318) compared to contemporary antifungal agents against clinical Aspergillus fumigatus isolates, and review of azole resistance phenotype and genotype epidemiology in China.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02546.
    PubMed     Abstract available


  96. CHO HK, Karau MJ, Greenwood-Quaintance KE, Hansford KA, et al
    In Vitro Activity of Vancapticin MCC5145 against Methicillin-Resistant Staphylococcus aureus from Periprosthetic Joint Infection.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.02443.
    PubMed     Abstract available


  97. PEREZ-CANTERO A, Martin-Vicente A, Guarro J, Fortwendel JR, et al
    Analysis of the cyp51 genes contribution to azole resistance in Aspergillus section Nigri with the CRISPR-Cas9 technique.
    Antimicrob Agents Chemother. 2021 Mar 8. pii: AAC.01996.
    PubMed     Abstract available


  98. ERSOY SC, Chambers HF, Proctor RA, Rosato AE, et al
    Impact of Bicarbonate on PBP2a Production, Maturation, and Functionality in Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.02621.
    PubMed     Abstract available


  99. CANFIELD GS, Chatterjee A, Espinosa J, Mangalea MR, et al
    Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium.
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.00143.
    PubMed     Abstract available


  100. COJUTTI PG, Rinaldi M, Zamparini E, Rossi N, et al
    Population pharmacokinetics of dalbavancin and dosing consideration for optimal treatment of adult patients with staphylococcal osteoarticular infections.
    Antimicrob Agents Chemother. 2021 Mar 1. pii: AAC.02260.
    PubMed     Abstract available


    February 2021
  101. OMOLLO C, Singh V, Kigondu E, Wasuna A, et al
    Developing synergistic drug combinations to restore antibiotic sensitivity in drug-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02554.
    PubMed     Abstract available


  102. SHELTON CD, McNeil MB, Early JV, Ioerger TR, et al
    Deletion of Rv2571c confers resistance to arylamide compounds in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02334.
    PubMed     Abstract available


  103. SCHULTHESS B, Schafle D, Kalin N, Widmer T, et al
    Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous mycobacteria.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02131.
    PubMed     Abstract available


  104. VILCHEZE C, Jacobs WR Jr
    The promises and limitations of N-acetylcysteine as a potentiator of first-line and second-line tuberculosis drugs.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.01703.
    PubMed     Abstract available


  105. LI J, Coste AT, Liechti M, Bachmann D, et al
    Novel ERG11 and TAC1b mutations associated with azole resistance in Candida auris.
    Antimicrob Agents Chemother. 2021 Feb 22. pii: AAC.02663.
    PubMed     Abstract available


  106. ARIAS LS, Butcher MC, Short B, McKloud E, et al
    Correction for Arias et al., "Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model".
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  107. SANDARADURA I, Wojciechowski J, Marriott DJE, Day RO, et al
    Model-Optimized Fluconazole Dose Selection for Critically Ill Patients Improves Early Pharmacodynamic Target Attainment without the Need for Therapeutic Drug Monitoring.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  108. AEDO SJ, Tang J, Brynildsen MP
    Metabolites Potentiate Nitrofurans in Nongrowing Escherichia coli.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  109. WAN M, Gao X, Lv L, Cai Z, et al
    IS26 Mediates the Acquisition of Tigecycline Resistance Gene Cluster tmexCD1-toprJ1 by IncHI1B-FIB Plasmids in Klebsiella pneumoniae and Klebsiella quasipneumoniae from Food Market Sewage.
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  110. BOONSTRA JM, Martson AG, Sandaradura I, Kosterink JGW, et al
    Optimization of Fluconazole Dosing for the Prevention and Treatment of Invasive Candidiasis Based on the Pharmacokinetics of Fluconazole in Critically Ill Patients.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  111. POT M, Guyomard-Rabenirina S, Couvin D, Ducat C, et al
    Dissemination of Extended-Spectrum-beta-Lactamase-Producing Enterobacter cloacae Complex from a Hospital to the Nearby Environment in Guadeloupe (French West Indies): ST114 Lineage Coding for a Successful IncHI2/ST1 Plasmid.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  112. PAPP-WALLACE KM, Shapiro AB, Becka SA, Zeiser ET, et al
    In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam-Durlobactam against Pathogenic Burkholderia Species.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  113. FRANCISCO EC, de Almeida Junior JN, Queiroz-Telles F, Aquino VR, et al
    Correlation of Trichosporon asahii Genotypes with Anatomical Sites and Antifungal Susceptibility Profiles: Data Analyses from 284 Isolates Collected in the Last 22 Years across 24 Medical Centers.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  114. LE W, Su X, Lou X, Li X, et al
    Susceptibility Trends of Zoliflodacin against Multidrug-Resistant Neisseria gonorrhoeae Clinical Isolates in Nanjing, China, 2014 to 2018.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  115. SCHAFLE D, Selchow P, Borer B, Meuli M, et al
    Rifabutin Is Inactivated by Mycobacterium abscessus Arr.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  116. KEATING CL, Zuckerman JB, Singh PK, McKevitt M, et al
    Pseudomonas aeruginosa Susceptibility Patterns and Associated Clinical Outcomes in People with Cystic Fibrosis following Approval of Aztreonam Lysine for Inhalation.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  117. BEGANOVIC M, Daffinee KE, Luther MK, LaPlante KL, et al
    Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  118. LUO P, Huang Y, Hang X, Tong Q, et al
    Dihydrotanshinone I Is Effective against Drug-Resistant Helicobacter pylori In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  119. FANG Y, Kirsch JR, Li L, Brooks SA, et al
    Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  120. BROWN-ELLIOTT BA, Wallace RJ Jr
    In Vitro Susceptibility Testing of Omadacycline against Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  121. FEKKAR A, Blaize M, Bougle A, Normand AC, et al
    Hospital outbreak of fluconazole-resistant Candida parapsilosis: arguments for clonal transmission and long-term persistence.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02036.
    PubMed     Abstract available


  122. NUNEZ-OTERO C, Bahnan W, Vielfort K, Silver J, et al
    A 2-pyridone amide inhibitor of transcriptional activity in Chlamydia trachomatis.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.01826.
    PubMed     Abstract available


  123. NONG Y, Taiaroa G, Pasricha S, Guerillot R, et al
    Clinical relevance of topical antibiotic use in co-selecting for multidrug-resistant Staphylococcus aureus: Insights from in vitro and ex vivo models.
    Antimicrob Agents Chemother. 2021 Feb 16. pii: AAC.02048.
    PubMed     Abstract available


  124. GHANNOUM M, Herrada J, McCormick TS, Long L, et al
    A Novel Transdermal Application for Clearing Skin Colonization by Candida auris.
    Antimicrob Agents Chemother. 2021 Feb 8. pii: AAC.02303.
    PubMed     Abstract available


  125. LUN S, Xiao S, Zhang W, Wang S, et al
    Therapeutic potential of coumestan Pks13 inhibitors for tuberculosis.
    Antimicrob Agents Chemother. 2021 Feb 8. pii: AAC.02190.
    PubMed     Abstract available


  126. PIETERMAN ED, van den Berg S, van der Meijden A, Svensson EM, et al
    Higher dosing of rifamycins does not increase activity against M. tuberculosis in the hollow fibre infection model.
    Antimicrob Agents Chemother. 2021 Feb 8. pii: AAC.02255.
    PubMed     Abstract available


  127. XU J, Converse PJ, Upton AM, Mdluli K, et al
    Comparative efficacy of the novel diarylquinoline TBAJ-587 and bedaquiline against a resistant Rv0678 mutant in a mouse model of tuberculosis.
    Antimicrob Agents Chemother. 2021 Feb 1. pii: AAC.02418.
    PubMed     Abstract available


    January 2021
  128. HO VQT, Verboom T, Rong MK, Habjan E, et al
    Heterologous expression of ethA and katG in Mycobacterium marinum enables the rapid identification of new prodrugs active against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.01445.
    PubMed     Abstract available


  129. SIOPI M, Perlin DS, Arendrup MC, Pournaras S, et al
    Comparative pharmacodynamics of echinocandins against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model that correlates with clinical response to caspofungin therapy: Is there a place for dose optimization?
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.01618.
    PubMed     Abstract available


  130. SMITH NM, Ang A, Tan F, Macias K, et al
    Interaction of Staphylococcus aureus and Acinetobacter baumannii during in vitro beta-lactam exposure.
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.02414.
    PubMed     Abstract available


  131. ASEMPA TE, Abdelraouf K, Nicolau DP
    The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models.
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  132. DAS S, Everett M, Zalacain M, Hope W, et al
    Reply to Asempa et al., "The Ongoing Challenge with NDM-Harboring Enterobacteriaceae in Murine Infection Models".
    Antimicrob Agents Chemother. 2021;65.
    PubMed    


  133. MOTA FERNANDES C, Dasilva D, Haranahalli K, McCarthy JB, et al
    The Future of Antifungal Drug Therapy: Novel Compounds and Targets.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  134. FOURNIER D, Carriere R, Bour M, Grisot E, et al
    Mechanisms of Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  135. HE R, Yang Y, Wu Y, Zhong LL, et al
    Characterization of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump in Klebsiella pneumoniae and Klebsiella quasipneumoniae from Patients in China.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  136. DRUSANO GL, Kim S, Almoslem M, Schmidt S, et al
    The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  137. PYBUS CA, Felder-Scott C, Obuekwe V, Greenberg DE, et al
    Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  138. LEE J, Ammerman N, Agarwal A, Naji M, et al
    Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  139. BERNET E, Lebughe M, Vincent AT, Haghdoost MM, et al
    Sodium Tetraphenylborate Displays Selective Bactericidal Activity against Neisseria meningitidis and N. gonorrhoeae and Is Effective at Reducing Bacterial Infection Load.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  140. MOTOS A, Li Bassi G, Pagliara F, Fernandez-Barat L, et al
    Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  141. CAVENEY NA, Serapio-Palacios A, Woodward SE, Bozorgmehr T, et al
    Structural and Cellular Insights into the l,d-Transpeptidase YcbB as a Therapeutic Target in Citrobacter rodentium, Salmonella Typhimurium, and Salmonella Typhi Infections.
    Antimicrob Agents Chemother. 2021;65.
    PubMed     Abstract available


  142. BEREDAKI MI, Arendrup MC, Andes D, Mouton JW, et al
    The Role of New Posaconazole Formulations in the Treatment of Candida albicans Infections:Data from an in Vitro Pharmacokinetic-Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01292.
    PubMed     Abstract available


  143. CHENG YS, Roma JS, Shen M, Fernandes CM, et al
    Identification of Antifungal Compounds against Multidrug Resistant Candida auris Utilizing a High Throughput Drug Repurposing Screen.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01305.
    PubMed     Abstract available


  144. KHAN MZ, Nandicoori VK
    Deletion of PknG abates reactivation of latent Mycobacterium tuberculosis in mice.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02095.
    PubMed     Abstract available


  145. PRATER AG, Mehta HH, Beabout K, Supandy A, et al
    Daptomycin resistance in Enterococcus faecium can be delayed by disruption of the LiaFSR stress response pathway.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01317.
    PubMed     Abstract available


  146. DRUSANO GL, Rogers S, Brown D, Peloquin CA, et al
    Dose-fractionation of moxifloxacin for the treatment of tuberculosis: impact of dosing interval and elimination half-life on microbial kill and resistance suppression.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02533.
    PubMed     Abstract available


  147. MIRANDA-CADENA K, Dias M, Costa-Barbosa A, Collins T, et al
    Development and Characterization of Monoolein-Based Liposomes of Carvacrol, Cinnamaldehyde, Citral or Thymol with anti-Candida Activities.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01628.
    PubMed     Abstract available


  148. YANG X, Ye L, Chan EW, Zhang R, et al
    Characterization of an IncFIB/IncHI1B plasmid encoding efflux pump TMexCD1-TOprJ1 in a clinical tigecycline and carbapenem-resistant Klebsiella pneumoniae strain.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02340.
    PubMed     Abstract available


  149. CHALKER VJ, Sharratt MG, Rees C, Bell OH, et al
    Tetracycline resistance mediated by tet(M) has variable Integrative Conjugative Element composition in Mycoplasma hominis isolated in the United Kingdom from 2005-2015.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.02513.
    PubMed     Abstract available


  150. ZHU H, Fu L, Wang B, Chen X, et al
    Activity of Clofazimine and TBI-166 against Mycobacterium tuberculosis, in different administration intervals in mouse tuberculosis models.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02164.
    PubMed     Abstract available


  151. PFALLER MA, Messer SA, Deshpande LM, Rhomberg PR, et al
    Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterisation of Candida auris Detected in a Surveillance Program.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02031.
    PubMed     Abstract available


  152. CAZER CL, Westblade LF, Simon MS, Magleby R, et al
    Analysis of multidrug resistance in Staphylococcus aureus with a machine learning generated antibiogram.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02132.
    PubMed     Abstract available


  153. DU W, Zhai P, Wang T, Bromley MJ, et al
    The C2H2 Transcription Factor SltA Contributes to Azole Resistance by Coregulating the Expression of the Drug Target Erg11A and the Drug Efflux Pump Mdr1 in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.01839.
    PubMed     Abstract available


    December 2020
  154. PETRAITIENE R, Petraitis V, Maung BBW, Mansbach RS, et al
    Efficacy and Pharmacokinetics of Fosmanogepix (APX001) in the Treatment of Candida Endophthalmitis and Hematogenous Meningoencephalitis in Non-neutropenic Rabbits.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.01795.
    PubMed     Abstract available


  155. VALAFAR SJ
    A Systematic Review of Mutations Associated with Isoniazid Resistance Points to Continuing Evolution and Subsequent Evasion of Molecular Detection, and Potential for Emergence of Multidrug Resistance in Clinical Strains of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02091.
    PubMed     Abstract available


  156. LIN SY, Feng JY, Lee CY, Lin YC, et al
    Completion and adverse drug events of latent tuberculosis infection treatment in patients receiving dialysis: predictors and impacts of different regimens in a prospective cohort study.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.02184.
    PubMed     Abstract available


  157. CAMPIONE E, Gaziano R, Doldo E, Marino D, et al
    Antifungal effect of all-trans retinoic acid against Aspergillus fumigatus in vitro and in a pulmonary aspergillosis in vivo model.
    Antimicrob Agents Chemother. 2020 Dec 23. pii: AAC.01874.
    PubMed     Abstract available


  158. MIESEL L, Cushion MT, Ashbaugh A, Lopez SR, et al
    Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01992.
    PubMed     Abstract available


  159. CHU S, Long L, McCormick TS, Borroto-Esoda K, et al
    A second generation fungerp analog SCY-247, shows potent in vivo activity in a murine model of hematogenously disseminated Candida albicans.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01989.
    PubMed     Abstract available


  160. CHU S, Long L, Sherif R, McCormick TS, et al
    A second generation fungerp analog SCY-247, shows potent in vitro activity against Candida auris and other clinically relevant fungal isolates.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01988.
    PubMed     Abstract available


    November 2020
  161. VIJAY S, Nhung HN, Bao NLH, Thu DDA, et al
    Most-probable number based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical M. tuberculosis isolates.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01439.
    PubMed     Abstract available


  162. ASADZADEH M, Dashti M, Ahmad S, Alfouzan W, et al
    Whole genome and targeted-amplicon sequencing of fluconazole-susceptible and -resistant Candida parapsilosis isolates from Kuwait reveals a previously undescribed N1132D polymorphism in CDR1.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01633.
    PubMed     Abstract available


  163. KAWAGUCHI N, Katsube T, Echols R, Wajima T, et al
    Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol, a Parenteral Siderophore Cephalosporin, in Patients with Pneumonia, Bloodstream Infection/Sepsis, or Complicated Urinary Tract Infection.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01437.
    PubMed     Abstract available


  164. SAITO S, Hayakawa K, Tsuzuki S, Ishikane M, et al
    The Impact of the Clinical Outcomes and Risk Factors of Patients with IMP-Type Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Japan: A Matched Case-Case-Control Study.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01483.
    PubMed     Abstract available


  165. IGNATIUS EH, Abdelwahab MT, Hendricks B, Gupte N, et al
    Pretomanid Pharmacokinetics in the Presence of Rifamycins: interim Results from a Randomized Trial among Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2020 Nov 23. pii: AAC.01196.
    PubMed     Abstract available


  166. FISHER C, Patel R
    Rifampin, Rifapentine, and Rifabutin are Active Against Intracellular Periprosthetic Joint Infection-Associated Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 2020 Nov 16. pii: AAC.01275.
    PubMed     Abstract available


  167. XIONG K, Su C, Sun Q, Lu Y, et al
    Efg1 and Cas5 Orchestrate Cell Wall Damage Response to Caspofungin in Candida albicans.
    Antimicrob Agents Chemother. 2020 Nov 9. pii: AAC.01584.
    PubMed     Abstract available


  168. GASTINE S, Hope W, Hempel G, Petraitiene R, et al
    Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy.
    Antimicrob Agents Chemother. 2020 Nov 9. pii: AAC.01574.
    PubMed     Abstract available


  169. PANJASAWATWONG N, Wattanakul T, Hoglund RM, Bang ND, et al
    Population pharmacokinetic properties of anti-tuberculosis drugs in Vietnamese children with tuberculous meningitis.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00487.
    PubMed     Abstract available


  170. GRZEGORZEWICZ AE, Lelievre J, Esquivias J, Angala B, et al
    Lack of Specificity of Phenotypic Screens for Inhibitors of the Mycobacterium tuberculosis FAS-II System.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01914.
    PubMed     Abstract available


  171. KANE A, Campbell L, Ky D, Hibbs D, et al
    The antifungal and synergistic effect of bisphosphonates in Cryptococcus.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.01753.
    PubMed     Abstract available


  172. PHAM CD, Nash E, Liu H, Schmerer MW, et al
    Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00885.
    PubMed     Abstract available


    October 2020
  173. KRAUSS S, Zipperer A, Wirtz S, Saur J, et al
    Secretion of and self-resistance to the novel fibupeptide antimicrobial lugdunin by distinct ABC transporters in Staphylococcus lugdunensis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01734.
    PubMed     Abstract available


  174. ARUN KB, Madhavan A, Abraham B, Balaji M, et al
    Acetylation of isoniazid - a novel mechanism of isoniazid resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.00456.
    PubMed     Abstract available


  175. WILLBY M, Chopra P, Lemmer D, Klein K, et al
    Molecular evaluation of fluoroquinolone resistance in serial Mycobacterium tuberculosis isolates from individuals diagnosed with multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01663.
    PubMed     Abstract available


  176. MALLIKAARJUN S, Chapagain ML, Sasaki T, Hariguchi N, et al
    Cumulative Fraction of Response for Once- and Twice-Daily Delamanid in Pulmonary Multidrug-Resistant Tuberculosis Patients.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01207.
    PubMed     Abstract available


  177. WANG X, Mallikaarjun S, Gibiansky E
    Population Pharmacokinetic Analysis of Delamanid in Patients with Pulmonary Multi-Drug Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01202.
    PubMed     Abstract available


  178. JAKOBSEN L, Vingsbro Lundberg C, Frimodt-Moller N
    Ciprofloxacin pharmacokinetics/pharmacodynamics (PKPD) against susceptible and low level resistant Escherichia coli in an experimental ascending urinary tract infection model in mice.
    Antimicrob Agents Chemother. 2020 Oct 26. pii: AAC.01804.
    PubMed     Abstract available


  179. BING J, Hu T, Zheng Q, Munoz JF, et al
    Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01466.
    PubMed     Abstract available


  180. NAVARRO-RODRIGUEZ P, Lopez-Fernandez L, Martin-Vicente A, Guarro J, et al
    ERG11 polymorphism in voriconazole-resistant Candida tropicalis. Weak role of ERG11 expression, ergosterol content and membrane permeability.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.00325.
    PubMed     Abstract available


  181. KOSMIDIS C, Otu A, Moore CB, Richardson MD, et al
    Isavuconazole therapeutic drug monitoring during long-term treatment for chronic pulmonary aspergillosis.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01511.
    PubMed     Abstract available


  182. RIFAT D, Li SY, Ioerger T, Shah K, et al
    Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01948.
    PubMed     Abstract available


  183. BARBEE LA, Soge OO, Ocbamichael N, LeClair A, et al
    A Single-arm Open-label Clinical Trial of 2g Aztreonam for the treatment of N. gonorrhoeae.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01739.
    PubMed     Abstract available


  184. BATTAGLINI D, Motos A, Bassi GL, Yang H, et al
    Efficacy of telavancin in comparison to linezolid in a porcine model of severe methicillin-resistant Staphylococcus aureus (MRSA) pneumonia.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.01009.
    PubMed     Abstract available


  185. SATHKUMARA HD, Hansen K, Miranda-Hernandez S, Govan B, et al
    Disparate effects of metformin on Mycobacterium tuberculosis infection in diabetic and non-diabetic mice.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.01422.
    PubMed     Abstract available


  186. VAN DER WALT ML, Shean K, Becker P, Keddy KH, et al
    Treatment outcomes and adverse drug effects of ethambutol, cycloserine and terizidone for treatment of multi-drug resistant tuberculosis in South Africa.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.00744.
    PubMed     Abstract available


  187. HERRERA-HIDALGO L, de Alarcon A, Lopez-Cortes LE, Luque-Marquez R, et al
    Is once-daily high-dose ceftriaxone plus ampicillin an alternative for Enterococcus faecalis infective endocarditis in OPAT?
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.02099.
    PubMed     Abstract available


  188. ELDESOUKY HE, Salama EA, Lanman NA, Hazbun TR, et al
    Potent synergistic interactions between lopinavir and azole antifungal drugs against emerging multidrug-resistant Candida auris.
    Antimicrob Agents Chemother. 2020 Oct 12. pii: AAC.00684.
    PubMed     Abstract available


  189. SERRANO-LOBO J, Gomez A, Sanchez-Yebra W, Fajardo M, et al
    Azole and amphotericin B minimum inhibitory concentrations against Aspergillus fumigatus: high agreement between spectrophotometric and visual readings using the EUCAST 9.3.2 procedure.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01693.
    PubMed     Abstract available


  190. SAKOULAS G
    Imipenem/Cilistatin and Fosfomycin for Refractory Methicillin-Resistant Staphylococcus aureus Infection: a Novel Combination Therapy.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.02039.
    PubMed     Abstract available


  191. NESPOROVA K, Wyrsch ER, Valcek A, Bitar I, et al
    Escherichia coli ST457: an emerging extended-spectrum beta-lactam resistant lineage with reservoirs in wildlife and food-producing animals.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01118.
    PubMed     Abstract available


    September 2020
  192. CACACI M, Menchinelli G, Torelli R, Sanglard D, et al
    Fenticonazole against Fluconazole-Resistant Candida Species: New In Vitro Activity Data.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01459.
    PubMed     Abstract available


  193. COURJON J, Garzaro M, Roger PM, Ruimy R, et al
    Continuous infusion of cloxacillin during Staphylococcus aureus bone and joint infections: a population pharmacokinetic analysis.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01562.
    PubMed     Abstract available


  194. ZHUCHENKO G, Schmidt-Malan S, Patel R
    Planktonic and Biofilm Activity of Eravacycline against Staphylococci Isolated From Periprosthetic Joint Infections.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01304.
    PubMed     Abstract available


  195. DRUSANO GL, Duncanson B, Scanga CA, Kim S, et al
    Developing new drugs for the therapy of Mycobacterium tuberculosis: What information do we get from pre-clinical animal models?
    Antimicrob Agents Chemother. 2020 Sep 21. pii: AAC.01376.
    PubMed     Abstract available


  196. LI M, Nyantakyi SA, Go ML, Dick T, et al
    Resistance against membrane-inserting MmpL3 inhibitor through upregulation of MmpL5 in M. tuberculosis.
    Antimicrob Agents Chemother. 2020 Sep 21. pii: AAC.01100.
    PubMed     Abstract available


  197. LUO D, Huang L, Gondil VS, Zhou W, et al
    A choline-recognizing monomeric lysin ClyJ-3m showing elevated activity against Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2020 Sep 21. pii: AAC.00311.
    PubMed     Abstract available


  198. ZHOU YF, Liu P, Dai SH, Sun J, et al
    In Vivo Pharmacodynamic Target Assessment of Antofloxacin against Streptococcus pneumoniae and Staphylococcus aureus in a Neutropenic Murine Pneumonia Model.
    Antimicrob Agents Chemother. 2020 Sep 14. pii: AAC.01354.
    PubMed     Abstract available


  199. IMBERT S, Normand AC, Cassaing S, Gabriel F, et al
    Multicentric analysis of the species distribution and antifungal susceptibility of cryptic isolates from Aspergillus section Fumigati.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.01374.
    PubMed     Abstract available


  200. LIM HJ, Shin JH, Kim MN, Yong D, et al
    Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.00740.
    PubMed     Abstract available


    August 2020
  201. REICHMUTH ML, Homke R, Zurcher K, Sander P, et al
    Natural Polymorphisms in Mycobacterium tuberculosis Conferring Resistance to Delamanid in Drug-naive Patients.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00513.
    PubMed     Abstract available


  202. MADUNA LD, Kock MM, van der Veer BMJW, Radebe O, et al
    Antimicrobial resistance of Neisseria gonorrhoeae isolates from high risk men in Johannesburg, South Africa.
    Antimicrob Agents Chemother. 2020 Aug 31. pii: AAC.00906.
    PubMed     Abstract available


  203. ARENSMAN K, Shields M, Beganovic M, Miller JL, et al
    Fluoroquinolone versus beta-lactam oral step-down therapy for uncomplicated streptococcal bloodstream infections.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01515.
    PubMed     Abstract available


  204. ZHU Y, Kilburn S, Kapoor M, Chaturvedi S, et al
    Evaluation of in vitro activity of manogepix against multidrug-resistant and pan-resistant Candida auris from the New York Outbreak.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01124.
    PubMed     Abstract available


  205. WANG C, Ye C, Liao L, Wang Z, et al
    Adjuvant beta-lactam therapy combined with vancomycin or daptomycin for methicillin-resistant Staphylococcus aureus bacteraemia: a systematic review and meta-analysis.
    Antimicrob Agents Chemother. 2020 Aug 24. pii: AAC.01377.
    PubMed     Abstract available


  206. CHIREHWA MT, Court R, De Kock M, Wiesner L, et al
    Population pharmacokinetics of cycloserine, and pharmacokinetic/pharmacodynamic target attainment, in MDR-tuberculosis patients dosed with terizidone.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01381.
    PubMed     Abstract available


  207. GUO Y, Yang Y, Zheng Y, Wu S, et al
    Comparative in Vitro Activities of Ceftaroline and Tedizolid against Clinical Strains of Staphylococcus aureus and Enterococcus: Results from the China Antimicrobial Surveillance Network (CHINET) in 2018.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01461.
    PubMed     Abstract available


  208. DAO TH, Alsallaq R, Parsons J, Ferrolino J, et al
    Vancomycin Heteroresistance and Clinical Outcomes in Coagulase-Negative Staphylococcal Bloodstream Infections.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.00944.
    PubMed     Abstract available


  209. HAGMANN SHF, Angelo KM, Huits R, Plewes K, et al
    Epidemiological, and Clinical Characteristics of International Travelers with Enteric Fever and Antibiotic Resistance Profiles of their Isolates: A GeoSentinel Analysis.
    Antimicrob Agents Chemother. 2020 Aug 17. pii: AAC.01084.
    PubMed     Abstract available


  210. ISNARD C, Hernandez SB, Guerin F, Joalland F, et al
    Unexpected cell wall alteration-mediated bactericidal activity of the antifungal caspofungin against vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.01261.
    PubMed     Abstract available


  211. ALGHAMDI WA, Al-Shaer MH, An G, Alsultan A, et al
    Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimens Simulation and Target Attainment Analysis.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.01174.
    PubMed     Abstract available


  212. ADAMOWICZ EM, Harcombe WR
    Weakest link dynamics predict apparent antibiotic interactions in a model cross-feeding community.
    Antimicrob Agents Chemother. 2020 Aug 10. pii: AAC.00465.
    PubMed     Abstract available


  213. WITTKE F, Vincent C, Chen J, Heller B, et al
    Afabicin, a first-in-class anti-staphylococcal antibiotic, in the treatment of acute bacterial skin and skin structure infections: clinical non-inferiority to vancomycin/linezolid.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00250.
    PubMed     Abstract available


  214. KIM H, Kim ES, Lee SC, Yang E, et al
    Decreased incidence of methicillin-resistant Staphylococcus aureus bacteremia in intensive care units: a 10-year clinical, microbiological, and genotypic analysis in a tertiary hospital.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01082.
    PubMed     Abstract available


  215. PEIRANO G, Chen L, Kreiswirth BN, Pitout JDD, et al
    Emerging Antimicrobial Resistant High-Risk clones among Klebsiella pneumoniae: ST307 and ST147.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.01148.
    PubMed     Abstract available


  216. SKIPPER C, Atukunda M, Stadelman A, Engen N, et al
    Safety and tolerability of a novel oral formulation of amphotericin B: Phase I EnACT Trial.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00838.
    PubMed     Abstract available


  217. STAPLETON AE, Wagenlehner FME, Mulgirigama A, Twynholm M, et al
    E. coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection In Women: A Systematic Review.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00862.
    PubMed     Abstract available


    July 2020
  218. HERNANDO-ORTIZ A, Mateo E, Ortega-Riveros M, De-la-Pinta I, et al
    Caenorhabditis elegans as a model system to assess Candida glabrata, Candida nivariensis and Candida bracarensis virulence and antifungal efficacy.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00824.
    PubMed     Abstract available


  219. LOISEAU C, Brites D, Reinhard M, Zurcher K, et al
    HIV coinfection is associated with low fitness rpoB variants in rifampicin-resistant Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00782.
    PubMed     Abstract available


  220. BAYER AS, Tong SYC
    DAPTOMYCIN RESISTANCE IN STAPHYLOCOCCUS ARGENTEUS: FROM NORTHERN AUSTRALIA TO SAN FRANCISCO.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.01502.
    PubMed     Abstract available


  221. CAO D, Wu R, Dong S, Wang F, et al
    Azole resistance in environmental Aspergillus fumigatus isolates from China: A five-year survey from 2014 to 2018.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00904.
    PubMed     Abstract available


  222. GHANNOUM M, Isham N, Angulo D, Borroto-Esoda K, et al
    Efficacy of Ibrexafungerp (SCY-078) Against Candida auris in an In Vivo Guinea Pig Cutaneous Infection Model.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00854.
    PubMed     Abstract available


  223. KLOTZ SA, Gaur NK, Rauceo J, Lake DF, et al
    Correction for Klotz et al., "Inhibition of Adherence and Killing of Candida albicans with a 23-Mer Peptide (Fn/23) with Dual Antifungal Properties".
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  224. SINGH M, Matsuo M, Sasaki T, Hishinuma T, et al
    RNA sequencing identifies a common physiology in vancomycin- and ciprofloxacin-tolerant Staphylococcus aureus induced by ileS mutations.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.00827.
    PubMed     Abstract available


  225. TITS J, Cools F, De Cremer K, De Brucker K, et al
    Combination of miconazole and domiphen bromide is fungicidal against biofilms of resistant Candida spp.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01296.
    PubMed     Abstract available


  226. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Fang W, et al
    First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and/or Y132F+K143R in Turkey.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01001.
    PubMed     Abstract available


  227. MARIOTTI S, Teloni R, de Turris V, Pardini M, et al
    Amphotericin B inhibits Mycobacterium tuberculosis infection of human alveolar type II epithelial A549 cells.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.01164.
    PubMed     Abstract available


  228. ARENDRUP MC, Chowdhary A, Jorgensen KM, Meletiadis J, et al
    Manogepix (APX001A) in vitro activity against Candida auris. A head to head comparison of EUCAST and CLSI MICs.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00656.
    PubMed     Abstract available


  229. ROUNDTREE MT, Juvvadi PR, Shwab EK, Cole DC, et al
    Aspergillus fumigatus Cyp51A and Cyp51B Proteins are Compensatory in Function and Localize Differentially in Response to Antifungals and Cell Wall Inhibitors.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00735.
    PubMed     Abstract available


  230. MCNEIL JC, Sommer LM, Boyle M, Hogan P, et al
    The Cefazolin Inoculum Effect and Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children: Does it Matter?
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00703.
    PubMed     Abstract available


  231. AL-SHAER MH, Martson AG, Alghamdi WA, Alsultan A, et al
    Ethionamide population pharmacokinetic model and target attainment in multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00713.
    PubMed     Abstract available


  232. VILCHEZE C, Saranathan R, Weinrick B, Jacobs WR Jr, et al
    Characterization of large deletion mutants of Mycobacterium tuberculosis selected for isoniazid resistance.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00792.
    PubMed     Abstract available


  233. HAO M, He Y, Zhang H, Liao XP, et al
    CRISPR/Cas9-mediated carbapenemase genes and plasmids curing in carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020 Jul 6. pii: AAC.00843.
    PubMed     Abstract available


    June 2020
  234. JENSON RE, Baines SL, Howden BP, Mishra NN, et al
    Prolonged exposure to beta-lactam antibiotics reestablishes susceptibility of daptomycin-nonsusceptible Staphylococcus aureus to daptomycin.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00890.
    PubMed     Abstract available


  235. HAO S, Abdelghany M, Lyden A, Sit R, et al
    Genomic Profiling of Evolving Daptomycin Resistance in a Patient with Recurrent Staphylococcus argenteus Sepsis.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00961.
    PubMed     Abstract available


  236. REITZEL RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, et al
    Erratum for Reitzel et al., "Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution Is Highly Effective In Vitro for Eradication of Candida auris Biofilms".
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  237. RODRIGUEZ LOPEZ AL, Lee MR, Wang NB, Dunn KK, et al
    Correction for Rodriguez Lopez et al., "Small-Molecule Morphogenesis Modulators Enhance the Ability of 14-Helical beta-Peptides To Prevent Candida albicans Biofilm Formation".
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  238. LEPELLETIER D, Maillard JY, Pozzetto B, Simon A, et al
    Povidone Iodine: Properties, Mechanisms of Action and Role in Infection Control and Staphylococcus aureus Decolonization.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00682.
    PubMed     Abstract available


  239. SAFI H, Lingaraju S, Ma S, Husain S, et al
    Rapidly-correcting Frameshift Mutations in the Mycobacterium tuberculosis orn Gene Produce Reversible Ethambutol Resistance and Small Colony Variant Morphology.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00213.
    PubMed     Abstract available


  240. KHALIFA HO, Arai T, Majima H, Watanabe A, et al
    Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00783.
    PubMed     Abstract available


  241. PAIS P, California R, Galocha M, Viana R, et al
    Candida glabrata Transcription Factor Rpn4 Mediates Fluconazole Resistance Through Regulation of Ergosterol Biosynthesis and Plasma Membrane Permeability.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00554.
    PubMed     Abstract available


  242. MORRISETTE T, Lev KL, Kebriaei R, Abdul-Mutakabbir J, et al
    Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00993.
    PubMed     Abstract available


  243. PARMAR NR, Singh R, Martin I, Perera SR, et al
    Genomic Analysis Reveals Antibiotic Susceptible Clones and Emerging Resistance in Neisseria gonorrhoeae (Saskatchewan, Canada).
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.02514.
    PubMed     Abstract available


  244. NGUYEN CT, Bethel C, Pettit NN, Charnot-Katsikas A, et al
    From Etest to Vitek 2: Impact of Enterococcal Linezolid Susceptibility Testing Methodology on Time to Active Therapy.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00302.
    PubMed     Abstract available


  245. NIU Y, Wang K, Zheng S, Wang Y, et al
    The antibacterial effect of caffeic acid phenethyl ester on cariogenic bacteria and Streptococcus mutans biofilms.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00251.
    PubMed     Abstract available


  246. COHEN KA, Stott KE, Munsamy V, Manson AL, et al
    Evidence for expanding the role of streptomycin in the management of drug-resistant M. tuberculosis.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00860.
    PubMed     Abstract available


  247. ARIAS LS, Butcher MC, Short B, McKloud E, et al
    Chitosan ameliorates Candida auris virulence in a Galleria mellonella infection model.
    Antimicrob Agents Chemother. 2020 Jun 1. pii: AAC.00476.
    PubMed     Abstract available


    May 2020
  248. HUANG HN, Pan CY, Chan YL, Chen JY, et al
    Retraction for Huang et al., "Use of the Antimicrobial Peptide Pardaxin (GE33) To Protect against Methicillin-Resistant Staphylococcus aureus Infection in Mice with Skin Injuries".
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  249. MACEDO D, Brito Devoto T, Pola S, Finquelievich JL, et al
    A novel combination of CYP51A mutations confers pan-azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.02501.
    PubMed     Abstract available


  250. HOLLAND TL
    Early Oral Antibiotic Switch for Staphylococcus aureus Bacteremia: Many are Called, but Few are Chosen.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00317.
    PubMed     Abstract available


  251. KEBRIAEI R, Lev K, Morrisette T, Stamper K, et al
    Bacteriophage-Antibiotic Combination Strategy: An Alternative against Methicillin-resistant Phenotypes of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00461.
    PubMed     Abstract available


  252. SFEIR MM
    Methicillin-resistant Staphylococcus aureus (MRSA) nasal screening: Clinical use for excluding diabetic foot infection with MRSA.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00635.
    PubMed     Abstract available


  253. MERGENHAGEN KA, Croix M, Starr KE, Sellick JA, et al
    Reply to Sfeir, "Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening: Clinical Use for Excluding Diabetic Foot Infection with MRSA".
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00803.
    PubMed     Abstract available


  254. LI Y, Dong W, Lan T, Fan J, et al
    Distribution of linezolid in tuberculosis lesions in patients with spinal multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00450.
    PubMed     Abstract available


  255. KIM HY, Srivastava S, Kumar Ak H, Marais BJ, et al
    Optimal dose or optimal exposure? Consideration for linezolid in tuberculosis treatment.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00287.
    PubMed     Abstract available


  256. DIACON AH, De Jager VR, Dawson R, Narunsky K, et al
    Reply to Kim et al., "Optimal Dose or Optimal Exposure? Consideration for Linezolid in Tuberculosis Treatment".
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00709.
    PubMed     Abstract available


  257. WILSEY HA, Burgess DR, Burgess DS
    Focusing the lens on the CAMERA concepts: Early combination beta-lactam and vancomycin therapy in methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.00360.
    PubMed     Abstract available


  258. SHIRAKAWA T, Sekizuka T, Kuroda M, Suzuki S, et al
    Comparative Genomic Analysis of Third Generation Cephalosporin-Resistant Escherichia coli Harboring bla CMY-2-Positive IncI1 group, IncB/O/K/Z, and IncC Plasmids Isolated from Healthy Broilers in Japan.
    Antimicrob Agents Chemother. 2020 May 4. pii: AAC.02385.
    PubMed     Abstract available


    April 2020
  259. PIETERMAN ED, Sarink MJ, Sala C, Cole ST, et al
    Advanced quantification methods to improve the 18b dormancy model for assessing the activity of tuberculosis drugs in vitro.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.00280.
    PubMed     Abstract available


  260. SPOONMORE TJ, Ford CA, Curry JM, Guelcher SA, et al
    Concurrent local delivery of diflunisal limits bone destruction but fails to improve systemic vancomycin efficacy during Staphylococcus aureus osteomyelitis.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.00182.
    PubMed     Abstract available


  261. KIM D, Yoon EJ, Hong JS, Lee H, et al
    Impact of vanA-positive Enterococcus faecium exhibiting diverse susceptibility phenotypes to glycopeptides on 30-day mortality of patients with a bloodstream infection.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.02180.
    PubMed     Abstract available


  262. SHAH SU, Xiong YQ, Abdelhady W, Iwaz J, et al
    Effect of the Lysin, Exebacase, on Cardiac Vegetation Progression in a Rabbit Model of Methicillin-Resistant Staphylococcus aureus (MRSA) Endocarditis as Determined by Echocardiography.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.00482.
    PubMed     Abstract available


  263. GAGLIARDI A, Selchow P, Luthra S, Schafle D, et al
    KatG as Counterselection Marker for Nontuberculous Mycobacteria.
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  264. VAN MATRE ET, Teitelbaum I, Kiser TH
    Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  265. FARAJ A, Svensson RJ, Diacon AH, Simonsson USH, et al
    Drug Effect of Clofazimine on Persisters Explains an Unexpected Increase in Bacterial Load in Patients.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  266. DUBOIS J, Dubois M, Martel JF
    In Vitro and Intracellular Activities of Omadacycline against Legionella pneumophila.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  267. COLQUE CA, Albarracin Orio AG, Feliziani S, Marvig RL, et al
    Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  268. DI J, Zhang J, Cao L, Huang TT, et al
    Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pylori In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  269. ARECHIGA-ALVARADO NA, Medellin-Garibay SE, Milan-Segovia RDC, Ortiz-Alvarez A, et al
    Population Pharmacokinetics of Amikacin Administered Once Daily in Patients with Different Renal Functions.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  270. SAK B, Brdickova K, Holubova N, Kvetonova D, et al
    Encephalitozoon cuniculi Genotype III Evinces a Resistance to Albendazole Treatment in both Immunodeficient and Immunocompetent Mice.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  271. MATSUO N, Nonogaki R, Hayashi M, Wachino JI, et al
    Characterization of bla CTX-M-27/F1:A2:B20 Plasmids Harbored by Escherichia coli Sequence Type 131 Sublineage C1/H30R Isolates Spreading among Elderly Japanese in Nonacute-Care Settings.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  272. HAYASHI M, Nishiyama A, Kitamoto R, Tateishi Y, et al
    Adduct Formation of Delamanid with NAD in Mycobacteria.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  273. LIN YT, Cheng YH, Chuang C, Chou SH, et al
    Molecular and Clinical Characterization of Multidrug-Resistant and Hypervirulent Klebsiella pneumoniae Strains from Liver Abscess in Taiwan.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  274. PALWE S, Veeraraghavan B, Periasamy H, Khobragade K, et al
    Unorthodox Parenteral beta-Lactam and beta-Lactamase Inhibitor Combinations: Flouting Antimicrobial Stewardship and Compromising Patient Care.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  275. ESHAGHI A, Zittermann S, Bharat A, Mulvey MR, et al
    Importation of Extensively Drug-Resistant Salmonella enterica Serovar Typhi Cases in Ontario, Canada.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  276. WAACK U, Weinstein EA, Farley JJ
    Assessing Animal Models of Bacterial Pneumonia Used in Investigational New Drug Applications for the Treatment of Bacterial Pneumonia.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  277. ADAMS MD, Pasteran F, Traglia GM, Martinez J, et al
    Distinct Mechanisms of Dissemination of NDM-1 Metallo-beta-Lactamase in Acinetobacter Species in Argentina.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  278. STOESSER N, Phan HTT, Seale AC, Aiken Z, et al
    Genomic Epidemiology of Complex, Multispecies, Plasmid-Borne bla KPC Carbapenemase in Enterobacterales in the United Kingdom from 2009 to 2014.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  279. CASTANHEIRA M, Sader HS, Mendes RE, Jones RN, et al
    Activity of Plazomicin Tested against Enterobacterales Isolates Collected from U.S. Hospitals in 2016-2017: Effect of Different Breakpoint Criteria on Susceptibility Rates among Aminoglycosides.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  280. SADER HS, Carvalhaes CG, Duncan LR, Shortridge D, et al
    Antimicrobial Activity of Ceftolozane-Tazobactam and Comparators against Clinical Isolates of Haemophilus influenzae from the United States and Europe.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  281. YUAN WL, Xu JL, Guo L, Deng QF, et al
    Predominant Distribution of OXA-48-Like Carbapenemase in Fecal Colonization.
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  282. KAYE KS, Boucher HW, Brown ML, Aggrey A, et al
    Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patients with Imipenem-Nonsusceptible Bacterial Infections.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  283. SCHMERER MW, Abrams AJ, Seby S, Thomas JC 4th, et al
    Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  284. STONE GG, Bradford PA, Tawadrous M, Taylor D, et al
    In Vitro Activity of Ceftazidime-Avibactam against Isolates from Respiratory and Blood Specimens from Patients with Nosocomial Pneumonia, Including Ventilator-Associated Pneumonia, in a Phase 3 Clinical Trial.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  285. LANOIX JP, Joseph C, Peltier F, Castelain S, et al
    Synergistic Activity of Clofazimine and Clarithromycin in an Aerosol Mouse Model of Mycobacterium avium Infection.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  286. PFALLER MA, Huband MD, Shortridge D, Flamm RK, et al
    Surveillance of Omadacycline Activity Tested against Clinical Isolates from the United States and Europe: Report from the SENTRY Antimicrobial Surveillance Program, 2016 to 2018.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  287. RAYNAUD C, Daher W, Roquet-Baneres F, Johansen MD, et al
    Synergistic Interactions of Indole-2-Carboxamides and beta-Lactam Antibiotics against Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  288. NARMANDAKH E, Tumenbayar O, Borolzoi T, Erkhembayar B, et al
    Genetic Mutations Associated with Isoniazid Resistance in Mycobacterium tuberculosis in Mongolia.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00537.
    PubMed     Abstract available


  289. CARRARA B, Richards R, Imbert S, Morio F, et al
    Species Distribution and Comparison between EUCAST and Gradient Concentration Strips Methods for Antifungal Susceptibility Testing of 112 Aspergillus Section Nigri Isolates.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.02510.
    PubMed     Abstract available


  290. MOLINA KC, Morrisette T, Miller MA, Huang V, et al
    The Emerging Role of beta-lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00468.
    PubMed     Abstract available


  291. KANCHUGAL P S, Selmer M
    Structural recognition of spectinomycin by resistance enzyme ANT(9) from Enterococcus faecalis.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00371.
    PubMed     Abstract available


  292. ALMEIDA LM, Lebreton F, Gaca A, Bispo PM, et al
    Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00142.
    PubMed     Abstract available


  293. ABBOTT IJ, van Gorp E, van der Meijden A, Wijma RA, et al
    Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic In Vitro Model.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00342.
    PubMed     Abstract available


  294. BROWN MM, Kwiecinski JM, Mejia Cruz L, Shahbandi A, et al
    Novel peptide from commensal Staphylococcus simulans blocks MRSA quorum sensing and protects host skin from damage.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00172.
    PubMed     Abstract available


    March 2020
  295. HARIGUCHI N, Chen X, Hayashi Y, Kawano Y, et al
    OPC-167832, a novel carbostyril derivative with potent anti-tuberculosis activity as a DprE1 inhibitor.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.02020.
    PubMed     Abstract available


  296. BEREDAKI MI, Georgiou PC, Siopi M, Kanioura L, et al
    Towards harmonization of voriconazole CLSI and EUCAST breakpoints for Candida albicans using a validated in vitro pharmacokinetic/pharmacodynamic model.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.00170.
    PubMed     Abstract available


  297. YANG T, Pan L, Wu N, Wang L, et al
    Antimicrobial resistance in clinical Ureaplasma spp. and Mycoplasma hominis and structural mechanisms underlying the quinolone resistance.
    Antimicrob Agents Chemother. 2020 Mar 30. pii: AAC.02560.
    PubMed     Abstract available


  298. CABRERA NL, Malek AE, Aitken SL, Arias CA, et al
    Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results.
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  299. SEKAGGYA-WILTSHIRE C, Chirehwa M, Musaazi J, von Braun A, et al
    Erratum for Sekaggya-Wiltshire et al., "Low Antituberculosis Drug Concentrations in HIV-Tuberculosis-Coinfected Adults with Low Body Weight: Is It Time To Update Dosing Guidelines?"
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  300. KIM D, Lee H, Yoon EJ, Hong JS, et al
    Reply to Cabrera et al., "Outcomes of Patients with Bloodstream Infections Caused by Ampicillin-Susceptible but Penicillin-Resistant Enterococcus faecalis: Caution in Interpreting the Results".
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  301. SHIELDS RK
    Case Commentary: the Need for Cefiderocol Is Clear, but Are the Supporting Clinical Data?
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  302. TSIVKOVSKI R, Lomovskaya O
    Potency of Vaborbactam Is Less Affected than That of Avibactam in Strains Producing KPC-2 Mutations That Confer Resistance to Ceftazidime-Avibactam.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  303. WILLIX JL, Stockton JL, Olson RM, Anderson PE, et al
    Activation of Heme Oxygenase Expression by Cobalt Protoporphyrin Treatment Prevents Pneumonic Plague Caused by Inhalation of Yersinia pestis.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  304. KESTER JC, Brubaker DK, Velazquez J, Wright C, et al
    Clostridioides difficile-Associated Antibiotics Alter Human Mucosal Barrier Functions by Microbiome-Independent Mechanisms.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  305. COPPI M, Di Pilato V, Monaco F, Giani T, et al
    Ceftazidime-Avibactam Resistance Associated with Increased bla KPC-3 Gene Copy Number Mediated by pKpQIL Plasmid Derivatives in Sequence Type 258 Klebsiella pneumoniae.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  306. CONTRERAS DA, Fitzwater SP, Nanayakkara DD, Schaenman J, et al
    Coinfections of Two Strains of NDM-1- and OXA-232-Coproducing Klebsiella pneumoniae in a Kidney Transplant Patient.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  307. PETRAITIENE R, Petraitis V, Kavaliauskas P, Maung BBW, et al
    Pharmacokinetics and Efficacy of Ceftazidime-Avibactam in the Treatment of Experimental Pneumonia Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae in Persistently Neutropenic Rabbits.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  308. SHAW D, Singh S, Dogra S, Jayaraman J, et al
    MIC and Upper Limit of Wild-Type Distribution for 13 Antifungal Agents against a Trichophyton mentagrophytes-Trichophyton interdigitale Complex of Indian Origin.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  309. RICHARD G, MacKenzie CR, Henry KA, Vinogradov E, et al
    Antibody Binding to the O-Specific Antigen of Pseudomonas aeruginosa O6 Inhibits Cell Growth.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  310. MOON SH, Kaufmann Y, Huang E
    Paenipeptin Analogues Potentiate Clarithromycin and Rifampin against mcr-1-Mediated Polymyxin-Resistant Escherichia coli In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  311. MUHLEN S, Ramming I, Pils MC, Koeppel M, et al
    Identification of Antibiotics That Diminish Disease in a Murine Model of Enterohemorrhagic Escherichia coli Infection.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  312. WEBB BJ, Subramanian A, Lopansri B, Goodman B, et al
    Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  313. SIMONETTI O, Lucarini G, Morroni G, Orlando F, et al
    New Evidence and Insights on Dalbavancin and Wound Healing in a Mouse Model of Skin Infection.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  314. KONTOU A, Sarafidis K, Begou O, Gika HG, et al
    Population Pharmacokinetics of Teicoplanin in Preterm and Term Neonates: Is It Time for a New Dosing Regimen?
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  315. MONTERO M, Domene Ochoa S, Lopez-Causape C, VanScoy B, et al
    Efficacy of Ceftolozane-Tazobactam in Combination with Colistin against Extensively Drug-Resistant Pseudomonas aeruginosa, Including High-Risk Clones, in an In Vitro Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  316. DIAZ IGLESIAS Y, Van Bambeke F
    Activity of Antibiotics against Pseudomonas aeruginosa in an In Vitro Model of Biofilms in the Context of Cystic Fibrosis: Influence of the Culture Medium.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  317. ARCARI G, Di Lella FM, Bibbolino G, Mengoni F, et al
    A Multispecies Cluster of VIM-1 Carbapenemase-Producing Enterobacterales Linked by a Novel, Highly Conjugative, and Broad-Host-Range IncA Plasmid Forebodes the Reemergence of VIM-1.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  318. LOGAN LK, Zhang L, Green SJ, Dorevitch S, et al
    A Pilot Study of Chicago Waterways as Reservoirs of Multidrug-Resistant Enterobacteriaceae (MDR-Ent) in a High-Risk Region for Community-Acquired MDR-Ent Infection in Children.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  319. GUDIOL C, Albasanz-Puig A, Laporte-Amargos J, Pallares N, et al
    Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  320. DELMA FZ, Al-Hatmi AMS, Buil JB, van der Lee H, et al
    Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for In Vitro Antifungal Susceptibility Testing of Cryptococcus neoformans.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  321. SABET M, Tarazi Z, Griffith DC
    Pharmacodynamics of Meropenem against Acinetobacter baumannii in a Neutropenic Mouse Thigh Infection Model.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  322. MCLEOD SM, Moussa SH, Hackel MA, Miller AA, et al
    In Vitro Activity of Sulbactam-Durlobactam against Acinetobacter baumannii-calcoaceticus Complex Isolates Collected Globally in 2016 and 2017.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  323. BRILHANTE M, Menezes J, Belas A, Feudi C, et al
    OXA-181-Producing Extraintestinal Pathogenic Escherichia coli Sequence Type 410 Isolated from a Dog in Portugal.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  324. SARATHY JP, Ganapathy US, Zimmerman MD, Dartois V, et al
    TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  325. JORGENSEN SCJ, Trinh TD, Zasowski EJ, Lagnf AM, et al
    Real-World Experience with Ceftolozane-Tazobactam for Multidrug-Resistant Gram-Negative Bacterial Infections.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  326. GONG J, Bing J, Guan G, Nobile CJ, et al
    The Als3 cell wall adhesin plays a critical role in human Serum amyloid A1 (SAA1)-induced cell death and aggregation in Candida albicans.
    Antimicrob Agents Chemother. 2020 Mar 23. pii: AAC.00024.
    PubMed     Abstract available


  327. LISTON SD, Whitesell L, Kapoor M, Shaw KJ, et al
    Enhanced efflux pump expression in Candida mutants results in decreased manogepix susceptibility.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.00261.
    PubMed     Abstract available


  328. PETRAITIS V, Petraitiene R, Katragkou A, Maung BBW, et al
    Combination Therapy with Ibrexafungerp (formerly SCY-078), a First-in-Class Triterpenoid Inhibitor of (1-->3)-beta-D-Glucan Synthesis, and Isavuconazole for Treatment of Experimental Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.02429.
    PubMed     Abstract available


  329. CHATTERJEE A, Poon R, Chatterjee SS
    Stp1 loss of function promotes beta-lactam resistance in S. aureus that is independent of classical genes.
    Antimicrob Agents Chemother. 2020 Mar 16. pii: AAC.02222.
    PubMed     Abstract available


  330. MACFADDEN DR, Coburn B, Brinda K, Corbeil A, et al
    Using Genetic Distance from Archived Samples for the Prediction of Antibiotic Resistance in Escherichia coli.
    Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.02417.
    PubMed     Abstract available


  331. JOHNSTON BD, Thuras P, Porter SB, Anacker M, et al
    Activity of imipenem/relebactam against carbapenem-resistant Escherichia coli isolates from the United States in relation to clonal background, resistance genes, co-resistance, and region.
    Antimicrob Agents Chemother. 2020 Mar 9. pii: AAC.02408.
    PubMed     Abstract available


  332. SCHWENDENER S, Dona V, Perreten V
    The novel macrolide resistance genes mef(D), msr(F) and msr(H) are present on resistance islands in Macrococcus canis, Macrococcus caseolyticus and Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.00160.
    PubMed     Abstract available


  333. FRAPWELL CJ, Skipp PJ, Howlin RP, Angus EM, et al
    Antimicrobial activity of the quinoline derivative HT61 against Staphylococcus aureus biofilms.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02073.
    PubMed     Abstract available


  334. ENKIRCH T, Werngren J, Groenheit R, Alm E, et al
    Systematic review of whole genome sequencing data to predict phenotypic drug resistance and susceptibility in Swedish Mycobacterium tuberculosis isolates 2016-2018.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02550.
    PubMed     Abstract available


  335. SINGH KV, Arias CA, Murray BE
    Tedizolid as step-down therapy following daptomycin versus continuation of daptomycin against enterococci and Staphylococcus aureus (MRSA/VRSA) in a rat endocarditis model.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02303.
    PubMed     Abstract available


  336. CUI CY, Chen C, Liu BT, He Q, et al
    Co-occurrence of plasmid-mediated tigecycline and carbapenem resistance in Acinetobacter spp. from waterfowls and their neighboring environment.
    Antimicrob Agents Chemother. 2020 Mar 2. pii: AAC.02502.
    PubMed     Abstract available


    February 2020
  337. JAHANBAKHSH S, Singh NB, Yim J, Kebriaei R, et al
    Impact of Daptomycin Dose Exposure Alone or in Combination with beta- lactams or Rifampin against Vancomycin-Resistant Enterococci (VRE) in an In vitro Biofilm Model.
    Antimicrob Agents Chemother. 2020 Feb 24. pii: AAC.02074.
    PubMed     Abstract available


  338. ACKLEY R, Roshdy D, Meredith J, Minor S, et al
    Meropenem/Vaborbactam versus Ceftazidime/Avibactam for Treatment of Carbapenem-Resistant Enterobacteriaceae Infections.
    Antimicrob Agents Chemother. 2020 Feb 24. pii: AAC.02313.
    PubMed     Abstract available


  339. SIOPI M, Tarpatzi A, Kalogeropoulou E, Damianidou S, et al
    Epidemiological Trends of Fungemia in Greece with a Focus on Candidemia during the Recent Financial Crisis: a 10-Year Survey in a Tertiary Care Academic Hospital and Review of Literature.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  340. DECEMBRINO N, Perruccio K, Zecca M, Colombini A, et al
    A Case Series and Literature Review of Isavuconazole Use in Pediatric Patients with Hemato-oncologic Diseases and Hematopoietic Stem Cell Transplantation.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  341. TIMBROOK TT, McKay L, Sutton JD, Spivak ES, et al
    Disproportionality Analysis of Safety with Nafcillin and Oxacillin with the FDA Adverse Event Reporting System (FAERS).
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  342. JI XW, Xue F, Kang ZS, Zhong W, et al
    Model-Informed Drug Development, Pharmacokinetic/Pharmacodynamic Cutoff Value Determination, and Antibacterial Efficacy of Benapenem against Enterobacteriaceae.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  343. MORRISSEY I, Hawser S, Lob SH, Karlowsky JA, et al
    In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  344. LIU Y, Tan Y, Islam MM, Cao Y, et al
    Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  345. SONNABEND MS, Klein K, Beier S, Angelov A, et al
    Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  346. HAMDI AM, Fida M, Deml SM, Abu Saleh OM, et al
    Retrospective Analysis of Antimicrobial Susceptibility Profiles of Nocardia Species from a Tertiary Hospital and Reference Laboratory, 2011 to 2017.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  347. ALKHAZRAJI S, Gebremariam T, Alqarihi A, Gu Y, et al
    Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  348. ABBOTT IJ, van Gorp E, Wijma RA, Meletiadis J, et al
    Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for Growth Outcome.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  349. LEE A, Prideaux B, Zimmerman M, Carter C, et al
    Penetration of Ibrexafungerp (Formerly SCY-078) at the Site of Infection in an Intra-abdominal Candidiasis Mouse Model.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  350. MCCURDY S, Keedy K, Lawrence L, Nenninger A, et al
    Efficacy of Delafloxacin versus Moxifloxacin against Bacterial Respiratory Pathogens in Adults with Community-Acquired Bacterial Pneumonia (CABP): Microbiology Results from the Delafloxacin Phase 3 CABP Trial.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  351. ARENDRUP MC, Jorgensen KM, Hare RK, Chowdhary A, et al
    In Vitro Activity of Ibrexafungerp (SCY-078) against Candida auris Isolates as Determined by EUCAST Methodology and Comparison with Activity against C. albicans and C. glabrata and with the Activities of Six Comparator Agents.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  352. LAI JCY, Svedin P, Ek CJ, Mottahedin A, et al
    Vancomycin Is Protective in a Neonatal Mouse Model of Staphylococcus epidermidis-Potentiated Hypoxic-Ischemic Brain Injury.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  353. RABIE H, Tikiso T, Lee J, Fairlie L, et al
    Abacavir exposure in children co-treated for tuberculosis with rifampicin and super-boosted lopinavir-ritonavir.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.01923.
    PubMed     Abstract available


  354. WALSH KF, McAulay K, Lee MH, Vilbrun SC, et al
    Early bactericidal activity trial of nitazoxanide for pulmonary tuberculosis.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.01956.
    PubMed     Abstract available


  355. CARVAJAL LP, Rincon S, Echeverri AM, Porras J, et al
    Novel Insights Into The Classification of Staphylococcal beta-Lactamases In Relation To The Cefazolin Inoculum Effect.
    Antimicrob Agents Chemother. 2020 Feb 18. pii: AAC.02511.
    PubMed     Abstract available


  356. ERSOY SC, Otmishi M, Milan VT, Li L, et al
    Scope and Predictive Genetic/Phenotypic Signatures of 'Bicarbonate [NaHCO3]-Responsiveness' and beta-Lactam Sensitization Among Methicillin-Resistant Staphylococcus aureus (MRSA).
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02445.
    PubMed     Abstract available


  357. GENGENBACHER M, Zimmerman MD, Sarathy JP, Kaya F, et al
    Tissue distribution of doxycycline in animal models of tuberculosis.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02479.
    PubMed     Abstract available


  358. DJORIC D, Little JL, Kristich CJ
    Multiple low-reactivity class B penicillin-binding proteins are required for cephalosporin resistance in enterococci.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.02273.
    PubMed     Abstract available


  359. CHOI S, Moon SM, Park SJ, Lee SC, et al
    Antagonistic effect of colistin on vancomycin activity against methicillin-resistant Staphylococcus aureus in in vitro and in vivo studies.
    Antimicrob Agents Chemother. 2020 Feb 10. pii: AAC.01925.
    PubMed     Abstract available


  360. ARAI T, Majima H, Watanabe A, Kamei K, et al
    A simple method to detect point mutations in Aspergillus fumigatus cyp51A gene using a Surveyor Nuclease assay.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02271.
    PubMed     Abstract available


  361. HELLEBERG M, Jorgensen KM, Hare RK, Datcu R, et al
    Rezafungin In Vitro Activity against Contemporary Clinical Nordic Candida Isolates and Candida auris Determined by the EUCAST Reference Method.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02438.
    PubMed     Abstract available


  362. BUPHA-INTR O, Blackmore T, Bloomfield M
    Efficacy of early oral switch with beta-lactams for low-risk Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.02345.
    PubMed     Abstract available


  363. CARVALHAES CG, Sader HS, Flamm RK, Streit JM, et al
    Assessment of Tedizolid In Vitro Activity and Resistance Mechanisms against a Collection of Enterococcus spp. Causing Invasive Infections Including Isolates Requiring an Optimized Dosing Strategy for Daptomycin from United States and European Medical
    Antimicrob Agents Chemother. 2020 Feb 3. pii: AAC.00175.
    PubMed     Abstract available


    January 2020
  364. KEMPKER RR, Alghamdi WA, Al-Shaer MH, Burch G, et al
    Correction for Kempker et al., "A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment".
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  365. DIACON AH, De Jager VR, Dawson R, Narunsky K, et al
    Fourteen-Day Bactericidal Activity, Safety, and Pharmacokinetics of Linezolid in Adults with Drug-Sensitive Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.02012.
    PubMed     Abstract available


  366. ROSSI SA, de Oliveira HC, Agreda-Mellon D, Lucio J, et al
    Identification of off-patent drugs that show synergism with Amphotericin B or that present antifungal action against Cryptococcus neoformans and Candida spp.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.01921.
    PubMed     Abstract available


  367. MERGENHAGEN KA, Croix M, Starr KE, Sellick JA, et al
    The utility of methicillin-resistant Staphylococcus aureus nares screening for patients with a diabetic foot infection.
    Antimicrob Agents Chemother. 2020 Jan 27. pii: AAC.02213.
    PubMed     Abstract available


  368. EKKELENKAMP MB, Canton R, Diez-Aguilar M, Tunney MM, et al
    Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  369. BROUTIN A, Bigot J, Senghor Y, Moreno-Sabater A, et al
    In Vitro Susceptibility of Fusarium to Isavuconazole.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  370. WU X, Venkataramanan R, Rivosecchi RM, Tang C, et al
    Population Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  371. YANG H, Luo D, Etobayeva I, Li X, et al
    Linker Editing of Pneumococcal Lysin ClyJ Conveys Improved Bactericidal Activity.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  372. KOLPEN M, Jensen PO, Qvist T, Kragh KN, et al
    Biofilms of Mycobacterium abscessus Complex Can Be Sensitized to Antibiotics by Disaggregation and Oxygenation.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  373. ROSOWSKI EE, He J, Huisken J, Keller NP, et al
    Efficacy of Voriconazole against Aspergillus fumigatus Infection Depends on Host Immune Function.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  374. DONG W, Li S, Wen S, Jing W, et al
    In Vitro Susceptibility Testing of GSK656 against Mycobacterium Species.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  375. LU RY, Ni TJ, Wu J, Yan L, et al
    New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans In Vitro and In Vivo.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  376. SONG H, Liu D, Li R, Fu Y, et al
    Polymorphism Existence of Mobile Tigecycline Resistance Gene tet(X4) in Escherichia coli.
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  377. RICHARD M, Gutierrez AV, Kremer L
    Dissecting erm(41)-Mediated Macrolide-Inducible Resistance in Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  378. CHI X, Zhang J, Xu H, Yu X, et al
    Emergence of KPC-2-Producing Raoultella ornithinolytica Isolated from a Hospital Wastewater Treatment Plant.
    Antimicrob Agents Chemother. 2020;64.
    PubMed    


  379. SUN Q, Xiong K, Yuan Y, Yu J, et al
    Inhibiting Fungal Echinocandin Resistance by Small-Molecule Disruption of Geranylgeranyltransferase Type I Activity.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  380. REINGEWERTZ TH, Meyer T, McIntosh F, Sullivan J, et al
    Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  381. DICK T, Shin SJ, Koh WJ, Dartois V, et al
    Rifabutin Is Active against Mycobacterium abscessus in Mice.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  382. SABET M, Griffith DC
    Activity of Aerosolized Levofloxacin against Burkholderia cepacia in a Mouse Model of Chronic Lung Infection.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  383. ALBAC S, Medina M, Labrousse D, Hayez D, et al
    Efficacy of Bacteriophages in a Staphylococcus aureus Nondiabetic or Diabetic Foot Infection Murine Model.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  384. FANG LX, Jiang Q, Deng GH, He B, et al
    Diverse and Flexible Transmission of fosA3 Associated with Heterogeneous Multidrug Resistance Regions in Salmonella enterica Serovar Typhimurium and Indiana Isolates.
    Antimicrob Agents Chemother. 2020;64.
    PubMed     Abstract available


  385. WATERER G, Lord J, Hofmann T, Jouhikainen T, et al
    A Phase I, dose-escalating study of safety and pharmacokinetics of inhaled dry powder vancomycin (AeroVanc) in volunteers and patients with cystic fibrosis: a new approach to therapy for methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2020 Jan 21. pii: AAC.01776.
    PubMed     Abstract available


  386. MTHIYANE T, Millard J, Adamson J, Balakrishna Y, et al
    N-acetyltransferase 2 genotypes amongst Zulu Speaking South Africans and isoniazid/N-acetyl-isoniazid pharmacokinetics during anti-tuberculosis treatment.
    Antimicrob Agents Chemother. 2020 Jan 21. pii: AAC.02376.
    PubMed     Abstract available


  387. REITZEL RA, Rosenblatt J, Gerges BZ, Vargas-Cruz N, et al
    Minocycline-EDTA-Ethanol Antimicrobial Catheter Lock Solution is highly effective in vitro for Eradication of Candida auris Biofilms.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02146.
    PubMed     Abstract available


  388. JIN Y, Guo Y, Zhan Q, Shang Y, et al
    Sub-Inhibitory Concentrations of Mupirocin Stimulate Staphylococcus aureus Biofilm Formation by Up-regulating cidA.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01912.
    PubMed     Abstract available


  389. MILLER CR, Dey S, Smolenski PD, Kulkarni PS, et al
    Distinct Subpopulations of Intravalvular Methicillin-Resistant Staphylococcus aureus With Variable Susceptibility to Daptomycin in Tricuspid Valve Endocarditis.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01593.
    PubMed     Abstract available


  390. ROTONDO CM, Sychantha D, Koteva K, Wright GD, et al
    Suppression of beta-Lactam Resistance by Aspergillomarasmine A is Influenced by Both the Metallo-beta-Lactamase Target and the Antibiotic Partner.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01386.
    PubMed     Abstract available


  391. RICARDO E, Grenouillet F, Miranda IM, Silva RM, et al
    Mechanisms of acquired in vivo and in vitro resistance to voriconazole by Candida krusei following exposure to suboptimal drug concentration.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.01651.
    PubMed     Abstract available


  392. O'BRIEN B, Chaturvedi S, Chaturvedi V
    In vitro Evaluation of Antifungal Drug Combinations against Multidrug-resistant Candida auris isolates from New York Outbreak.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02195.
    PubMed     Abstract available


  393. WASSERMAN S, Huo S, Ky K, Malig YN, et al
    CORRELATION OF LINEZOLID HAIR CONCENTRATIONS WITH PLASMA EXPOSURE IN PATIENTS WITH DRUG-RESISTANT TB.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02145.
    PubMed     Abstract available


  394. BIAGI M, Shajee A, Vialichka A, Jurkovic M, et al
    Activity of imipenem-relebactam and meropenem-vaborbactam against carbapenem-resistant SME-producing Serratia marcescens.
    Antimicrob Agents Chemother. 2020 Jan 13. pii: AAC.02255.
    PubMed     Abstract available


  395. ALLAN DS, Del Carmen Parquet M, Savage KA, Holbein BE, et al
    Iron sequestrant DIBI, potential alternative for nares decolonization of MRSA Staphylococcus aureus, is anti-infective and inhibitory for mupirocin resistant isolates.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.02353.
    PubMed     Abstract available


  396. HASBUN R
    Delayed cerebral vasculitis associated with the development of ceftriaxone resistant pneumococcal meningitis.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.02251.
    PubMed     Abstract available


  397. ZHANG N, Strydom N, Tyagi S, Soni H, et al
    Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01727.
    PubMed     Abstract available


  398. PERICAS JM, Cervera C, Garcia-de-la-Maria C, Sharma-Kuinkel BK, et al
    Relationship between Vancomycin Minimum Inhibitory Concentration with Virulence Genes Expression and Clonal Complexes of Methicillin-Susceptible Staphylococcus aureus (MSSA) Strains Isolated from Left-sided Endocarditis.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01579.
    PubMed     Abstract available


  399. JING W, Zong Z, Tang B, Wang J, et al
    Population Pharmacokinetic Analysis of Isoniazid among Pulmonary Tuberculosis Patients from China.
    Antimicrob Agents Chemother. 2020 Jan 6. pii: AAC.01736.
    PubMed     Abstract available


    December 2019
  400. BJUGARD NYBERG H, Draper HR, Garcia-Prats AJ, Thee S, et al
    Population pharmacokinetics and dosing of ethionamide in children with tuberculosis.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.01984.
    PubMed     Abstract available


  401. PONTES L, Beraquet CAG, Arai T, Pigolli GL, et al
    Aspergillus fumigatus clinical isolates carrying CYP51A TR34/L98H/S297T/F495I mutation detected after 4 years retrospective azole resistance screening test in Brazil.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02059.
    PubMed     Abstract available


  402. ELINGS W, Gaur A, Blok AJ, Timmer M, et al
    beta-Lactamase of Mycobacterium tuberculosis shows dynamics in the active site that increase upon inhibitor binding.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02025.
    PubMed     Abstract available


  403. LIN Z, Pu Z, Xu G, Bai B, et al
    Omadacycline efficacy against Enterococcus faecalis isolated in China: in vitro activity, heteroresistance, and resistance mechanisms.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02097.
    PubMed     Abstract available


  404. KOLENDA C, Josse J, Medina M, Fevre C, et al
    Evaluation of the activity of a combination of three bacteriophages alone or in association with antibiotics on Staphylococcus aureus embedded in biofilm or internalised in osteoblasts.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02231.
    PubMed     Abstract available


  405. BRYSON D, Hettle AG, Boraston AB, Hobbs JK, et al
    Clinical Mutations that Partially Activate the Stringent Response Confer Multi-Drug Tolerance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Dec 23. pii: AAC.02103.
    PubMed     Abstract available


  406. EDELSTEIN PH
    Azithromycin Phenotypic versus Clinical Resistance.
    Antimicrob Agents Chemother. 2019;64.
    PubMed    


  407. RICHTER WJ, Cohen KA
    No Amikacin, No Problem: a Successful Treatment Approach for Pediatric Otomastoiditis Due to Amikacin-Resistant Mycobacterium abscessus.
    Antimicrob Agents Chemother. 2019;64.
    PubMed     Abstract available


  408. VU TTT, Nguyen NTQ, Tran VG, Gras E, et al
    Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in Rabbit Model of Staphylococcus aureus Necrotizing Pneumonia.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02220.
    PubMed     Abstract available


  409. DELLIERE S, Verdurme L, Bigot J, Dannaoui E, et al
    Comparison of the MICs Obtained by Gradient Concentration Strip and EUCAST Methods for Four Azole Drugs and Amphotericin B Against azole-susceptible and -resistant Aspergillus section Fumigati clinical isolates.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01597.
    PubMed     Abstract available


  410. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    The Novel Arylamidine T-2307 Demonstrates In vitro and In vivo Activity Against Candida auris.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02198.
    PubMed     Abstract available


  411. ROSE WE, Bienvenida AM, Xiong YQ, Chambers HF, et al
    Ability of Bicarbonate Supplementation to Sensitize Selected Methicillin-Resistant Staphylococcus aureus (MRSA) Strains to beta-Lactam Antibiotics in an Ex Vivo Simulated Endocardial Vegetation Model.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02072.
    PubMed     Abstract available


  412. ABDELWAHAB MT, Leisegang R, Dooley KE, Mathad JS, et al
    Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in South African Pregnant Women with Tuberculosis and HIV.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.01978.
    PubMed     Abstract available


  413. AGUILERA-ALONSO D, Escosa-Garcia L, Saavedra-Lozano J, Cercenado E, et al
    Carbapenem-Resistant Gram-Negative Infections in Children.
    Antimicrob Agents Chemother. 2019 Dec 16. pii: AAC.02183.
    PubMed     Abstract available


  414. TORRES SR, Pichowicz A, Torres-Velez F, Song R, et al
    Impact of Candida auris infection in a neutropenic murine model.
    Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.01625.
    PubMed     Abstract available


  415. ASEMPA TE, Abdelraouf K, Carabeo T, Schuch R, et al
    Synergistic Activity of Exebacase (CF-301) in Addition to Daptomycin against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.02176.
    PubMed     Abstract available


  416. TSOLAKI V, Mantzarlis K, Mpakalis A, Malli E, et al
    Ceftazidime-avibactam to treat life-threatening infections from carbapenem resistant pathogens in critically ill mechanically ventilated patients.
    Antimicrob Agents Chemother. 2019 Dec 9. pii: AAC.02320.
    PubMed     Abstract available


  417. WU Y, Totten M, Memon W, Ying C, et al
    In vitro antifungal susceptibility of miltefosine alone and in combination with amphotericin B against emerging multidrug resistant Candida auris.
    Antimicrob Agents Chemother. 2019 Dec 2. pii: AAC.02063.
    PubMed     Abstract available


    November 2019
  418. RECIO R, Mancheno M, Viedma E, Villa J, et al
    Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa: Impact of Antimicrobial Resistance and Bacterial Virulence.
    Antimicrob Agents Chemother. 2019 Nov 25. pii: AAC.01759.
    PubMed     Abstract available


  419. ALBAC S, Labrousse D, Hayez D, Anzala N, et al
    Activity of different anti-staphylococcal therapies, alone or combined, in a rat model of methicillin-resistant Staphylococcus epidermidis osteitis without implant.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01865.
    PubMed     Abstract available


  420. FAN H, Chen Y, Duan L, Zhao J, et al
    Characterization of azole resistance in Aspergillus fumigatus from potting soil samples in a Chinese hospital:comparison of two typing methods.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.01578.
    PubMed     Abstract available


  421. GHOSH D, Veeraraghavan B, Elangovan R, Vivekanandan P, et al
    Antibiotic resistance and epigenetics: more to it than meets the eye.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.02225.
    PubMed     Abstract available


  422. FRAILE-RIBOT P, Zamorano L, Orellana R, Barrio-Tofino ED, et al
    Activity of imipenem/relebactam against a large collection of Pseudomonas aeruginosa clinical isolates and isogenic beta-lactam resistant mutants.
    Antimicrob Agents Chemother. 2019 Nov 18. pii: AAC.02165.
    PubMed     Abstract available


  423. MIZRAHI A, Marvaud JC, Pilmis B, Nguyen Van JC, et al
    Emergence of ceftriaxone resistance during a pneumococcal meningitis with fatal evolution.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01958.
    PubMed     Abstract available


  424. WATSON A, Sauve K, Cassino C, Schuch R, et al
    Exebacase demonstrates in vitro synergy with a broad range of antibiotics against both methicillin-resistant and methicillin-susceptible Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01885.
    PubMed     Abstract available


  425. LEPAK AJ, Zhao M, Marchillo K, VanHecker J, et al
    In Vivo Pharmacodynamic Evaluation of Omadacycline against Staphylococcus aureus in the Neutropenic Mouse Pneumonia Model.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.02058.
    PubMed     Abstract available


  426. LOWES DJ, Hevener KE, Peters BM
    The second-generation anti-diabetic sulfonylureas inhibit Candida albicans and Candidalysin mediated activation of the NLRP3 inflammasome.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01777.
    PubMed     Abstract available


  427. SUNDELL J, Bienvenu E, Birgersson S, Abelo A, et al
    Population pharmacokinetics and pharmacogenetics of ethambutol in adult patients co-infected with tuberculosis and HIV.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01583.
    PubMed     Abstract available


  428. CASTANHEIRA M, Doyle TB, Kantro V, Mendes RE, et al
    Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals During 2016-2018.
    Antimicrob Agents Chemother. 2019 Nov 11. pii: AAC.01951.
    PubMed     Abstract available


  429. GEBREMARIAM T, Alkhazraji S, Gu Y, Singh S, et al
    Galactomannan is a Biomarker of Fosmanogepix (APX001) Efficacy in Treating Experimental Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01966.
    PubMed     Abstract available


  430. GONG J, Wu J, Ikeh M, Tao L, et al
    Antifungal Activity of Mammalian Serum amyloid A1 against Candida albicans.
    Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01975.
    PubMed     Abstract available


  431. THALSO-MADSEN I, Torrubia FR, Xu L, Petersen A, et al
    The Sle1 Cell Wall Amidase is essential for beta-Lactam Resistance in Community Acquired Methicillin Resistant Staphylococcus aureus USA300.
    Antimicrob Agents Chemother. 2019 Nov 4. pii: AAC.01931.
    PubMed     Abstract available


  432. CHOUDHARY DK, Bhakt P, Kaur R
    Erratum for Choudhary et al., "Essential Role for the Phosphatidylinositol 3,5-Bisphosphate Synthesis Complex in Caspofungin Tolerance and Virulence in Candida glabrata".
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


  433. KAYE KS, Patel T, Drusano G
    Is Daptomycin plus Ceftaroline the Way To Go for Methicillin-Resistant Staphylococcus aureus Bacteremia?
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


  434. SAKOULAS G, Geriak M, Haddad F, Rose W, et al
    Reply to Kalil et al., "Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?"
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


  435. KALIL AC, Holubar M, Deresinski S, Chambers HF, et al
    Is Daptomycin plus Ceftaroline Associated with Better Clinical Outcomes than Standard of Care Monotherapy for Staphylococcus aureus Bacteremia?
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


    October 2019
  436. KHAN A, Shropshire WC, Hanson B, Dinh AQ, et al
    Simultaneous Infection with Enterobacteriaceae and Pseudomonas aeruginosa harboring Multiple Carbapenemases in a Returning Traveler colonized with Candida auris.
    Antimicrob Agents Chemother. 2019 Oct 28. pii: AAC.01466.
    PubMed     Abstract available


  437. KANG CK, Song KH, Kim SE, Kim ES, et al
    Durations of Staphylococcus aureus bacteremia according to different phenotypes and a new concept of persistent bacteremia: a prospective cohort study.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01656.
    PubMed     Abstract available


  438. VERDEROSA AD, Dhouib R, Fairfull-Smith KE, Totsika M, et al
    Nitroxide functionalized antibiotics are promising eradication agents against Staphylococcus aureus biofilms.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01685.
    PubMed     Abstract available


  439. IOVLEVA A, Mettus RT, McElheny CL, Griffifth MP, et al
    High-level carbapenem resistance triggered by ertapenem therapy in OXA-232-producing Raoultella ornithinolytica.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01335.
    PubMed     Abstract available


  440. YADAV R, Bergen PJ, Rogers KE, Kirkpatrick CMJ, et al
    Meropenem-tobramycin combination regimens combat carbapenem-resistant Pseudomonas aeruginosa in the hollow-fiber infection model simulating augmented renal clearance in critically ill patients.
    Antimicrob Agents Chemother. 2019 Oct 21. pii: AAC.01679.
    PubMed     Abstract available


  441. CEBALLOS S, Kim C, Qian Y, Mobashery S, et al
    Susceptibility of methicillin-resistant Staphylococcus aureus to five quinazolinone antibacterials.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01344.
    PubMed     Abstract available


  442. DONNELLAN S, Aljayyoussi G, Moyo E, Ardrey A, et al
    Intracellular pharmacodynamic modelling (PDi) is predictive of the clinical activity of fluoroquinolones against Tuberculosis.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.00989.
    PubMed     Abstract available


  443. KAPOOR M, Moloney M, Soltow QA, Pillar CM, et al
    Evaluation of Resistance Development to the Gwt1 inhibitor Manogepix (APX001A) in Candida Species.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01387.
    PubMed     Abstract available


  444. KUIPERS S, Ruth MM, Mientjes M, de Sevaux RGL, et al
    Successful treatment of chronic relapsing urinary tract infection with bacteriophages in a renal transplant recipient - a Dutch case report.
    Antimicrob Agents Chemother. 2019 Oct 14. pii: AAC.01281.
    PubMed     Abstract available


  445. BIDAUD AL, Botterel F, Chowdhary A, Dannaoui E, et al
    In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01393.
    PubMed     Abstract available


  446. PETRAITIS V, Petraitiene R, Valdez JM, Pyrgos V, et al
    Amphotericin B Penetrates into the Central Nervous System Through Focal Disruption of the Blood Brain Barrier in Experimental Hematogenous Candida Meningoencephalitis.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01626.
    PubMed     Abstract available


  447. KEMPKER RR, Alghamdi WA, Al-Shaer MH, Burch G, et al
    A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01215.
    PubMed     Abstract available


  448. CLARKE RS, Bruderer MS, Ha KP, Edwards AM, et al
    RexAB is essential for the mutagenic repair of Staphylococcus aureus DNA damage caused by co-trimoxazole.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.00944.
    PubMed     Abstract available


  449. ALAMIRI F, Riesbeck K, Hakansson AP
    HAMLET, a protein complex from human milk has bactericidal activity and enhances the activity of antibiotics against pathogenic Streptococci.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01193.
    PubMed     Abstract available


  450. KORDALEWSKA M, Lee A, Zhao Y, Perlin DS, et al
    Detection of Candida auris antifungal drug resistance markers directly from clinical skin swabs.
    Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01754.
    PubMed     Abstract available


  451. LURASCHI A, Richard S, Hauser PM
    Reply to Nevez and Le Gal, "Caspofungin and Pneumocystis Pneumonia: It Is Time To Go Ahead".
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


  452. NEVEZ G, Le Gal S
    Caspofungin and Pneumocystis Pneumonia: It Is Time To Go Ahead.
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


    September 2019
  453. LYONS MA
    Modeling and Simulation of Pretomanid Pharmacodynamics in Pulmonary Tuberculosis Patients.
    Antimicrob Agents Chemother. 2019 Sep 30. pii: AAC.00732.
    PubMed     Abstract available


  454. LOPES AA, Yoshii Y, Yamada S, Nagakura M, et al
    Roles of lytic transglycosylases in biofilm formation and beta-lactam resistance in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Sep 30. pii: AAC.01277.
    PubMed     Abstract available


  455. GHANNOUM M, Long L, Isham N, Hager C, et al
    Activity of a novel 1,3-beta-D-glucan Synthase Inhibitor, Ibrexafungerp (formerly SCY-078), Against Candida glabrata.
    Antimicrob Agents Chemother. 2019 Sep 30. pii: AAC.01510.
    PubMed     Abstract available


  456. CARRIGY NB, Larsen SE, Reese V, Pecor T, et al
    Prophylaxis of Mycobacterium tuberculosis H37Rv Infection in a Preclinical Mouse Model via Inhalation of Nebulized Bacteriophage D29.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00871.
    PubMed     Abstract available


  457. WATKINS RR, Holubar M, David MZ
    Antimicrobial resistance in methicillin-resistant Staphylococcus aureus to newer antimicrobial agents.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01216.
    PubMed     Abstract available


  458. RODRIGUES M, McBride SW, Hullahalli K, Palmer KL, et al
    Conjugative delivery of CRISPR-Cas9 for the selective depletion of antibiotic-resistant enterococci.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01454.
    PubMed     Abstract available


  459. SOMMER R, Cole ST
    Monitoring Tuberculosis Drug Activity in Live Animals by Near-Infrared Fluorescence Imaging.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.01280.
    PubMed     Abstract available


  460. HENDON-DUNN CL, Pertinez H, Marriott AAN, Hatch K, et al
    Re-growth of Mycobacterium tuberculosis populations exposed to antibiotic combinations is due to the presence of isoniazid and not bacterial growth rate.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00570.
    PubMed     Abstract available


  461. JO KW, Kim M, Kim YJ, Lee HK, et al
    Early discontinuation of ethambutol in pulmonary tuberculosis treatment based on results of the GenoType MTBDRplus assay: A prospective, multicenter, non-inferiority randomized trial in South Korea.
    Antimicrob Agents Chemother. 2019 Sep 16. pii: AAC.00980.
    PubMed     Abstract available


  462. BRINK M, Glimaker M, Sjolin J, Naucler P, et al
    Meropenem versus cefotaxime and ampicillin as empirical antibiotic treatment in adult bacterial meningitis: A quality registry study 2008-2016.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.00883.
    PubMed     Abstract available


  463. YADAV R, Saini A, Agarwal P, Kapoor P, et al
    A rare D94F change in gyrA gene of multi-drug resistant Mycobacterium tuberculosis possibly contributing to an unfavorable treatment outcome.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01312.
    PubMed     Abstract available


  464. KIM D, Hong JS, Yoon EJ, Lee H, et al
    Toxic shock syndrome toxin 1-producing methicillin-resistant Staphylococcus aureus of clonal complex 5, the New York/Japan epidemic clone, causing a high early mortality rate in patients with bloodstream infections.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01362.
    PubMed     Abstract available


  465. RICHARDS JP, Cai W, Zill NA, Zhang W, et al
    Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01213.
    PubMed     Abstract available


  466. YUI ETO K, Firth N, Davis AM, Kwong SM, et al
    Evolution of a 72-kb cointegrant, conjugative multiresistance plasmid from early community-associated methicillin-resistant Staphylococcus aureus isolates.
    Antimicrob Agents Chemother. 2019 Sep 9. pii: AAC.01560.
    PubMed     Abstract available


  467. NUNNALLY NS, Etienne KA, Angulo D, Lockhart SR, et al
    In vitro activity of ibrexafungerp, a novel glucan synthase inhibitor against Candida glabrata isolates with FKS mutations.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01692.
    PubMed     Abstract available


  468. LAMOTH F, Kontoyiannis DP
    Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01244.
    PubMed     Abstract available


  469. LEPAK AJ, Zhao M, Andes DR
    Determination of Pharmacodynamic Target Exposures for Rezafungin against Candida tropicalis and Candida dubliniensis in the Neutropenic Mouse Disseminated Candidiasis Model.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.01556.
    PubMed     Abstract available


  470. MURASE LS, de Souza JVP, Meneguello JE, Seixas FAV, et al
    Possible binding of piperine in Mycobacterium tuberculosis RNA-polymerase and rifampicin synergism.
    Antimicrob Agents Chemother. 2019 Sep 3. pii: AAC.02520.
    PubMed     Abstract available


  471. DEMARCO VP, Ordonez AA, Klunk M, Prideaux B, et al
    Erratum for DeMarco et al., "Determination of [(11)C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging".
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


    August 2019
  472. SALINGER DH, Nedelman JR, Mendel C, Spigelman M, et al
    Daily Dosing for Bedaquiline in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00463.
    PubMed     Abstract available


  473. TALBOT JJ, Frisvad JC, Meis JF, Hagen F, et al
    Cyp51A mutations, Extrolite Profiles and Antifungal Susceptibility in Clinical and Environmental Isolates of the Aspergillus viridinutans Species Complex.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00632.
    PubMed     Abstract available


  474. ALBANO M, Karau MJ, Greenwood-Quaintance KE, Osmon DR, et al
    In vitro Activity of Rifampin, Rifabutin, Rifapentine and Rifaximin Against Planktonic and Biofilm States of Staphylococci Isolated from Periprosthetic Joint Infection.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.00959.
    PubMed     Abstract available


  475. KISHIMOTO T, Ishida W, Fukuda K, Nakajima I, et al
    Therapeutic Effects of Intravitreously Administered Bacteriophage in a Mouse Model of Endophthalmitis Caused by Vancomycin-Sensitive or -Resistant Enterococcus faecalis.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.01088.
    PubMed     Abstract available


  476. HAN JH, Lapp Z, Bushman F, Lautenbach E, et al
    Whole Genome Sequencing to Identify Drivers of Carbapenem-Resistant Klebsiella pneumoniae Transmission Within and Between Regional Long-Term Acute Care Hospitals.
    Antimicrob Agents Chemother. 2019 Aug 26. pii: AAC.01622.
    PubMed     Abstract available


  477. WIEDERHOLD NP, Najvar LK, Shaw KJ, Jaramillo R, et al
    Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01120.
    PubMed     Abstract available


  478. TANNER L, Evans JC, Seldon R, Jordaan A, et al
    In vitro efficacies, ADME, and pharmacokinetic properties of phenoxazine derivatives active against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01010.
    PubMed     Abstract available


  479. XIAO S, Guo H, Weiner WS, Maddox C, et al
    Revisiting the beta-lactams for tuberculosis therapy: a compound-compound synthetic lethality approach.
    Antimicrob Agents Chemother. 2019 Aug 19. pii: AAC.01319.
    PubMed     Abstract available


  480. WILLEMS HME, Stultz JS, Coltrane ME, Fortwendel JP, et al
    Disparate Candida albicans biofilm formation in clinical lipid emulsions due to capric acid mediated inhibition.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01394.
    PubMed     Abstract available


  481. WANG Q, Modongo C, Allender C, Engelthaler DM, et al
    Utility of targeted, amplicon-based deep sequencing to detect resistance to first-line tuberculosis drugs in Botswana.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00982.
    PubMed     Abstract available


  482. NAKAMURA I, Ohsumi K, Takeda S, Katsumata K, et al
    ASP2397, a novel natural compound that exhibits rapid and potent fungicidal activity against Aspergillus species through a specific transporter.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.02689.
    PubMed     Abstract available


  483. WIEDERHOLD NP, Najvar LK, Jaramillo R, Olivo M, et al
    Extended-Interval Dosing of Rezafungin against Azole-Resistant Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.01165.
    PubMed     Abstract available


  484. JIA X, Ren H, Nie X, Li Y, et al
    Antibiotic resistance and azithromycin resistance mechanism of Legionella pneumophila serogroup 1 in China.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00768.
    PubMed     Abstract available


  485. SALINGER DH, Subramoney V, Everitt D, Nedelman JR, et al
    Population Pharmacokinetics of Pretomanid.
    Antimicrob Agents Chemother. 2019 Aug 12. pii: AAC.00907.
    PubMed     Abstract available


  486. PARK Y, Ahn YM, Jonnala S, Oh S, et al
    Inhibition of CorA dependent Magnesium Homeostasis is cidal in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01006.
    PubMed     Abstract available


  487. TUCKER EW, Pieterse L, Zimmerman MD, Udwadia ZF, et al
    Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.00913.
    PubMed     Abstract available


  488. NISHIMOTO AT, Whaley SG, Wiederhold NP, Zhang Q, et al
    Impact of the major Candida glabrata triazole resistance determinants on the activity of the novel investigational tetrazoles VT-1598 and VT-1161.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01304.
    PubMed     Abstract available


  489. MARIMUTHU K, Ng OT, Cherng BPZ, Fong RKC, et al
    Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (NCPCRE) and Carbapenemase-Producing Enterobacteriaceae (CPE).
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.00845.
    PubMed     Abstract available


  490. VAZQUEZ-UCHA JC, Martinez-Guitian M, Maneiro M, Conde-Perez K, et al
    Therapeutic efficacy of LN-1-255 in combination with imipenem in severe infection caused by carbapenem-resistant Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2019 Aug 5. pii: AAC.01092.
    PubMed     Abstract available


  491. WRIGHT WF, Bejou N, Shields RK, Marr K, et al
    Amphotericin B Induction with Voriconazole Consolidation as Salvage Therapy for FKS-Associated Echinocandin Resistance in Candida glabrata Septic Arthritis and Osteomyelitis.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


    July 2019
  492. KARAU MJ, Schmidt-Malan SM, Yan Q, Greenwood-Quaintance KE, et al
    Exebacase in Addition to Daptomycin is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.01235.
    PubMed     Abstract available


  493. LI H, Salinger DH, Everitt D, Li M, et al
    Long-Term Effects on QT prolongation of Pretomanid, Alone and in Combinations, in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00445.
    PubMed     Abstract available


  494. SARATHY JP, Ragunathan P, Shin J, Cooper CB, et al
    TBAJ-876 retains Bedaquiline's activity against subunit c and of Mycobacterium tuberculosis F-ATP synthase.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.01191.
    PubMed     Abstract available


  495. GONCALVES BV, Portela R, Lobo R, Figueiredo TA, et al
    The role of MurT C-terminal domain in the amidation of Staphylococcus aureus peptidoglycan.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00957.
    PubMed     Abstract available


  496. XU Q, Chen T, Yan B, Zhang L, et al
    Dual role of gnaA in antibiotic resistance and virulence in Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2019 Jul 29. pii: AAC.00694.
    PubMed     Abstract available


  497. PRATER AG, Mehta HH, Kosgei AJ, Miller WR, et al
    Environment Shapes the Accessible Daptomycin Resistance Mechanisms in Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00790.
    PubMed     Abstract available


  498. WATSON A, Oh JT, Sauve K, Bradford PA, et al
    Antimicrobial Activity of Exebacase (Lysin CF-301) Against the Most Common Causes of Infective Endocarditis.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.01078.
    PubMed     Abstract available


  499. KORYCKA-MACHALA M, Viljoen A, Pawelczyk J, Borowka P, et al
    1H-benzo[d]imidazole derivatives affect MmpL3 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jul 22. pii: AAC.00441.
    PubMed     Abstract available


  500. G C B, Sahukhal GS, Elasri MO
    Role of the msaABCR operon in cell wall biosynthesis, autolysis, integrity, and antibiotic resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00680.
    PubMed     Abstract available


  501. BELLOUARD R, Deschanvres C, Deslandes G, Dailly E, et al
    Cefazolin dosage adaptation in bacteremia and infective endocarditis based on a nomogram: a population pharmacokinetic study.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00806.
    PubMed     Abstract available


  502. YOUSFI H, Cassagne C, Ranque S, Rolain JM, et al
    Repurposing of ribavirin as an adjunct therapy against invasive Candida strains: In vitro study.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.00263.
    PubMed     Abstract available


  503. DONG N, Sun Q, Huang Y, Shu L, et al
    Evolution of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae by acquisition of bla VIM-1-bearing plasmid.
    Antimicrob Agents Chemother. 2019 Jul 15. pii: AAC.01056.
    PubMed     Abstract available


  504. RIVERO-MENENDEZ O, Soto-Debran JC, Medina N, Lucio J, et al
    Molecular identification, antifungal susceptibility testing and mechanisms of azole resistance in Aspergillus spp. received within a surveillance program on antifungal resistance in Spain.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00865.
    PubMed     Abstract available


  505. VATANSHENASSAN M, Arastehfar A, Boekhout T, Berman J, et al
    Rapid antifungal susceptibility testing of Candida glabrata isolates against anidulafungin from positive blood culture by MBT ASTRA.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00554.
    PubMed     Abstract available


  506. KIDWAI S, Bouzeyen R, Chakraborti S, Khare N, et al
    NU-6027 inhibits growth of Mycobacterium tuberculosis by targeting Protein Kinase D and Protein Kinase G.
    Antimicrob Agents Chemother. 2019 Jul 8. pii: AAC.00996.
    PubMed     Abstract available


  507. DAHESH S, Wong B, Nizet V, Sakoulas G, et al
    Treatment of Multidrug-Resistant Vancomycin-Resistant Enterococcus faecium Hardware-Associated Vertebral Osteomyelitis with Oritavancin plus Ampicillin.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


  508. GHODOUSI A, Rizvi AH, Baloch AQ, Ghafoor A, et al
    Acquisition of cross-resistance to Bedaquiline and Clofazimine following treatment for Tuberculosis in Pakistan.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00915.
    PubMed     Abstract available


  509. LI Q, Cheng J, Wu Y, Wang Z, et al
    Effects of Delayed Antibiotic Therapy on Outcomes in Children with Streptococcus pneumoniae Sepsis.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00623.
    PubMed     Abstract available


  510. CANVER MC, Satlin MJ, Westblade LF, Kreiswirth BN, et al
    Activity of imipenem-relebactam and comparator agents against genetically characterized isolates of carbapenem-resistant Enterobacteriaceae.
    Antimicrob Agents Chemother. 2019 Jul 1. pii: AAC.00672.
    PubMed     Abstract available


    June 2019
  511. GREGOIRE M, Dailly E, Turnier PL, Garot D, et al
    High-dose ceftriaxone for bacterial meningitis: optimization of administration scheme based on nomogram.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00634.
    PubMed     Abstract available


  512. YAMASHITA Y, Nagaoka K, Kimura H, Suzuki M, et al
    Efficacy of azithromycin in a mouse pneumonia model against hospital-acquired methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00149.
    PubMed     Abstract available


  513. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Penicillin-binding protein typing, antibiotic resistance gene identification and molecular phylogenetic analysis of meropenem-resistant Streptococcus pneumoniae serotype 19A-CC3111 strains in Japan.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00711.
    PubMed     Abstract available


  514. SEWELL TR, Zhang Y, Brackin AP, Shelton JMG, et al
    Elevated prevalence of azole resistant Aspergillus fumigatus in urban versus rural environments in the United Kingdom.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00548.
    PubMed     Abstract available


  515. PAULSHUS E, Thorell K, Guzman-Otazo J, Joffre E, et al
    Repeated isolation of ESBL positive Escherichia coli ST648 and ST131 from community wastewater - are sewage systems important sources of emerging clones of antibiotic resistant bacteria?
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00823.
    PubMed     Abstract available


  516. LAM SW, Athans V
    Clinical and Microbiological Outcomes in Obese Patients Receiving Colistin for Carbapenem-Resistant Gram-negative Bloodstream Infection.
    Antimicrob Agents Chemother. 2019 Jun 24. pii: AAC.00531.
    PubMed     Abstract available


  517. REHBERG N, Omeje E, Ebada SS, van Geelen L, et al
    3-O-Methyl-alkylgallates inhibit fatty acid desaturation in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00136.
    PubMed     Abstract available


  518. RODRIGUEZ LOPEZ AL, Lee MR, Wang NB, Dunn KK, et al
    Small-molecule morphogenesis modulators enhance the ability of 14-helical beta-peptides to prevent Candida albicans biofilm formation.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02653.
    PubMed     Abstract available


  519. LI D, Li XY, Schwarz S, Yang M, et al
    Tn6674, a Novel Enterococcal optrA-Carrying Multiresistance Transposon of the Tn554 Family.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00809.
    PubMed     Abstract available


  520. LEE H, Boyle-Vavra S, Ren J, Jarusiewicz J, et al
    Identification of small molecules exhibiting oxacillin synergy through a novel assay for inhibition of vraTSR expression in methicillin resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.02593.
    PubMed     Abstract available


  521. BHAGWAT SS, Periasamy H, Takalkar SS, Chavan R, et al
    In vivo pharmacokinetic/pharmacodynamic targets of levonadifloxacin against Staphylococcus aureus in a neutropenic murine lung infection model.
    Antimicrob Agents Chemother. 2019 Jun 17. pii: AAC.00909.
    PubMed     Abstract available


  522. PERICAS JM, Nathavitharana R, Garcia-de-la-Maria C, Falces C, et al
    Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00516.
    PubMed     Abstract available


  523. OKUSANYA OO, Forrest A, Bhavnani SM, Fernandes P, et al
    Pharmacokinetic/Pharmacodynamic Evaluation of Solithromycin Against Streptococcus pneumoniae Using Data from a Neutropenic Murine-Lung Infection Model.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.02606.
    PubMed     Abstract available


  524. TENERO D, Derimanov G, Carlton A, Tonkyn J, et al
    First time in human (FTIH) study and prediction of early bactericidal activity for GSK3036656, a potent Leucyl - tRNA synthetase inhibitor for tuberculosis treatment.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00240.
    PubMed     Abstract available


  525. KIM DH, Jhun BW, Moon SM, Kim SY, et al
    In Vitro Activity of Bedaquiline and Delamanid Against Nontuberculous Mycobacteria Including Macrolide-Resistant Clinical Isolates.
    Antimicrob Agents Chemother. 2019 Jun 10. pii: AAC.00665.
    PubMed     Abstract available


  526. MCNEIL MB, Cook GM
    Utilization of CRISPR interference to validate MmpL3 as a drug target in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00629.
    PubMed     Abstract available


  527. KOHLHOFF S, Huerta N, Hammerschlag MR
    In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.01048.
    PubMed     Abstract available


  528. GARCIA MT, Valenzuela MV, Ferrandiz MJ, de la Campa AG, et al
    Reactive Oxygen Species Production is a Major Factor Directing the Post-antibiotic Effect of Fluoroquinolones in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00737.
    PubMed     Abstract available


  529. LE HN, Tran VG, Vu TTT, Gras E, et al
    Treatment Efficacy of MEDI3902 in Pseudomonas aeruginosa blood stream infection and acute pneumonia rabbit models.
    Antimicrob Agents Chemother. 2019 Jun 3. pii: AAC.00710.
    PubMed     Abstract available


  530. O'DONNELL MR, Larsen MH, Brown TS, Jain P, et al
    Erratum for O'Donnell et al., "Early Detection of Emergent Extensively Drug-Resistant Tuberculosis by Flow Cytometry-Based Phenotyping and Whole-Genome Sequencing".
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


  531. MACDONALD D, Thomson DD, Johns A, Valenzuela AC, et al
    Correction for Macdonald et al., "Inducible Cell Fusion Permits Use of Competitive Fitness Profiling in the Human Pathogenic Fungus Aspergillus fumigatus".
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


    May 2019
  532. YU X, Gao X, Li C, Luo J, et al
    In Vitro Activity of bedaquiline and delamanid against Non-tuberculous Mycobacteria isolated in Beijing, China.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00031.
    PubMed     Abstract available


  533. CHOUDHARY DK, Bhakt P, Kaur R
    An essential role for the PI(3,5)P2 synthesis complex in caspofungin tolerance and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00886.
    PubMed     Abstract available


  534. ORTINES RV, Wang Y, Liu H, Dikeman DA, et al
    Efficacy of a multimechanistic monoclonal antibody combination against Staphylococcus aureus surgical site infections in mice.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00346.
    PubMed     Abstract available


  535. ARUANNO M, Glampedakis E, Lamoth F
    Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00399.
    PubMed     Abstract available


  536. TOHYA M, Tada T, Watanabe S, Kuwahara-Arai K, et al
    Emergence of carbapenem-resistant Pseudomonas asiatica producing NDM-1 and VIM-2 metallo-beta-lactamases in Myanmar.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00475.
    PubMed     Abstract available


  537. TAMMA PD, Kazmi A, Bergman Y, Goodman KE, et al
    The Likelihood of Developing a Carbapenem-Resistant Enterobacteriaceae Infection during the Hospital Stay.
    Antimicrob Agents Chemother. 2019 May 28. pii: AAC.00757.
    PubMed     Abstract available


  538. SUVICHAPANICH S, Wattanapokayakit S, Mushiroda T, Yanai H, et al
    Genome-Wide Association Study Confirming the Association of NAT2 with Susceptibility to Anti-tuberculosis Drug-Induced Liver Injury in Thai Patients.
    Antimicrob Agents Chemother. 2019 May 20. pii: AAC.02692.
    PubMed     Abstract available


  539. SEIFERT M, Capparelli E, Catanzaro DG, Rodwell TC, et al
    Using Mycobacterium tuberculosis single nucleotide polymorphisms to predict fluoroquinolone treatment response.
    Antimicrob Agents Chemother. 2019 May 13. pii: AAC.00076.
    PubMed     Abstract available


  540. ARUANNO M, Bachmann D, Sanglard D, Lamoth F, et al
    Link between heat shock protein 90 (Hsp90) and the mitochondrial respiratory chain in the caspofungin stress response of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00208.
    PubMed     Abstract available


  541. SANGUINETTI M, Canton E, Torelli R, Tumietto F, et al
    In Vitro Activity of Fenticonazole against Candida and Bacterial Vaginitis Isolates Determined by Mono- or Dual-Species Testing Assays.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.02693.
    PubMed     Abstract available


  542. PEREZ-CANTERO A, Lopez-Fernandez L, Guarro J, Capilla J, et al
    New insights into the Cyp51 contribution to azole resistance in Aspergillus section Nigri.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00543.
    PubMed     Abstract available


  543. MURI L, Perny M, Zemp J, Grandgirard D, et al
    Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage and Hearing Loss in Infant Rat Pneumococcal Meningitis.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00220.
    PubMed     Abstract available


  544. ZHANG Y, Zhu H, Fu L, Wang B, et al
    Identifying regimens containing a new drug candidate TBI-166 against Mycobacterium tuberculosis in vitro and in vivo.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.02496.
    PubMed     Abstract available


  545. AL-SHAER MH, Alghamdi WA, Alsultan A, An G, et al
    Fluoroquinolones in drug-resistant tuberculosis: culture conversion and pharmacokinetic/pharmacodynamic target attainment to guide dose selection.
    Antimicrob Agents Chemother. 2019 May 6. pii: AAC.00279.
    PubMed     Abstract available


    April 2019
  546. LEPAK AJ, Zhao M, Marchillo K, VanHecker J, et al
    In vivo Pharmacodynamics of Omadacycline against Staphylococcus aureus in the Neutropenic Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00624.
    PubMed     Abstract available


  547. VARGAS-CRUZ N, Reitzel RA, Rosenblatt J, Chaftari AM, et al
    Nitroglycerin-Citrate-Ethanol (NiCE) Catheter Lock Solution is Highly Effective for in vitro Eradication of Candida auris Biofilm.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00299.
    PubMed     Abstract available


  548. KASPAR JR, Godwin MJ, Velsko IM, Richards VP, et al
    Spontaneously Arising Streptococcus mutans Variants With Reduced Susceptibility to Chlorhexidine Display Genetic Defects and Diminished Fitness.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00161.
    PubMed     Abstract available


  549. DIAZ IGLESIAS Y, Wilms T, Vanbever R, Van Bambeke F, et al
    Activity of antibiotics against Staphylococcus aureus in an in vitro model of biofilms in the context of cystic fibrosis: influence of the culture medium.
    Antimicrob Agents Chemother. 2019 Apr 29. pii: AAC.00602.
    PubMed     Abstract available


  550. VAN DEN ELSEN SHJ, Sturkenboom MGG, Akkerman OW, Manika K, et al
    Limited sampling strategies using linear regression and the Bayesian approach for therapeutic drug monitoring of moxifloxacin in tuberculosis patients.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00384.
    PubMed     Abstract available


  551. GHODOUSI A, Tagliani E, Karunaratne E, Niemann S, et al
    Isoniazid resistance in Mycobacterium tuberculosis is a heterogeneous phenotype comprised of overlapping MIC distributions with different underlying resistance mechanisms.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00092.
    PubMed     Abstract available


  552. IACOBINO A, Giannoni F, Pardini M, Piccaro G, et al
    The combination rifampin-nitazoxanide, but not rifampin-isoniazid-pyrazinamide-ethambutol, kills dormant Mycobacterium tuberculosis in hypoxia at neutral pH.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00273.
    PubMed     Abstract available


  553. LUN S, Tasneen R, Chaira T, Stec J, et al
    Advancing the therapeutic potential of indoleamides for tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00343.
    PubMed     Abstract available


  554. ERSOY SC, Abdelhady W, Li L, Chambers HF, et al
    Bicarbonate Resensitization of Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00496.
    PubMed     Abstract available


  555. KIM D, Lee H, Yoon EJ, Hong JS, et al
    Clinical prognoses of patients with a bloodstream infection caused by ampicillin-susceptible but penicillin-resistant Enterococcus faecalis: prospective observational study.
    Antimicrob Agents Chemother. 2019 Apr 22. pii: AAC.00291.
    PubMed     Abstract available


  556. ADDETIA A, Greninger AL, Adler A, Yuan S, et al
    A novel, widespread qacA allele results in reduced chlorhexidine susceptibility in Staphylococcus epidermidis.
    Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.02607.
    PubMed     Abstract available


  557. LEE A, Prideaux B, Lee MH, Zimmerman M, et al
    Tissue distribution and penetration of isavuconazole at the site of infection in Experimental Invasive Aspergillosis in Mice with underlying Chronic Granulomatous Disease.
    Antimicrob Agents Chemother. 2019 Apr 15. pii: AAC.00524.
    PubMed     Abstract available


  558. LOISEAU C, Brites D, Moser I, Coll F, et al
    Revised interpretation of the Hain Lifescience GenoType MTBC to differentiate Mycobacterium canettii and members of the M. tuberculosis complex.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00159.
    PubMed     Abstract available


  559. KEBRIAEI R, Rice SA, Stamper KC, Seepersaud R, et al
    Daptomycin Dose-Ranging Evaluation with Single vs. Multi-Dose Ceftriaxone Combinations against Streptococcus mitis-oralis in an Ex Vivo Simulated Endocarditis Vegetation Model.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00386.
    PubMed     Abstract available


  560. BERUBE BJ, Russell D, Castro L, Choi SR, et al
    Novel MenA inhibitors are bactericidal against Mycobacterium tuberculosis and synergize with electron-transport chain inhibitors.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02661.
    PubMed     Abstract available


  561. RANJAN R, Srivastava A, Bharti R, Roy T, et al
    Preclinical development of inhalable D-cycloserine and ethionamide to overcome pharmacokinetic interaction and enhance efficacy against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.00099.
    PubMed     Abstract available


  562. SIOPI M, Mouton J, Pournaras S, Meletiadis J, et al
    In vitro and in vivo exposure-effect relationship of liposomal amphotericin B against Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2019 Apr 8. pii: AAC.02673.
    PubMed     Abstract available


  563. HUANG Y, Alumasa JN, Callaghan LT, Baugh RS, et al
    A Small-Molecule Inhibitor of trans-Translation Synergistically Interacts with Cathelicidin Antimicrobial Peptides To Impair Survival of Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


  564. TETZ G, Collins M, Vikina D, Tetz V, et al
    In Vitro Activity of a Novel Antifungal Compound, MYC-053, against Clinically Significant Antifungal-Resistant Strains of Candida glabrata, Candida auris, Cryptococcus neoformans, and Pneumocystis spp.
    Antimicrob Agents Chemother. 2019;63.
    PubMed     Abstract available


  565. LI Y, Liu G, Zhai Z, Liu L, et al
    Erratum for Li et al., "Antibacterial Properties of Magnesium In Vitro and in an In Vivo Model of Implant-Associated Methicillin-Resistant Staphylococcus aureus Infection".
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


  566. ARASTEHFAR A, Daneshnia F, Zomorodian K, Najafzadeh MJ, et al
    Low level of antifungal resistance in Iranian isolates of Candida glabrata recovered from blood samples from multicenter (2015-2018): Potential prognostic values of genotyping and sequencing of PDR1.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02503.
    PubMed     Abstract available


  567. OH JT, Cassino C, Schuch R
    Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity Against Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.02616.
    PubMed     Abstract available


  568. AIGNER M, Wanner M, Kreidl P, Lass-Florl C, et al
    Candida in the respiratory tract potentially triggers galactomannan-positivity in non-haematological patients.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.00138.
    PubMed     Abstract available


  569. SAINI V, Ammerman NC, Chang YS, Tasneen R, et al
    Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis.
    Antimicrob Agents Chemother. 2019 Apr 1. pii: AAC.00388.
    PubMed     Abstract available


    March 2019
  570. NISHIMOTO AT, Wiederhold NP, Flowers SA, Zhang Q, et al
    In vitro activities of the novel investigational tetrazoles VT-1161 and VT-1598 compared to the triazole antifungals against azole-resistant strains and clinical isolates of Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.00341.
    PubMed     Abstract available


  571. PECK M, Rothenberg ME, Deng R, Lewin-Koh N, et al
    A phase 1, randomized, single ascending-dose study to investigate the safety, tolerability, and pharmacokinetics of DSTA4637S, an anti-Staphylococcus aureus THIOMAB antibody-antibiotic conjugate, in healthy volunteers.
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.02588.
    PubMed     Abstract available


  572. SEKAGGYA-WILTSHIRE C, Chirehwa M, Musaazi J, von Braun A, et al
    Low anti-tuberculosis drug concentrations in HIV-Tuberculosis co-infected adults with low body weight; is it time to update dosing guidelines?
    Antimicrob Agents Chemother. 2019 Mar 25. pii: AAC.02174.
    PubMed     Abstract available


  573. SEYEDMOUSAVI S, Chang Y, Law D, Birch M, et al
    Efficacy of olorofim (F901318) against Aspergillus fumigatus, A. nidulans, and A. tanneri in murine models of profound neutropenia and chronic granulomatous disease.
    Antimicrob Agents Chemother. 2019 Mar 18. pii: AAC.00129.
    PubMed     Abstract available


  574. SINGH KV, Murray BE
    Loss of a Major Enterococcal Polysaccharide Antigen (Epa) by Enterococcus faecalis is Associated with Increased Resistance to Ceftriaxone and Carbapenems.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00481.
    PubMed     Abstract available


  575. SHI W, Cui P, Niu H, Zhang S, et al
    Introducing RpsA Point Mutations Delta438A and D123A into the Chromosome of M. tuberculosis Confirms their Role in Causing Resistance to Pyrazinamide.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02681.
    PubMed     Abstract available


  576. ALGHAMDI WA, Alsultan A, Al-Shaer MH, An G, et al
    Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00055.
    PubMed     Abstract available


  577. BUTTS A, Reitler P, Nishimoto AT, DeJarnette C, et al
    A systematic screen reveals a diverse collection of medications induce antifungal resistance in Candida species.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.00054.
    PubMed     Abstract available


  578. GERIAK M, Haddad F, Rizvi K, Rose W, et al
    Clinical Data on Daptomycin Plus Ceftaroline Versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02483.
    PubMed     Abstract available


  579. JANARDHANAN J, Bouley R, Martinez-Caballero S, Peng Z, et al
    The quinazolinone allosteric inhibitor of PBP2a synergizes with piperacillin and tazobactam against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Mar 11. pii: AAC.02637.
    PubMed     Abstract available


  580. XU J, Li SY, Almeida DV, Tasneen R, et al
    Contribution of pretomanid to novel regimens containing bedaquiline with either linezolid or moxifloxacin and pyrazinamide in murine models of tuberculosis.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.00021.
    PubMed     Abstract available


  581. NISHIMOTO AT, Zhang Q, Hazlett B, Morschhauser J, et al
    The contribution of clinically-derived mutations in the gene encoding the zinc cluster transcription factor Mrr2 to fluconazole antifungal resistance and CDR1 expression in Candida albicans.
    Antimicrob Agents Chemother. 2019 Mar 4. pii: AAC.00078.
    PubMed     Abstract available


    February 2019
  582. NAKANO S, Fujisawa T, Ito Y, Chang B, et al
    Whole-genome sequencing analysis of multidrug-resistant serotype 15A Streptococcus pneumoniae in Japan and the emergence of a highly resistant serotype 15A-ST9084 clone.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02579.
    PubMed     Abstract available


  583. SARATHY J, Blanc L, Alvarez-Cabrera N, O'Brien P, et al
    Fluoroquinolone efficacy against tuberculosis is driven by penetration into lesions and activity against resident bacterial populations.
    Antimicrob Agents Chemother. 2019 Feb 25. pii: AAC.02516.
    PubMed     Abstract available


  584. BAINES SL, Jensen SO, Firth N, Goncalves da Silva A, et al
    Remodelling of pSK1 Family Plasmids and Enhanced Chlorhexidine Tolerance in a Dominant Hospital Lineage of Methicillin-Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02356.
    PubMed     Abstract available


  585. WARRILOW AG, Nishimoto AT, Parker JE, Price CL, et al
    The Evolution of Azole Resistance in Candida albicans Sterol 14alpha-Demethylase (CYP51) through Incremental Amino Acid Substitutions.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02586.
    PubMed     Abstract available


  586. GINGRAS H, Patron K, Bhattacharya A, Leprohon P, et al
    Gain and loss of function screens coupled to next generation sequencing for antibiotic mode of action and resistance studies in Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02381.
    PubMed     Abstract available


  587. DENEGA I, d'Enfert C, Bachellier-Bassi S
    Candida albicans biofilms are generally devoid of persister cells.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01979.
    PubMed     Abstract available


  588. XU J, Wang B, Fu L, Zhu H, et al
    In vitro and in vivo activities of the riminophenazine TBI-166 against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02155.
    PubMed     Abstract available


  589. LIESE J, Schule L, Oberhettinger P, Tschorner L, et al
    Expansion of Vancomycin-resistant Enterococcus faecium in an academic tertiary hospital in Southwest Germany: a large-scale whole genome-based outbreak investigation.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.01978.
    PubMed     Abstract available


  590. VERREAULT D, Ennis J, Whaley K, Killeen SZ, et al
    Effective Treatment of Staphylococcal Enterotoxin B (SEB) Aerosol Intoxication in Rhesus Macaques using two parentally-administered High Affinity Monoclonal Antibodies.
    Antimicrob Agents Chemother. 2019 Feb 19. pii: AAC.02049.
    PubMed     Abstract available


  591. ROBERTSON GT, Ektnitphong VA, Scherman MS, McNeil MB, et al
    Efficacy and improved resistance potential of a cofactor-independent InhA inhibitor of Mycobacterium tuberculosis in a C3HeB/FeJ mouse model.
    Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.02071.
    PubMed     Abstract available


  592. KAUSHIK A, Ammerman NC, Tyagi S, Saini V, et al
    Activity of a long-acting injectable bedaquiline formulation in a paucibacillary mouse model of latent tuberculosis infection.
    Antimicrob Agents Chemother. 2019 Feb 11. pii: AAC.00007.
    PubMed     Abstract available


  593. GYGLI SM, Keller PM, Ballif M, Blochliger N, et al
    Whole genome sequencing for drug resistance profile prediction in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02175.
    PubMed     Abstract available


  594. ZHANG H, Liu S, Yue J, Sun S, et al
    In vitro antimicrobial activity of diacerein on 76 gram-positive cocci isolates from bacterial keratitis patients and an in vivo study of diacerein eye drops on Staphylococcus aureus keratitis in mice.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.01874.
    PubMed     Abstract available


  595. PEE CJE, Pader V, Ledger EVK, Edwards AM, et al
    A FASII inhibitor prevents staphylococcal evasion of daptomycin by inhibiting phospholipid decoy production.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02105.
    PubMed     Abstract available


  596. HONG SI, Lee YM, Park KH, Ryu BH, et al
    Clinical and Molecular Characteristics of qacA/B-Positive Methicillin-resistant Staphylococcus aureus Causing Bloodstream Infections.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02157.
    PubMed     Abstract available


  597. PURI S, Kumar R, Rojas IG, Salvatori O, et al
    Iron Chelator Deferasirox Reduces Candida albicans Invasion of Oral Epithelial Cells and Infection Levels in Murine Oropharyngeal Candidiasis.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.02152.
    PubMed     Abstract available


  598. RYBAK JM, Doorley LA, Nishimoto AT, Barker KS, et al
    Abrogation of triazole resistance upon deletion of CDR1 in a clinical isolate of Candida auris.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.00057.
    PubMed     Abstract available


  599. KINNEAR CL, Patel TS, Young CL, Marshall V, et al
    Impact of an antimicrobial stewardship intervention on within and between patient daptomycin resistance evolution in vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2019 Feb 4. pii: AAC.01800.
    PubMed     Abstract available


  600. SAVAGE KA, Parquet MDC, Allan DS, Davidson RJ, et al
    Erratum for Savage et al., "Iron Restriction to Clinical Isolates of Candida albicans by the Novel Chelator DIBI Inhibits Growth and Increases Sensitivity to Azoles In Vitro and In Vivo in a Murine Model of Experimental Vaginitis".
    Antimicrob Agents Chemother. 2019;63.
    PubMed    


    January 2019
  601. MENG L, Zhao H, Zhao S, Sun X, et al
    Inhibition of yeast-to-hypha transition and virulence of Candida albicans by 2-alkylaminoquinoline derivatives.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01891.
    PubMed     Abstract available


  602. KEBRIAEI R, Rice SA, Stamper KC, Rybak MJ, et al
    Dalbavancin Alone and in Combination with Ceftaroline against Four Different Phenotypes of Staphylococcus aureus in a PK/PD Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01743.
    PubMed     Abstract available


  603. SINGH KV, Arias CA, Murray BE
    Efficacy of Tedizolid Against Enterococci and Staphylococci, including cfr+ strains, in a Mouse Peritonitis Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02627.
    PubMed     Abstract available


  604. INDIANI C, Sauve K, Raz A, Abdelhady W, et al
    The Anti-Staphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood to Potentiate MRSA Bacteriolysis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02291.
    PubMed     Abstract available


  605. ZHAO M, Lepak AJ, Marchillo K, Vanhecker J, et al
    APX001 Pharmacokinetic/Pharmacodynamic Target Determination against Aspergillus fumigatus in an in vivo Model of Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02372.
    PubMed     Abstract available


  606. O'DONNELL MR, Larsen MH, Brown TS, Jain P, et al
    Early detection of emergent extensively drug resistant tuberculosis (XDR-TB) by flow cytometry-based phenotyping and whole genome sequencing.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01834.
    PubMed     Abstract available


  607. GARCIA-PRATS AJ, Purchase SE, Osman M, Draper HR, et al
    Pharmacokinetics, safety, and dosing of novel pediatric levofloxacin dispersible tablets in children with multidrug-resistant tuberculosis exposure.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01865.
    PubMed     Abstract available


  608. BAE JY, Jun KI, Kang CK, Song KH, et al
    The Efficacy of Intranasal Administration of the Recombinant Endolysin, SAL200, in a Lethal Murine Staphylococcus aureus Pneumonia Model.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02009.
    PubMed     Abstract available


  609. RUIZ P, Causse M, Vaquero M, Casal M, et al
    In vitro activity of Tedizolid against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.01939.
    PubMed     Abstract available


  610. MARSHALL AC, Kidd SE, Lamont-Friedrich SJ, Arentz G, et al
    Aspergillus fumigatus thioredoxin reductase: structure, mechanism, and inhibition.
    Antimicrob Agents Chemother. 2019 Jan 14. pii: AAC.02281.
    PubMed     Abstract available


  611. JIANG JH, Dexter C, Cameron DR, Monk IR, et al
    Evolution of daptomycin resistance in coagulase negative staphylococci involves mutations of the essential two component regulator WalKR.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.01926.
    PubMed     Abstract available


  612. DILWORTH TJ, Casapao AM, Ibrahim OM, Jacobs DM, et al
    Adjuvant beta-lactam therapy combined with vancomycin for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: Does beta-lactam class matter?
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02211.
    PubMed     Abstract available


  613. WASSERMAN S, Denti P, Brust JCM, Tareq M, et al
    Linezolid pharmacokinetics in South African patients with drug resistant tuberculosis and a high prevalence of HIV co-infection.
    Antimicrob Agents Chemother. 2019 Jan 7. pii: AAC.02164.
    PubMed     Abstract available


  614. GHAJAVAND H, Kargarpour Kamakoli M, Khanipour S, Pourazar Dizaji S, et al
    High Prevalence of Bedaquiline Resistance in Treatment-naive Tuberculosis Patients and Verapamil Effectiveness.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02530.
    PubMed     Abstract available


  615. CHOULES MP, Wolf NM, Lee H, Anderson JR, et al
    Rufomycin Targets ClpC1 Proteolysis in Mycobacterium tuberculosis and M. abscessus.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.02204.
    PubMed     Abstract available


  616. KHALIL ZG, Hill TA, De Leon Rodriguez LM, Lohman RJ, et al
    Structure-activity relationships of wollamide cyclic hexapeptides with activity against drug-resistant and intracellular Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2019 Jan 2. pii: AAC.01773.
    PubMed     Abstract available


    December 2018
  617. BORDALLO-CARDONA MA, Sanchez-Carrillo C, Bouza E, Munoz P, et al
    Detection of echinocandin-resistant Candida glabrata in blood cultures spiked with different percentages of FKS2 mutants.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.02004.
    PubMed     Abstract available


  618. MENETREY A, Janin A, Pullman J, Overcash JS, et al
    Bone and Joint Tissues Penetration of the Staphylococcus-Selective Antibiotic Afabicin in Patients Undergoing Elective Hip Replacement Surgery.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.01669.
    PubMed     Abstract available


  619. HEIDARI A, Quinlan M, Benjamin DJ, Laurence B, et al
    Isavuconazole in the Treatment of Coccidioidal Meningitis.
    Antimicrob Agents Chemother. 2018 Dec 17. pii: AAC.02232.
    PubMed     Abstract available


  620. WIEDERHOLD NP, Lockhart SR, Najvar LK, Berkow EL, et al
    The Fungal Cyp51 Specific Inhibitor VT-1598 Demonstrates In vitro and In vivo Activity against Candida auris.
    Antimicrob Agents Chemother. 2018 Dec 10. pii: AAC.02233.
    PubMed     Abstract available


  621. ANDREONI F, Toyofuku M, Menzi C, Kalawong R, et al
    Antibiotics stimulate vesicles formation in Staphylococcus aureus in a phage-dependent and independent fashion and via different routes.
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.01439.
    PubMed     Abstract available


  622. KOHLHOFF SA, Huerta N, Hammerschlag MR
    In vitro activity of Omadacycline against Chlamydia pneumoniae.
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.01907.
    PubMed     Abstract available


  623. MATSUO M, Hiramatsu M, Singh M, Sasaki T, et al
    Genetic and transcriptomic analyses of ciprofloxacin-tolerant Staphylococcus aureus isolated by the Replica Plating Tolerance Isolation System (REPTIS).
    Antimicrob Agents Chemother. 2018 Dec 3. pii: AAC.02019.
    PubMed     Abstract available


  624. STOTT KE, Beardsley J, Kolamunnage-Dona R, Castelazo AS, et al
    Correction for Stott et al., "Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


  625. STOTT KE, Beardsley J, Whalley S, Mukasa Kibengo F, et al
    Correction for Stott et al., "Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


    November 2018
  626. BARBER AE, Weber M, Kaerger K, Linde J, et al
    Comparative genomics of serial Candida glabrata isolates and the rapid acquisition of echinocandin resistance during therapy.
    Antimicrob Agents Chemother. 2018 Nov 26. pii: AAC.01628.
    PubMed     Abstract available


  627. AHMAD S, Joseph L, Parker JE, Asadzadeh M, et al
    ERG6 and ERG2 are major targets conferring reduced susceptibility to amphotericin B in clinical Candida glabrata isolates in Kuwait.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01900.
    PubMed     Abstract available


  628. WURSTER S, Lewis RE, Albert ND, Kontoyiannis DP, et al
    Pre-Exposure to Isavuconazole Increases the Virulence of Mucorales but not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01896.
    PubMed     Abstract available


  629. SCHMIDT S, Schubert R, Tramsen L, Lehrnbecher T, et al
    Impact of Antifungal Compounds on Viability and Anti-Aspergillus Activity of Human Natural Killer Cells.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01993.
    PubMed     Abstract available


  630. GEBREMARIAM T, Alkhazraji S, Alqarihi A, Jeon HH, et al
    APX001 is Effective in the Treatment of Murine Invasive Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01713.
    PubMed     Abstract available


  631. DEKKERS BGJ, Akkerman OW, Alffenaar JWC
    The role of therapeutic drug monitoring in treatment optimization in tuberculosis and diabetes mellitus co-morbidity.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.02074.
    PubMed     Abstract available


  632. VAN RIJN SP, Zuur MA, Anthony R, Wilffert B, et al
    Evaluation of carbapenems for multi/extensive-drug resistant Mycobacterium tuberculosis treatment.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01489.
    PubMed     Abstract available


  633. MATSUO M, Yamamoto N, Hishinuma T, Hiramatsu K, et al
    Identification of a novel gene associated with high-level beta-lactam resistance in heterogeneous vancomycin-intermediate Staphylococcus aureus strain Mu3 and methicillin-resistant S. aureus strain N315.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.00712.
    PubMed     Abstract available


  634. ZIMMERLI W, Sendi P
    The Role of Rifampin against Staphylococcal Biofilm Infections in Vitro, in Animal Models, and in Orthopedic Device-Related Infections.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01746.
    PubMed     Abstract available


  635. ANDRES S, Groschel MI, Hillemann D, Merker M, et al
    A diagnostic algorithm to investigate pyrazinamide and ethambutol resistance in rifampicin resistant Mycobacterium tuberculosis isolates in a low incidence setting.
    Antimicrob Agents Chemother. 2018 Nov 19. pii: AAC.01798.
    PubMed     Abstract available


  636. PERSYN A, Rogiers O, Brock M, Vande Velde G, et al
    Monitoring of fluconazole and caspofungin activity against in vivo Candida glabrata biofilms by bioluminescence imaging.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01555.
    PubMed     Abstract available


  637. CHOJNACKI M, Philbrick A, Wucher B, Reed JN, et al
    Development of a broad-spectrum antimicrobial combination for the treatment of Staphylococcus aureus and Pseudomonas aeruginosa corneal infections.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01929.
    PubMed     Abstract available


  638. GREGOIRE M, Gaborit B, Deschanvres C, Lecomte R, et al
    High-dosage cefazolin achieves sufficient cerebrospinal diffusion to treat an external ventricular drainage-related Staphylococcus aureus ventriculitis.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01844.
    PubMed     Abstract available


  639. MEIKLE V, Mossberg AK, Mitra A, Hakansson AP, et al
    A protein complex from human milk enhances the activity of antibiotics and drugs against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Nov 12. pii: AAC.01846.
    PubMed     Abstract available


  640. MACDONALD D, Thomson DD, Johns A, Contreras Valenzuela A, et al
    Inducible cell fusion permits use of competitive fitness profiling in the human pathogenic fungus Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01615.
    PubMed     Abstract available


  641. BORDALLO-CARDONA MA, Agnelli C, Gomez-Nunez A, Sanchez-Carrillo C, et al
    MSH2 gene point mutations are not antifungal resistance markers in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01876.
    PubMed     Abstract available


  642. CHOI MJ, Won EJ, Joo MY, Park YJ, et al
    Emergence of Voriconazole-resistant Aspergillus flavus Isolates in Korean Hospitals: Microsatellite Typing and Resistance Mechanism Analysis.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01610.
    PubMed     Abstract available


  643. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log-phase, Acid-phase and Non-Replicating-Persister (NRP)-phase in an in vitro Assay.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01695.
    PubMed     Abstract available


  644. BARROS EM, Martin MJ, Selleck EM, Lebreton F, et al
    Daptomycin resistance and tolerance due to loss-of-function in Staphylococcus aureus dsp1 and asp23.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01542.
    PubMed     Abstract available


  645. HOU X, Lee A, Jimenez-Ortigosa C, Kordalewska M, et al
    Rapid Detection of ERG11-Associated Azole Resistance and FKS-Associated Echinocandin Resistance in Candida auris.
    Antimicrob Agents Chemother. 2018 Nov 5. pii: AAC.01811.
    PubMed     Abstract available


  646. PICCINELLI G, Fernandes P, Bonfanti C, Caccuri F, et al
    Erratum for Piccinelli et al., "In Vitro Activity of Solithromycin against Erythromycin-Resistant Streptococcus agalactiae".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


  647. GOMEZ-SANZ E, Schwendener S, Thomann A, Gobeli Brawand S, et al
    Correction for Gomez-Sanz et al., "First Staphylococcal Cassette Chromosome mec Containing a mecB-Carrying Gene Complex Independent of Transposon Tn6045 in a Macrococcus caseolyticus Isolate from a Canine Infection".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


  648. VILCHEZE C, Jacobs WR Jr
    Reply to Yew et al., "Vitamin C and Mycobacterium tuberculosis Persisters".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


  649. YEW WW, Chang KC, Leung CC, Chan DP, et al
    Vitamin C and Mycobacterium tuberculosis Persisters.
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


    October 2018
  650. RAFFAI T, Burian K, Janovak L, Bogdanov A, et al
    Vaginal gel component hydroxyethyl cellulose significantly enhances the infectivity of Chlamydia trachomatis serovars D and E.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.02034.
    PubMed     Abstract available


  651. VAN DEN ELSEN SHJ, Sturkenboom MGG, van 't Boveneind-Vrubleuskaya N, Skrahina A, et al
    Population pharmacokinetic model and limited sampling strategies for personalized dosing of levofloxacin in tuberculosis patients.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01092.
    PubMed     Abstract available


  652. SHIELDS RK, Kline EG, Healey KR, Kordalewska M, et al
    Spontaneous mutational frequency and FKS mutation rates vary by echinocandin agent against Candida glabrata.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01692.
    PubMed     Abstract available


  653. ANDES DR, Ghannoum MA, Mukherjee PK, Kovanda LL, et al
    Outcomes by Minimum Inhibitory Concentrations for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials.
    Antimicrob Agents Chemother. 2018 Oct 29. pii: AAC.01634.
    PubMed     Abstract available


  654. CAVALHEIRO M, Costa C, Silva-Dias A, Miranda IM, et al
    Unveiling the mechanisms of in vitro evolution towards fluconazole resistance of a Candida glabrata clinical isolate: a transcriptomics approach.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.00995.
    PubMed     Abstract available


  655. TANABE K, Bonus M, Tomiyama S, Miyoshi K, et al
    FK506 resistance of Saccharomyces cerevisiae Pdr5 and Candida albicans Cdr1 involves mutations in the transmembrane domains and extracellular loops.
    Antimicrob Agents Chemother. 2018 Oct 22. pii: AAC.01146.
    PubMed     Abstract available


  656. LUNA-TAPIA A, Butts A, Palmer GE
    Loss of C-5 sterol desaturase activity in Candida albicans - azole resistance or merely trailing growth?
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01337.
    PubMed     Abstract available


  657. MELIEF E, Bonnett SA, Zuniga ES, Parish T, et al
    Activation of 2,4-diaminoquinazoline in Mycobacterium tuberculosis by Rv3161c, a putative dioxygenase.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01505.
    PubMed     Abstract available


  658. RYBNIKER J, Andreas Kohl T, Barilar I, Niemann S, et al
    No evidence for acquired mutations associated with cytochrome bc 1-inhibitor resistance in 13,559 clinical Mycobacterium tuberculosis complex isolates.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01317.
    PubMed     Abstract available


  659. ESPINEL-INGROFF A, Turnidge J, Alastruey-Izquierdo A, Botterel F, et al
    Method-dependent epidemiological cutoff values (ECVs) for detection of triazole resistance in Candida and Aspergillus species for the SYO colorimetric broth and Etest agar diffusion methods.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01651.
    PubMed     Abstract available


  660. GLAMPEDAKIS E, Coste AT, Aruanno M, Bachmann D, et al
    Efficacy of antifungal monotherapies and combinations against Aspergillus calidoustus.
    Antimicrob Agents Chemother. 2018 Oct 15. pii: AAC.01137.
    PubMed     Abstract available


  661. ROUARD C, Garnier F, Leraut J, Lepainteur M, et al
    Emergence and within-host genetic evolution of methicillin-resistant Staphylococcus aureus resistant to linezolid in a cystic fibrosis patient.
    Antimicrob Agents Chemother. 2018 Oct 1. pii: AAC.00720.
    PubMed     Abstract available


    September 2018
  662. DOAN TN, Cao P, Emeto TI, McCaw JM, et al
    Predicting the Outcomes of New Short-Course Regimens for Multi-Drug Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modelling.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01487.
    PubMed     Abstract available


  663. LOUIE A, Duncanson B, Myrick J, Maynard M, et al
    The Activity of Moxifloxacin against Acid-Phase and Non-Replicative Persister Phenotype Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01470.
    PubMed     Abstract available


  664. SAMPAIO ADG, Gontijo AVL, Araujo HM, Koga-Ito CY, et al
    In vivo efficacy of ellagic acid against Candida albicans in a Drosophila melanogaster infection model.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01716.
    PubMed     Abstract available


  665. PADILLA E, Oms L, Espejo E, Gomez L, et al
    Rifampin resistance in staphylococci after rifaximin intake for surgical prophylaxis in elective colorectal surgery.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01353.
    PubMed     Abstract available


  666. RAMIREZ-ZAVALA B, Manz H, Englert F, Rogers PD, et al
    A hyperactive form of the zinc cluster transcription factor Stb5 causes YOR1 overexpression and beauvericin resistance in Candida albicans.
    Antimicrob Agents Chemother. 2018 Sep 24. pii: AAC.01655.
    PubMed     Abstract available


  667. TAN D, Htun HL, Koh J, Kanagasabai K, et al
    Comparative epidemiology of vancomycin-resistant enterococci colonization in an acute care hospital and its affiliated intermediate- and long-term care facilities in Singapore.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01507.
    PubMed     Abstract available


  668. DIAN S, Yunivita V, Ganiem AR, Pramaesya T, et al
    A double-blinded randomised placebo-controlled phase II trial to evaluate high dose rifampicin for tuberculous meningitis: a dose finding study.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01014.
    PubMed     Abstract available


  669. AURITI C, Ronchetti MP, Bersani I, Gennari F, et al
    Intrahepatic Administration of Amphotericin B Liposomal (Ambisome(R)) for the Management of a Liver Abscess from Candida albicans in a preterm infant.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01239.
    PubMed     Abstract available


  670. GUEST JM, Singh PK, Revankar SG, Chandrasekar PH, et al
    Isavuconazole for treatment of experimental fungal endophthalmitis caused by Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.01537.
    PubMed     Abstract available


  671. LEPAK AJ, Zhao M, Andes DR
    Pharmacodynamic Evaluation of Rezafungin (CD101) Against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.01572.
    PubMed     Abstract available


  672. DOMON H, Maekawa T, Yonezawa D, Nagai K, et al
    Mechanism of macrolide-induced inhibition of pneumolysin release involves impairment of autolysin release in macrolide-resistant Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.00161.
    PubMed     Abstract available


    August 2018
  673. CARTER GP, Ussher JE, Goncalves Da Silva A, Baines SL, et al
    Genomic analysis of multi-resistant Staphylococcus capitis associated with neonatal sepsis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.00898.
    PubMed     Abstract available


  674. MILLER WR, Singh KV, Arias CA, Murray BE, et al
    Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01158.
    PubMed     Abstract available


  675. ROUARD C, Doucet-Populaire F, Guillet-Caruba C, Villet M, et al
    Deletion of one 23S rDNA (rrl) copy contributes to the development of resistance to linezolid in Staphylococcus warneri.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01139.
    PubMed     Abstract available


  676. KENIYA MV, Sabherwal M, Wilson RK, Woods MA, et al
    Crystal structures of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provide tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01134.
    PubMed     Abstract available


  677. UKAI Y, Kuroiwa M, Kurihara N, Naruse H, et al
    Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01216.
    PubMed     Abstract available


  678. KENIYA MV, Ruma YN, Tyndall JDA, Monk BC, et al
    Heterologous expression of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01131.
    PubMed     Abstract available


  679. CAO R, Teskey G, Islamoglu H, Abrahem R, et al
    Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01132.
    PubMed     Abstract available


  680. PAUL RA, Rudramurthy SM, Dhaliwal M, Singh P, et al
    Voriconazole resistance in clinical and environmental isolates of Aspergillus flavus - frequency and investigation into the role of multidrug efflux pumps.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01022.
    PubMed     Abstract available


  681. ALFARISI O, Mave V, Gaikwad S, Sahasrabudhe T, et al
    The effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01383.
    PubMed     Abstract available


  682. LUPIEN A, Vocat A, Foo CS, Blattes E, et al
    An optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone Macozinone (PBTZ169).
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.00840.
    PubMed     Abstract available


  683. WIEDERHOLD NP, Xu X, Wang A, Najvar LK, et al
    In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01315.
    PubMed     Abstract available


  684. WALL G, Chaturvedi AK, Wormley FL Jr, Wiederhold NP, et al
    Screening a Repurposing Library for Inhibitors of Multi-Drug Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01084.
    PubMed     Abstract available


  685. HO K, Huo W, Pas S, Dao R, et al
    Loss of function mutations in epaR confer resistance to phage NPV1 infection in Enterococcus faecalis OG1RF.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.00758.
    PubMed     Abstract available


  686. KANDLER JL, Mercante AD, Dalton TL, Ezewudo MN, et al
    Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00974.
    PubMed     Abstract available


  687. ISLA G, Leonardelli F, Tiraboschi IN, Refojo N, et al
    First clinical isolation of an azole-resistant Aspergillus fumigatus harboring a TR46/Y121F/T289A mutation in South America.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00872.
    PubMed     Abstract available


  688. HEALEY KR, Kordalewska M, Jimenez Ortigosa C, Singh A, et al
    Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.01427.
    PubMed     Abstract available


  689. KOSER CU, Heyckendorf J, Andres S, Olaru ID, et al
    Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


  690. DOOKIE N, Naidoo K, Padayatchi N
    Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


    July 2018
  691. JAGIELSKI T, Bakula Z, Brzostek A, Minias A, et al
    Characterization of mutations conferring resistance to rifampicin in Mycobacterium tuberculosis clinical strains.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.01093.
    PubMed     Abstract available


  692. WEIKUM J, Ritzmann N, Jelden N, Klockner A, et al
    Sulfide protects Staphylococcus aureus from aminoglycoside antibiotics but cannot be regarded as a general defense mechanism against antibiotics.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00602.
    PubMed     Abstract available


  693. KIM NH, Park WB, Cho JE, Choi YJ, et al
    Effects of phage endolysin SAL200 combined with antibiotics on Staphylococcus aureus infection.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.00731.
    PubMed     Abstract available


  694. RAZ A, Serrano A, Thaker M, Alston T, et al
    Lysostaphin lysibody leads to effective opsonization and killing of methicillin resistant Staphylococcus aureus in a murine model.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01056.
    PubMed     Abstract available


  695. WHALEY SG, Zhang Q, Caudle KE, Rogers PD, et al
    Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01070.
    PubMed     Abstract available


  696. PELOQUIN CA, Phillips PPJ, Mitnick CD, Eisenach K, et al
    Increased Doses Lead to Higher Drug Exposures of Levofloxacin for the Treatment of Tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00770.
    PubMed     Abstract available


  697. ZHAO Y, Lee MH, Paderu P, Lee A, et al
    Significantly improved pharmacokinetics enhances in vivo efficacy of APX001 against echinocandin and multidrug resistant Candida isolates in a mouse model of invasive candidiasis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00425.
    PubMed     Abstract available


  698. YAN Q, Karau MJ, Raval YS, Patel R, et al
    Evaluation of Oritavancin in Combination with Rifampin, Gentamicin or Linezolid Against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00943.
    PubMed     Abstract available


  699. KANWAR A, Cadnum JL, Jencson AL, Donskey CJ, et al
    Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus Among Hospitalized Patients.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00609.
    PubMed     Abstract available


  700. KIDD JM, Abdelraouf K, Asempa TE, Humphries RM, et al
    Pharmacodynamics of Daptomycin Against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00506.
    PubMed     Abstract available


  701. PITON J, Vocat A, Lupien A, Foo C, et al
    Structure-based drug design and characterization of sulfonyl-piperazine benzothiazinone inhibitors of DprE1 from Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00681.
    PubMed     Abstract available


  702. PIETERMAN ED, Te Brake LHM, de Knegt GJ, van der Meijden A, et al
    Assessment of the additional value of verapamil to a moxifloxacin and linezolid combination regimen in a murine tuberculosis model.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01354.
    PubMed     Abstract available


  703. WIEDERHOLD NP, Najvar LK, Garvey EP, Brand SR, et al
    The Fungal Cyp-51 Inhibitor VT-1129 is Efficacious in an Experimental Model of Cryptococcal Meningitis.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01071.
    PubMed     Abstract available


  704. HOYER AR, Johnson CJ, Hoyer MR, Kernien JF, et al
    Echinocandin treatment of Candida albicans biofilms enhances neutrophil extracellular trap (NET) formation.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00797.
    PubMed     Abstract available


  705. AGUILAR-PEREZ C, Gracia B, Rodrigues L, Vitoria A, et al
    Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00359.
    PubMed     Abstract available


  706. DANION F, Jullien V, Rouzaud C, Abdel Fattah M, et al
    Is it time for systematic voriconazole pharmacogenomic investigation for central nervous system aspergillosis?
    Antimicrob Agents Chemother. 2018 Jul 2. pii: AAC.00705.
    PubMed     Abstract available


  707. PARDOS DE LA GANDARA M, Borges V, Chung M, Milheirico C, et al
    Correction for Pardos de la Gandara et al., "Genetic Determinants of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


    June 2018
  708. TAJ-ALDEEN SJ, Salah H, Perez WB, Almaslamani M, et al
    Molecular analysis of resistance and detection of non-wild type strains using ECV values of Etest for amphotericin B and echinocandins for bloodstream Candida infections from a tertiary hospital in Qatar.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00214.
    PubMed     Abstract available


  709. CAMPEAU SA, Schuetz AN, Kohner P, Arias CA, et al
    Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00745.
    PubMed     Abstract available


  710. LEE H, Yoon EJ, Kim D, Kim JW, et al
    Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00485.
    PubMed     Abstract available


  711. RANCOITA PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, et al
    Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00344.
    PubMed     Abstract available


  712. HORITA Y, Alsultan A, Kwara A, Antwi S, et al
    Evaluation of the Adequacy of WHO revised Dosages of the First-Line Anti-Tuberculosis Drugs in Children with Tuberculosis using Population Pharmacokinetic Modeling and Simulations.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00008.
    PubMed     Abstract available


  713. UMEYAMA T, Hayashi Y, Shimosaka H, Inukai T, et al
    Cas9/CRISPR genome editing to demonstrate the contribution of Cyp51A Gly138Ser to azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00894.
    PubMed     Abstract available


  714. STOTT KE, Beardsley J, Kolamunnage-Dona R, Santoyo Castelazo A, et al
    Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00885.
    PubMed     Abstract available


  715. TRUONG-BOLDUC QC, Wang Y, Hooper DC
    Tet38 Efflux Pump Contributes to Fosfomycin Resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00927.
    PubMed     Abstract available


  716. WANG SK, Gilchrist A, Loukitcheva A, Plotkin BJ, et al
    The Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types Among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00382.
    PubMed     Abstract available


  717. DABAS Y, Xess I, Bakshi S, Mahapatra M, et al
    "Emergence of azole resistant Aspergillus fumigatus from immunocompromised hosts in India".
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.02264.
    PubMed     Abstract available


  718. DU PRE S, Beckmann N, Almeida MC, Sibley GEM, et al
    The effect of the novel antifungal drug F901318 (Olorofim) on the growth and viability of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00231.
    PubMed     Abstract available


  719. SIMITSOPOULOU M, Chlichlia K, Kyrpitzi D, Walsh TJ, et al
    Pharmacodynamic and immunomodulatory effects of micafungin on host responses against biofilms of Candida parapsilosis in comparison to those of Candida albicans.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00478.
    PubMed     Abstract available


  720. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log-Phase, Acid-Phase and Non-Replicating-Persister (NRP)-Phase in an In vitro Assay.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00856.
    PubMed     Abstract available


  721. CEBALLOS S, Kim C, Ding D, Mobashery S, et al
    Activities of oxadiazole antibacterials against Staphylococcus aureus and other Gram-positive bacteria.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00453.
    PubMed     Abstract available


  722. DRUSANO GL, Myrick J, Maynard M, Nole J, et al
    Linezolid Kills Acid Phase and Non-replicative Persister Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00221.
    PubMed     Abstract available


    May 2018
  723. SAVAGE KA, Parquet MDC, Allan DS, Davidson RJ, et al
    Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.02576.
    PubMed     Abstract available


  724. ZONG Z, Jing W, Shi J, Wen S, et al
    Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.00165.
    PubMed     Abstract available


  725. JAHANBAKHSH S, Singh NB, Yim J, Rose WE, et al
    Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus (MRSA) in an in vitro Biofilm Model.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00567.
    PubMed     Abstract available


  726. SHOEN C, DeStefano M, Hafkin B, Cynamon M, et al
    In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00493.
    PubMed     Abstract available


  727. GOEMAERE B, Lagrou K, Spriet I, Hendrickx M, et al
    Clonal spread in Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00591.
    PubMed     Abstract available


  728. BROWN GANDT A, Griffith EC, Lister IM, Billings LL, et al
    In vivo and in vitro effects of a ClpP activating antibiotic against vancomycin resistant enterococci.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00424.
    PubMed     Abstract available


  729. KEBRIAEI R, Rice SA, Singh KV, Stamper KC, et al
    Efficacy of Daptomycin Monotherapy and In Combination with beta-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00315.
    PubMed     Abstract available


  730. POELMANS J, Himmelreich U, Vanherp L, Zhai L, et al
    A multimodal imaging approach enables in vivo assessment of antifungal treatment in a mouse model of invasive pulmonary aspergillosis.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00240.
    PubMed     Abstract available


  731. LUO J, Yu X, Jiang G, Fu Y, et al
    In Vitro Activity of Clofazimine against Non-tuberculous Mycobacteriaisolated in Beijing, China.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00072.
    PubMed     Abstract available


  732. LOPEZ-SANCHEZ A, Perez-Cantero A, Torrado-Salmeron C, Martin-Vicente A, et al
    Experimental Amphotericin B-Deoxycholate formulations for pulmonary aspergillosis: efficacy, biodistribution and nephrotoxicity.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00489.
    PubMed     Abstract available


  733. STOTT KE, Beardsley J, Whalley S, Kibengo FM, et al
    Amphotericin B Deoxycholate in adults with Cryptococcal Meningitis; a Population Pharmacokinetic Model and Meta-Analysis of Outcomes.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.02526.
    PubMed     Abstract available


  734. BOUDJEMAA R, Cabriel C, Dubois-Brissonnet F, Bourg N, et al
    Failure of daptomycin to kill Staphylococcus aureus: impact of bacterial membrane fatty acid composition.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00023.
    PubMed     Abstract available


  735. GUO H, Zhou L, He Y, Gao C, et al
    Natamycin and Azithromycin are Synergistic in vitro against Ocular Pathogenic Aspergillus flavus species complex and Fusarium solani species complex Isolates.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00077.
    PubMed     Abstract available


  736. AMMERMAN NC, Swanson RV, Bautista EM, Almeida DV, et al
    Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00636.
    PubMed     Abstract available


  737. TIWARI KB, Gatto C, Walker S, Wilkinson BJ, et al
    Targocil-exposure of Staphylococcus aureus Blocks Translocation of the Major Autolysin Atl Across the Membrane Resulting in a Significant Decrease in Autolysis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00323.
    PubMed     Abstract available


  738. KASPAR U, de Haro Sautto JA, Molinaro S, Peters G, et al
    The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA).
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00385.
    PubMed     Abstract available


  739. KAUFMANN SHE
    Indole Propionic Acid: a Small Molecule Links between Gut Microbiota and Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


    April 2018
  740. BUTTS A, Reitler P, Ge W, Fortwendel JR, et al
    Commonly used oncology drugs decrease antifungal effectiveness against Candida and Aspergillus species.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00504.
    PubMed     Abstract available


  741. BORDALLO-CARDONA MA, Marcos-Zambrano LJ, Sanchez-Carrillo C, Bouza E, et al
    Resistance to echinocandins in Candida can be detected by performing the Etest directly on blood culture samples.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00162.
    PubMed     Abstract available


  742. SIALA W, Rodriguez-Villalobos H, Fernandes P, Tulkens PM, et al
    Activity of combinations of antistaphylococcal antibiotics with fusidic acid against staphylococcal biofilms in in vitro static and dynamic models.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00598.
    PubMed     Abstract available


  743. SHI W, Chen J, Zhang S, Zhang W, et al
    Identification of novel mutations in LprG (rv1411c), rv0521,rv3630, rv0010c, ppsC,cyp128 associated with pyrazinoic acid/pyrazinamide resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00430.
    PubMed     Abstract available


  744. BUTLER-LAPORTE G, Lee TC, Cheng MP
    Increasing Rates of Penicillin Sensitivity in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00680.
    PubMed     Abstract available


  745. BOOT M, Commandeur S, Subudhi AK, Bahira M, et al
    Accelerating early anti-tuberculosis drug discovery by creating mycobacterial indicator strains that predict mode of action.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00083.
    PubMed     Abstract available


  746. ZHENG H, Williams JT, Coulson GB, Haiderer ER, et al
    HC2091 kills Mycobacterium tuberculosis by targeting the MmpL3 mycolic acid transporter.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.02459.
    PubMed     Abstract available


  747. BEN-SHMUEL A, Glinert I, Sittner A, Bar-David E, et al
    Treating Anthrax-Induced Meningitis in Rabbits.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00298.
    PubMed     Abstract available


  748. LIU Y, Pertinez H, Davies GR, Gillespie SH, et al
    Moxifloxacin replacement in contemporary tuberculosis drug regimens is ineffective against persistent Mycobacterium tuberculosis: Novel insights from the Cornell mouse model.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00190.
    PubMed     Abstract available


  749. LYONS MA
    Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.02359.
    PubMed     Abstract available


  750. STEFAN MA, Ugur FS, Garcia GA
    SOURCE OF THE FITNESS DEFECT IN RIFAMYCIN-RESISTANT M. TUBERCULOSIS RNA POLYMERASE AND THE MECHANISM OF COMPENSATION BY MUTATIONS IN THE beta'-SUBUNIT.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00164.
    PubMed     Abstract available


  751. KORDALEWSKA M, Lee A, Park S, Berrio I, et al
    Understanding echinocandin resistance in the emerging pathogen Candida auris.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00238.
    PubMed     Abstract available


  752. GARCIA-RUBIO R, Alcazar-Fuoli L, Monteiro MC, Monzon S, et al
    Aspergillus fumigatus cyp51A polymorphisms, an insight on their significance.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00241.
    PubMed     Abstract available


  753. LASKARIS P, Vicentefranqueira R, Helynck O, Jouvion G, et al
    A novel polyaminocarboxylate compound to treat murine pulmonary aspergillosis by interfering with zinc metabolism.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.02510.
    PubMed     Abstract available


  754. GHANNOUM M, Long L, Larkin EL, Isham N, et al
    SCY-078, a Novel Oral Glucan Synthase Inhibitor, for the Treatment of Invasive Aspergillosis: Evaluation of Antifungal Activity Singly and in Combination.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00244.
    PubMed     Abstract available


  755. LI JL, Yang N, Huang L, Chen D, et al
    Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02260.
    PubMed     Abstract available


  756. BARMAN TK, Kumar M, Mathur T, Namba E, et al
    In vitro and in vivo activities of DS-2969b, a novel GyrB inhibitor, and its water-soluble prodrug, DS11960558, against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02556.
    PubMed     Abstract available


  757. LAMONTAGNE BOULET M, Isabelle C, Guay I, Brouillette E, et al
    Tomatidine, a lead antibiotic molecule that targets Staphylococcus aureus ATP synthase subunit C.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02197.
    PubMed     Abstract available


  758. LI FJ, Palmer KL
    EfrEF and the transcription regulator ChlR are required for chlorhexidine stress response in Enterococcus faecalis V583.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00267.
    PubMed     Abstract available


  759. SINGH A, Healey KR, Yadav P, Upadhyaya G, et al
    Absence of azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in DNA mismatch repair pathway.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00195.
    PubMed     Abstract available


  760. GSALLER F, Furukawa T, Carr PD, Rash B, et al
    The mechanistic basis of pH-dependent 5-flucytosine resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02593.
    PubMed     Abstract available


  761. BASSO V, Garcia A, Tran DQ, Schaal JB, et al
    Fungicidal potency and mechanisms of theta-defensins against multi-drug resistant Candida species.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00111.
    PubMed     Abstract available


  762. GARCIA-DE-LA-MARIA C, Gasch O, Garcia-Gonzalez J, Soy D, et al
    The Combination of Daptomycin plus Fosfomycin has Synergistic, Potent and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) in a Rabbit Model of Experimental Endocarditis (EE).
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02633.
    PubMed     Abstract available


  763. YANG F, Zhang L, Wakabayashi H, Myers J, et al
    Correction for Yang et al., "Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


  764. CHEN Y, Mallick J, Maqnas A, Sun Y, et al
    Erratum for Chen et al., "Chemogenomic Profiling of the Fungal Pathogen Candida albicans".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


    March 2018
  765. CHEN CL, Cheng MH, Kuo CF, Cheng YL, et al
    Dextromethorphan Attenuates NADPH Oxidase-regulated GSK-3beta and NF-kappaB Activation and Reduces Nitric Oxide Production in Group A Streptococcal Infection.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02045.
    PubMed     Abstract available


  766. HIRAYAMA T, Miyazaki T, Yamagishi Y, Mikamo H, et al
    Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02528.
    PubMed     Abstract available


  767. ESCHENAUER GA, Carver PL, Patel TS, Lin SW, et al
    Survival in Patients with Candida glabrata Bloodstream Infections is Associated with Fluconazole Dose.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02566.
    PubMed     Abstract available


  768. HOU X, Xiao M, Wang H, Yu SY, et al
    Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multi-Center Study in China.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.00153.
    PubMed     Abstract available


  769. BADER JC, Lakota EA, Flanagan S, Ong V, et al
    Overcoming the Resistance Hurdle: PK-PD Target Attainment Analyses of Rezafungin (CD101) for Candida albicans and Candida glabrata.
    Antimicrob Agents Chemother. 2018 Mar 19. pii: AAC.02614.
    PubMed     Abstract available


  770. LUTHER MK, Parente DM, Caffrey AR, Daffinee K, et al
    Clinical and genetic risk factors for biofilm-forming Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02252.
    PubMed     Abstract available


  771. TOMAS ME, Mana TSC, Wilson BM, Nerandzic MM, et al
    Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota that Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02237.
    PubMed     Abstract available


  772. KOK EY, Vallejo JG, Sommer LM, Rosas L, et al
    Association of Vancomycin MIC and Molecular Characteristics With Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00084.
    PubMed     Abstract available


  773. SMITH JR, Yim J, Rice S, Stamper K, et al
    The combination of tedizolid and daptomycin against methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00101.
    PubMed     Abstract available


  774. CHEN Y, Li Z, Han X, Tian S, et al
    Elevated MIC values to imidazole drugs among Aspergillus fumigatus isolates with TR34/L98H/S297T/F495I mutation.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.01549.
    PubMed     Abstract available


  775. MERCER DK, Katvars LK, Hewitt F, Smith DW, et al
    Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


  776. ARIAS CA, Reyes J, Carvajal LP, Rincon S, et al
    Erratum for Arias et al., "A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries".
    Antimicrob Agents Chemother. 2018;62.
    PubMed    


    February 2018
  777. GUIRAO-ABAD JP, Sanchez-Fresneda R, Machado F, Arguelles JC, et al
    MICAFUNGIN ENHANCES THE HUMAN MACROPHAGE RESPONSE TO Candida albicans THROUGH beta-GLUCAN EXPOSURE.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.02161.
    PubMed     Abstract available


  778. LU Z, Jia X, Chen Y, Han X, et al
    Identification and Characterization of Key Charged Residues in the Cofilin Protein Involved in Azole Susceptibility, Apoptosis, and Virulence of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01659.
    PubMed     Abstract available


  779. GUPTA R, Felix CR, Akerman MP, Akerman KJ, et al
    Gold(III) macrocycles and chelates targeting Mycobacterium tuberculosis and Mycobacterium abscessus: evidence for inhibition of topoisomerase 1A.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01696.
    PubMed     Abstract available


  780. BERKOW EL, Nunnally NS, Bandea A, Kuykendall R, et al
    Detection of TR34/L98H Cyp51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the US, 2015-2017.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02240.
    PubMed     Abstract available


  781. CHEN C, Gardete S, Jansen RS, Shetty A, et al
    Verapamil targets membrane energetics in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02107.
    PubMed     Abstract available


  782. HEMANTH KUMAR AK, Kumar A, Kannan T, Bhatia R, et al
    Pharmacokinetics of second-line anti-tuberculosis drugs in children with multidrug-resistant tuberculosis in India.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02410.
    PubMed     Abstract available


  783. MELETIADIS J, Siopi M, Tsakris A, Mouton JW, et al
    A new marker of echinocandins activity in an in vitro PK/PD model correlates with an animal model of Aspergillus fumigatus infection.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02322.
    PubMed     Abstract available


  784. WEINER M, Gelfond J, Johnson-Pais TL, Engle M, et al
    Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.01802.
    PubMed     Abstract available


  785. ZUUR MA, Ghimire S, Bolhuis MS, Wessels AMA, et al
    The Pharmacokinetics of 2000 mg Ertapenem in Tuberculosis Patients.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.02250.
    PubMed     Abstract available


  786. COLLEY T, Sehra G, Chowdhary A, Alanio A, et al
    In Vitro and In Vivo Efficacy of a Novel and Long Acting Fungicidal Azole, PC1244 on Aspergillus fumigatus Infection.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.01941.
    PubMed     Abstract available


  787. MURATA M, Kosai K, Yamauchi S, Sasaki D, et al
    In vitro activity of lascufloxacin against Streptococcus pneumoniae with mutations in the quinolone resistance-determining regions (QRDRs).
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.01971.
    PubMed     Abstract available


  788. IMBERT S, Normand AC, Ranque S, Costa JM, et al
    Species identification and in vitro-antifungal susceptibility of Aspergillus terreus species complex clinical isolates: a French multicentre study.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.02315.
    PubMed     Abstract available


  789. CHEN Y, Yuan Z, Shen X, Wu J, et al
    Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02259.
    PubMed     Abstract available


  790. SAO EMANI C, Williams MJ, Wiid I, Baker B, et al
    Compounds with potential activity against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02236.
    PubMed     Abstract available


  791. ESPINEL-INGROFF A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, et al
    Posaconazole MIC distributions for Aspergillus fumigatus SC by four methods: Impact of Cyp51A mutations on estimation of epidemiological cutoff values (ECVs/ECOFFs).
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01916.
    PubMed     Abstract available


  792. KHAN Z, Ahmad S, Mokaddas E, Meis JF, et al
    Development of echinocandin resistance in Candida tropicalis following short-term exposure to caspofungin for empiric therapy.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01926.
    PubMed     Abstract available


  793. LYSKOVA P, Hubka V, Svobodova L, Barrs V, et al
    Antifungal susceptibility of the Aspergillus viridinutans complex: comparison of two in vitro methods.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01927.
    PubMed     Abstract available


  794. ELJAALY K, Alshehri S, Erstad BL
    Safety of Anti-Staphylococcal Penicillins versus Cefazolin: A Systematic Review and Meta-Analysis.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01816.
    PubMed     Abstract available


  795. RIAT A, Plojoux J, Gindro K, Schrenzel J, et al
    Azole resistance of Aspergillus fumigatus isolates from the environment and the clinic in Switzerland.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02088.
    PubMed     Abstract available


    January 2018
  796. IDELEVICH EA, Kriegeskorte A, Schleimer N, Peters G, et al
    In Vitro Susceptibility of Clinical Staphylococcus aureus Small Colony Variants to beta-Lactam and Non-ss-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02532.
    PubMed     Abstract available


  797. WANG Q, Pang Y, Jing W, Liu Y, et al
    Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02149.
    PubMed     Abstract available


  798. HUO F, Luo J, Shi J, Zong Z, et al
    Increasing Prevalence of Rifampicin-Resistant Mycobacterium tuberculosis is Associated with the Transmission of Strains Harboring Compensatory Mutations in China: A 10-year Comparative Analysis.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02303.
    PubMed     Abstract available


  799. ZHAO M, Lepak AJ, VanScoy B, Bader JC, et al
    In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02542.
    PubMed     Abstract available


  800. ADANI S, Bhowmick T, Weinstein MP, Narayanan N, et al
    Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting: Impact of Vancomycin MIC.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02512.
    PubMed     Abstract available


  801. PEYRUSSON F, Tulkens PM, Van Bambeke F
    Cellular pharmacokinetics and intracellular activity of gepotidacin against Staphylococcus aureus with different resistance phenotypes in models of cultured phagocytic cells.
    Antimicrob Agents Chemother. 2018 Jan 22. pii: AAC.02245.
    PubMed     Abstract available


  802. SUWUNNAKORN S, Wakabayashi H, Kordalewska M, Perlin DS, et al
    FKS2 and FKS3 genes of opportunistic human pathogen Candida albicans influence echinocandin susceptibility.
    Antimicrob Agents Chemother. 2018 Jan 22. pii: AAC.02299.
    PubMed     Abstract available


  803. CHACKO K, Sullivan M, Beckford C, Altman D, et al
    The genetic basis of emerging vancomycin, linezolid, and daptomycin heteroresistance in a case of persistent Enterococcus faecium bacteremia.
    Antimicrob Agents Chemother. 2018 Jan 16. pii: AAC.02007.
    PubMed     Abstract available


  804. ORTINES RV, Liu H, Cheng LI, Cohen TS, et al
    Neutralizing alpha-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02288.
    PubMed     Abstract available


  805. SHARMA C, Kumar R, Kumar N, Masih A, et al
    Investigation of multiple resistance mechanisms in voriconazole resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01928.
    PubMed     Abstract available


  806. GARNAUD C, Garcia-Oliver E, Wang Y, Maubon D, et al
    The Rim pathway mediates antifungal tolerance in Candida albicans through newly identified Rim101 transcriptional targets including Hsp90 and Ipt1.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01785.
    PubMed     Abstract available


  807. LONG N, Zeng L, Qiao S, Li L, et al
    Aspergillus fumigatus Afssn3-Afssn8 Pair Reverse regulates Azole Resistance by Conferring Extracellular Polysaccharide, Sphingolipid Pathway Intermediates and Efflux Pumps to Biofilm.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01978.
    PubMed     Abstract available


  808. YU SJ, Chang YL, Chen YL
    Deletion of ADA2 increases antifungal drug susceptibility and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01924.
    PubMed     Abstract available


  809. DIJKSTRA JA, van der Laan T, Akkerman OW, Bolhuis MS, et al
    In vitro drug susceptibility of Mycobacterium tuberculosis for amikacin, kanamycin and capreomycin.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01724.
    PubMed     Abstract available


  810. YU X, Zeng X, Shi W, Hu Y, et al
    The validation of Cycloserine efficacy in treatment of multidrug-resistant and extensively drug-resistant tuberculosis in Beijing, China.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01824.
    PubMed     Abstract available


  811. TOP J, Sinnige JC, Brouwer EC, Werner G, et al
    Identification of a novel genomic island associated with vanD-type vancomycin-resistance in six Dutch vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01793.
    PubMed     Abstract available


  812. HAGER CL, Larkin EL, Long L, Abidi FZ, et al
    In vitro and in vivo Evaluation of the Antifungal Activity of APX001A/APX001 Against Candida auris.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02319.
    PubMed     Abstract available


  813. BORDALLO-CARDONA MA, Marcos-Zambrano LJ, Sanchez-Carrillo C, de la Pedrosa EGG, et al
    Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01982.
    PubMed     Abstract available


  814. BHATTACHARYA S, Fries BC
    Enhanced Efflux Pump Activity in Old Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02227.
    PubMed     Abstract available


  815. VILCHEZE C, Kim J, Jacobs WR Jr
    Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line tuberculosis drugs isoniazid and rifampicin in mice.
    Antimicrob Agents Chemother. 2018 Jan 3. pii: AAC.02165.
    PubMed     Abstract available


  816. ALSULTAN A, Furin JJ, Du Bois J, van Brakel E, et al
    Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis".
    Antimicrob Agents Chemother. 2017;62.
    PubMed    


    December 2017
  817. SADER HS, Mendes RE, Duncan LR, Pfaller MA, et al
    Antimicrobial Activity of Dalbavancin Tested against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from United States Medical Centers.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.02397.
    PubMed     Abstract available


  818. DOMPREH A, Tang X, Zhou J, Yang H, et al
    Effect of genetic variation of NAT2 on isoniazid, SLCO1B1, and CES2 on rifampin pharmacokinetics in Ghanaian children with tuberculosis.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.02099.
    PubMed     Abstract available


  819. ELDESOUKY HE, Mayhoub A, Hazbun TR, Seleem MN, et al
    Reversal of azole resistance in Candida albicans by sulfa antibacterial drugs.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.00701.
    PubMed     Abstract available


  820. IKEH MAC, Fidel PL Jr, Noverr MC
    Prostaglandin E2 Receptor Antagonist with Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01920.
    PubMed     Abstract available


  821. JUMAH MTB, Vasoo S, Menon SR, De PP, et al
    Pharmacokinetic/pharmacodynamic (PK/PD) Determinants of Vancomycin Efficacy in Enterococcal Bacteremia.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01602.
    PubMed     Abstract available


  822. AUNG WW, Ei PW, Nyunt WW, Htwe MM, et al
    Pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Myanmar.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01984.
    PubMed     Abstract available


  823. DHINGRA S, Buckey JC, Cramer RA
    Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes.
    Antimicrob Agents Chemother. 2017 Dec 11. pii: AAC.01953.
    PubMed     Abstract available


  824. CARTER GP, Schultz MB, Baines SL, Goncalves da Silva A, et al
    Topical antibiotic use co-selects for the carriage of mobile genetic elements conferring resistance to unrelated antimicrobials in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Dec 11. pii: AAC.02000.
    PubMed     Abstract available


  825. SARATHY JP, Via LE, Weiner D, Blanc L, et al
    Extreme drug tolerance of Mycobacterium tuberculosis in caseum.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02266.
    PubMed     Abstract available


  826. CHEN Y, Mallick J, Maqnas A, Sun Y, et al
    Chemogenomic profiling of the fungal pathogen Candida albicans.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02365.
    PubMed     Abstract available


  827. HOGAN S, O'Gara JP, O'Neill E
    Novel treatment of Staphylococcus aureus device-related infections using fibrinolytic agents.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02008.
    PubMed     Abstract available


  828. LEE H, Ahn S, Hwang NY, Jeon K, et al
    Limited Effect of Later-generation Fluoroquinolones in the Treatment of Ofloxacin-resistant and Moxifloxacin-susceptible Multidrug-resistant Tuberculosis.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.01784.
    PubMed     Abstract available


    November 2017
  829. DESHPANDE D, Srivastava S, Bendet P, Martin KR, et al
    On the antibacterial and sterilizing effect of benzylpenicillin in tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.02232.
    PubMed     Abstract available


  830. CHANNABASAPPA S, Durgaiah M, Chikkamadaiah R, Kumar S, et al
    Efficacy of novel anti-staphylococcal ectolysin P128 in a rat model of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.01358.
    PubMed     Abstract available


  831. PATHIRANA RU, Friedman J, Norris HL, Salvatori O, et al
    Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.01872.
    PubMed     Abstract available


  832. BASAS J, Palau M, Ratia C, Luis Del Pozo J, et al
    High-dose daptomycin is effective as an antibiotic-lock therapy in a rabbit model of Staphylococcus epidermidis catheter-related infection.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.01777.
    PubMed     Abstract available


  833. ABBADI BL, Villela AD, Rodrigues-Junior VS, Subtil FT, et al
    Revisiting activation of and the mechanism of resistance to the compound IQG-607 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.02222.
    PubMed     Abstract available


  834. ZHENG X, Berti AD, McCrone S, Roch M, et al
    Combination antibiotic exposure selectively alters the development of vancomycin intermediate resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.02100.
    PubMed     Abstract available


  835. TRUONG J, Veillette JJ, Forland SC
    Outcomes of vancomycin plus a beta-lactam versus vancomycin only for the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01554.
    PubMed     Abstract available


  836. DENTI P, Garcia-Prats AJ, Draper HR, Wiesner L, et al
    Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01521.
    PubMed     Abstract available


  837. VAN DER LAAN LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, et al
    Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.00420.
    PubMed     Abstract available


  838. EL-HOSSARY EM, Forstner KU, Francois P, Baud D, et al
    A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-dependent Flavin Nitroreductase.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01510.
    PubMed     Abstract available


  839. HEYCKENDORF J, Andres S, Koser CU, Olaru ID, et al
    What is resistance? Impact of phenotypic versus molecular drug resistance testing on multi- and extensively drug-resistant tuberculosis therapy.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01550.
    PubMed     Abstract available


  840. CHANDRA J, Ghannoum MA
    CD101, a Novel Echinocandin Possesses Potent Anti-biofilm Activity Against Early and Mature Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01750.
    PubMed     Abstract available


  841. BELLEY A, Arhin FA, Moeck G
    Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an in vitro Pharmacokinetic/Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01873.
    PubMed     Abstract available


  842. GARDNER SG, Marshall DD, Daum RS, Powers R, et al
    Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01608.
    PubMed     Abstract available


    October 2017
  843. SUN Q, Xiao TY, Liu HC, Zhao XQ, et al
    Mutations within embCAB are associated with variable level of ethambutol resistance in Mycobacterium tuberculosis isolates from China.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01279.
    PubMed     Abstract available


  844. REFOS JM, Vonk AG, Ten Kate MT, Verbrugh HA, et al
    Chitinase induction prior to caspofungin treatment of experimental invasive aspergillosis in neutropenic rats does not enhance survival.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.00960.
    PubMed     Abstract available


  845. WILLBY MJ, Wijkander M, Havumaki J, Johnson K, et al
    Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO GenoscholarPZA-TB II as compared to conventional sequencing.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01871.
    PubMed     Abstract available


  846. ARGUDIN MA, Roisin S, Dodemont M, Nonhoff C, et al
    Mutations at the ribosomal S10 gene in clinical strains of Staphylococcus aureus with reduced susceptibility to tigecycline.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01852.
    PubMed     Abstract available


  847. BERUBE BJ, Parish T
    Combinations of respiratory chain inhibitors have enhanced bactericidal activity against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01677.
    PubMed     Abstract available


  848. GENESTET C, Ader F, Pichat C, Lina G, et al
    Combined Antibacterial Effect of Isoniazid and Rifampicin on Four Mycobacterium tuberculosis Strains: in Vitro Experiments and Response-Surface Modeling.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01413.
    PubMed     Abstract available


  849. SAPUTO S, Faustoferri RC, Quivey RG Jr
    Vitamin D compounds are bactericidal against Streptococcus mutans and target the bacitracin-associated efflux system.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01675.
    PubMed     Abstract available


  850. HOLTAPPELS M, Swinnen E, De Groef L, Wuyts J, et al
    The antifungal activity of oleylphosphocholine (OlPC) on in vitro and in vivo Candida albicans biofilms.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01767.
    PubMed     Abstract available


  851. SAPUTO S, Faustoferri RC, Quivey RG Jr
    A drug repositioning approach reveals Streptococcus mutans is susceptible to a diverse range of established antimicrobials and non-antibiotics.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01674.
    PubMed     Abstract available


  852. ACCOCEBERRY I, Rougeron A, Biteau N, Chevrel P, et al
    A CTG clade Candida yeast genetically engineered for the genotype-phenotype characterization of azole antifungal resistance in human pathogenic yeasts.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01483.
    PubMed     Abstract available


  853. BHARDWAJ P, Hans A, Ruikar K, Guan Z, et al
    Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant Enterococcus faecium after serial chlorhexidine exposure.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01235.
    PubMed     Abstract available


  854. JONES D, Elshaboury RH, Munson E, Dilworth TJ, et al
    A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable mecA by a Commercial PCR Assay Compared to Patients with Methicillin-resistant Sta
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01396.
    PubMed     Abstract available


  855. XU J, Tasneen R, Peloquin CA, Almeida DV, et al
    Verapamil increases the bioavailability and efficacy of bedaquiline but not clofazimine in a murine model of tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01692.
    PubMed     Abstract available


  856. RAFFETIN A, Courbin V, Jullien V, Dannaoui E, et al
    In vitro combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01382.
    PubMed     Abstract available


  857. DE WELZEN L, Eldholm V, Maharaj K, Manson AL, et al
    Whole transcriptome and genomic analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01461.
    PubMed     Abstract available


  858. MOUSAVI SF, Pana M, Feizabadi M, Jalali P, et al
    Diversity of mosaic pbp2x families of penicillin-resistant Streptococcus pneumoniae from Iran and Romania.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01535.
    PubMed     Abstract available


  859. NAKATANI Y, Opel-Reading HK, Merker M, Machado D, et al
    Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01575.
    PubMed     Abstract available


  860. HEALEY KR, Nagasaki Y, Zimmerman M, Kordalewska M, et al
    The gastrointestinal tract is a major source of echinocandin drug resistance in a murine model of Candida glabrata colonization and systemic dissemination.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01412.
    PubMed     Abstract available


    September 2017
  861. LIU BH, Lei CW, Zhang AY, Pan Y, et al
    Co-location of the multiresistance gene cfr and the fosfomycin resistance gene fosD on a novel plasmid in Staphylococcus arlettae from chicken farm.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01388.
    PubMed     Abstract available


  862. BUIL JB, van der Lee HAL, Rijs AJMM, Zoll J, et al
    AGAR-BASED SCREENING FOR AZOLE RESISTANCE IN ASPERGILLUS FUMIGATUS USING VIPcheck: A SINGLE CENTRE EVALUATION.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01250.
    PubMed     Abstract available


  863. DESAI AV, Kovanda LL, Hope WW, Andes D, et al
    Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01034.
    PubMed     Abstract available


  864. JIMENEZ-ORTIGOSA C, Moore C, Denning DW, Perlin DS, et al
    Emergence of Echinocandin Resistance due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01277.
    PubMed     Abstract available


  865. XU W, DeJesus MA, Rucker N, Engelhart CA, et al
    Chemical genomic interaction profiling reveals determinants of intrinsic antibiotic resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01334.
    PubMed     Abstract available


  866. BERNAL-MARTINEZ L, Gil H, Rivero-Menendez O, Gago S, et al
    Development and validation of a High Resolution Melting Assay to detect azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01083.
    PubMed     Abstract available


  867. KIDWAI S, Park CY, Mawatwal S, Tiwari P, et al
    The dual mechanism of action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00969.
    PubMed     Abstract available


  868. PARK YN, Srikantha T, Daniels KJ, Jacob MR, et al
    A Protocol For Identifying Natural Agents That Selectively Affect Adhesion, Thickness, Architecture, Cellular Phenotypes, ECM and Human White Cell Impenetrability of Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01319.
    PubMed     Abstract available


  869. KONG EF, Tsui C, Kucharikova S, Van Dijck P, et al
    Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01573.
    PubMed     Abstract available


  870. METCALFE JZ, Streicher E, Theron G, Colman RE, et al
    Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00888.
    PubMed     Abstract available


  871. NEGRI CE, Goncalves SS, Sousa ACP, Bergamasco MD, et al
    Triazole resistance is still not emerging in A fumigatus isolates causing invasive aspergillosis in Brazilian patients.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00608.
    PubMed     Abstract available


    August 2017
  872. VALENTINE-KING MA, Brown MB
    Antibacterial Resistance in Ureaplasma species and Mycoplasma hominis Isolates from Urine Cultures in College-aged Females.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01104.
    PubMed     Abstract available


    July 2017
  873. YAMADA K, Saito R, Muto S, Kashiwa M, et al
    Molecular characterization of fluoroquinolone-resistant Moraxella catarrhalis variants generated in vitro by stepwise selection.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.01336.
    PubMed     Abstract available


  874. CHOI H, Kim SY, Kim DH, Huh HJ, et al
    Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-resistant Mycobacterium abscessus Lung Disease.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.01146.
    PubMed     Abstract available


  875. CHHIBBER S, Shukla A, Kaur S
    Transfersomal phage cocktail: an effective treatment against methicillin resistant S.aureus (MRSA) mediated Skin and Soft tissue infections (SSTIs).
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.02146.
    PubMed     Abstract available


  876. GALLAGHER LA, Coughlan S, Black NS, Lalor P, et al
    Tandem amplification of SCCmec can drive high level methicillin resistance in MRSA.
    Antimicrob Agents Chemother. 2017 Jul 17. pii: AAC.00869.
    PubMed     Abstract available


  877. HEINE HS, Shadomy SV, Boyer AE, Chuvala L, et al
    Evaluation of Combination Drug Therapy for Treatment of Antibiotic Resistant Inhalation Anthrax in a Murine Model.
    Antimicrob Agents Chemother. 2017 Jul 10. pii: AAC.00788.
    PubMed     Abstract available


  878. HENNEBIQUE A, Bidart M, Jarraud S, Beraud L, et al
    Digital PCR for detection and quantification of fluoroquinolone resistance in Legionella pneumophila.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.00628.
    PubMed     Abstract available


    June 2017
  879. MATSUMOTO S, Singley CM, Hoover J, Nakamura R, et al
    Efficacy of Cefiderocol against Carbapenem-resistant Gram-negative bacilli in Immunocompetent Rat Respiratory Tract Infection Models Recreating Human Plasma pharmacokinetics.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00700.
    PubMed     Abstract available


  880. TODD DA, Parlet CP, Crosby HA, Malone CL, et al
    Targeting quorum sensing signal biosynthesis to fight antibiotic resistant infections: Ambuic acid as a model inhibitor.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00263.
    PubMed     Abstract available


    May 2017
  881. LODISE T, Ye MJ, Zhao Q
    Prevalence of Invasive Infections due to Carbapenem-Resistant Enterobacteriaceae Among Adult Patients Across US Hospitals.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00228.
    PubMed     Abstract available


  882. KUNKEL A, Lewnard JA, Pitzer VE, Cohen T, et al
    Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers.
    Antimicrob Agents Chemother. 2017 May 22. pii: AAC.00026.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: